#1.2
672	20
Name	Description	BT084	ICB1299	ICB1487	ICB1572	ICB984	MB002	MB009	MED1712	MED1911	MED211	MED2312	MED411	RCMB18	RCMB20	RCMB24	RCMB28	RCMB32	RCMB38	RCMB40	DMB006
tl-2-105	Not Clinically Relevant	0.6459999999999999	0.637	0.6629999999999999	0.5479999999999999	-0.624	0.574	0.628	-0.633	0.626	0.624	0.653	0.594	0.614	0.569	0.5529999999999999	0.63	0.61	0.639	0.6679999999999999	0.687
sb52334	Not Clinically Relevant	0.622	0.64	0.6629999999999999	0.562	0.5720000000000001	0.594	0.635	0.534	0.625	0.612	0.631	0.607	0.597	0.617	0.5489999999999999	0.635	0.584	0.623	0.6579999999999999	0.6629999999999999
gsk1070916	Not Clinically Relevant	0.606	0.652	0.6659999999999999	0.626	0.618	0.616	0.664	0.593	0.6459999999999999	0.614	0.645	0.632	0.617	0.644	0.631	0.6609999999999999	0.601	0.633	0.645	0.63
ql-xii-61	Not Clinically Relevant	0.594	0.605	-0.58	0.57	-0.594	0.593	0.61	-0.545	0.623	0.599	0.561	0.593	-0.588	0.5920000000000001	0.5760000000000001	0.593	-0.57	-0.602	0.619	-0.593
linsitinib	IGF-1R inhibitor	0.552	0.5720000000000001	0.561	0.527	0.528	0.522	0.5920000000000001	0.52	0.563	0.562	0.547	0.555	0.523	0.5379999999999999	0.507	0.552	0.5379999999999999	0.542	0.5820000000000001	0.584
gw-2580	Not Clinically Relevant	0.552	0.546	0.5820000000000001	0.5479999999999999	0.619	0.512	0.613	0.598	0.51	0.527	0.584	0.535	0.579	0.49	0.597	0.5529999999999999	0.5720000000000001	0.647	0.556	0.62
gsk429286a	Not Clinically Relevant	0.5479999999999999	0.5720000000000001	0.607	0.556	-0.5539999999999999	0.593	0.594	-0.503	0.603	-0.5870000000000001	0.5670000000000001	0.583	0.541	0.5529999999999999	0.541	0.59	0.546	0.5870000000000001	0.632	-0.608
tubastatin a	Not Clinically Relevant	0.536	0.525	0.536	0.52	-0.087	0.54	0.542	-0.07400000000000001	0.55	0.524	0.528	0.528	0.512	0.509	0.486	0.546	0.53	0.523	0.5379999999999999	0.536
bx-912	Not Clinically Relevant	0.535	0.5489999999999999	0.551	0.505	-0.5	0.505	0.5529999999999999	0.47100000000000003	0.541	0.51	0.556	0.5489999999999999	0.509	0.546	0.505	0.55	0.506	0.519	0.5579999999999999	0.539
vx-702	Not Clinically Relevant	0.531	0.578	0.555	0.552	0.536	0.5660000000000001	0.583	0.509	0.574	0.522	0.539	0.607	0.516	0.562	0.503	0.504	0.521	0.522	0.5660000000000001	0.5710000000000001
rucaparib	PARP inhibitor, inhibits DNA repair	0.519	0.506	0.515	0.456	0.486	-0.45899999999999996	-0.489	0.486	0.503	0.48200000000000004	0.519	0.528	0.491	-0.462	0.47200000000000003	0.499	0.504	0.505	0.521	0.498
navitoclax	Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w	0.509	0.495	0.504	0.48700000000000004	0.48	0.47200000000000003	0.511	0.46799999999999997	0.523	0.489	0.496	0.495	0.478	0.48200000000000004	0.47700000000000004	0.505	0.46299999999999997	0.5	0.521	0.512
xmd14-99	Not Clinically Relevant	0.48100000000000004	0.48700000000000004	0.525	-0.49200000000000005	-0.496	0.47200000000000003	0.539	-0.47600000000000003	0.499	-0.47200000000000003	0.527	0.47	-0.47700000000000004	0.467	0.495	0.527	-0.451	-0.498	0.508	-0.527
axitinib	VEGFR,c-KITandPDGFR inhibitor	0.47100000000000003	0.47	-0.077	0.474	-0.062	0.43200000000000005	0.483	-0.099	0.473	0.456	0.449	0.462	0.442	0.462	0.41	0.47	0.457	-0.079	0.457	0.46
hg-5-88-01	Not Clinically Relevant	0.466	0.499	0.462	0.439	0.456	0.478	0.498	0.376	0.467	0.426	0.45	0.47200000000000003	0.434	0.47200000000000003	0.39299999999999996	0.47600000000000003	-0.441	-0.43700000000000006	0.499	-0.46799999999999997
amuvatinib	Not Clinically Relevant	0.455	0.489	0.494	0.461	0.44	0.449	0.504	0.41200000000000003	0.5	0.47200000000000003	0.47100000000000003	0.495	0.457	0.47200000000000003	0.44	0.5	0.455	0.493	0.502	0.507
xmd13-2	Not Clinically Relevant	0.45	0.466	0.47100000000000003	0.444	-0.461	0.449	0.499	0.406	0.45899999999999996	0.451	0.465	0.462	0.425	0.465	0.433	0.49700000000000005	0.435	0.47	0.49	0.456
indisulam	carbonic anhydrase inibitor and  CDK inhibitor, targets G1 by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2	0.43700000000000006	0.433	0.396	0.37799999999999995	0.42	0.425	0.428	0.364	0.41100000000000003	0.45799999999999996	0.38299999999999995	0.45899999999999996	0.37799999999999995	0.415	0.345	0.442	0.396	0.37799999999999995	0.45799999999999996	0.42700000000000005
nsc-87877	Not Clinically Relevant	0.434	0.43	0.455	-0.413	0.41200000000000003	-0.43200000000000005	-0.452	0.439	-0.428	-0.41200000000000003	-0.45799999999999996	-0.46	-0.43799999999999994	-0.441	-0.44299999999999995	-0.457	0.465	-0.45	-0.478	0.47100000000000003
cil55	Not Clinically Relevant	0.43200000000000005	0.41200000000000003	0.402	0.38	0.386	-0.428	0.42	0.374	0.452	0.424	0.384	0.401	0.374	0.392	0.376	0.41600000000000004	0.37799999999999995	0.41100000000000003	0.395	0.418
16-beta-bromoandrosterone	Not Clinically Relevant	0.43	0.38299999999999995	0.38	0.35600000000000004	0.41	0.395	0.369	-0.35200000000000004	0.39299999999999996	0.42700000000000005	0.363	0.39299999999999996	0.40299999999999997	0.373	0.365	0.39899999999999997	0.359	0.363	0.40399999999999997	0.418
staurosporine	Not Clinically Relevant	0.426	0.445	0.408	0.385	0.465	0.46	0.413	0.44	0.419	0.42200000000000004	0.397	0.451	0.409	0.447	0.414	0.429	0.434	0.41200000000000003	0.425	0.364
bms-195614	Not Clinically Relevant	0.423	0.43200000000000005	0.368	0.40399999999999997	0.413	0.391	0.41600000000000004	0.386	0.413	0.433	0.39399999999999996	0.424	0.42200000000000004	0.423	0.405	0.418	0.418	0.39399999999999996	0.418	0.429
brd-k26531177	Not Clinically Relevant	0.42100000000000004	0.43700000000000006	0.39399999999999996	0.385	0.392	0.414	0.40299999999999997	0.365	0.414	0.439	0.40299999999999997	0.428	0.387	0.409	0.37	0.41	0.392	0.38299999999999995	0.46	0.42100000000000004
brd-k99006945	Not Clinically Relevant	0.42100000000000004	0.445	0.43700000000000006	0.396	0.40299999999999997	-0.37	0.42700000000000005	0.41700000000000004	0.425	-0.42700000000000005	0.429	-0.38	0.405	0.387	0.41700000000000004	0.363	0.389	0.40399999999999997	0.43200000000000005	0.441
olaparib	PARP Inhibitor	0.418	0.415	0.39899999999999997	-0.02	0.413	0.013999999999999999	-0.008	0.384	0.41200000000000003	0.027999999999999997	0.39899999999999997	0.418	0.40399999999999997	0.002	0.37200000000000005	-0.021	0.38799999999999996	-0.031	0.434	-0.013999999999999999
ispinesib mesylate	Not Clinically Relevant	0.41700000000000004	0.451	0.452	0.40299999999999997	-0.424	0.44	0.462	-0.42200000000000004	0.435	0.405	0.424	0.46	0.386	0.45899999999999996	0.392	0.47100000000000003	0.41100000000000003	-0.41700000000000004	0.46299999999999997	-0.43799999999999994
ml203	Not Clinically Relevant	0.41700000000000004	0.381	0.36700000000000005	0.369	0.42	0.38	0.379	0.364	0.377	0.418	0.327	0.386	0.39	0.358	0.359	0.40299999999999997	0.377	0.365	0.37799999999999995	0.409
abt-737	Bcl-2/Bcl-xL inhibitor	0.415	0.43	0.41	0.395	0.41200000000000003	0.391	0.42200000000000004	0.37200000000000005	0.408	0.45299999999999996	0.384	0.435	0.397	0.408	0.386	0.428	0.39799999999999996	0.429	0.457	0.444
brd-k51490254	Not Clinically Relevant	0.414	0.424	0.373	0.401	0.391	0.396	0.442	0.36	0.424	0.42100000000000004	0.359	0.413	0.39899999999999997	0.42	0.35200000000000004	0.408	0.37	0.374	0.424	0.439
gsk319347a	Not Clinically Relevant	0.41200000000000003	0.446	0.43799999999999994	0.41100000000000003	0.455	-0.42200000000000004	0.46299999999999997	0.445	0.46799999999999997	0.48700000000000004	0.439	0.457	0.429	0.44799999999999995	0.38799999999999996	0.45399999999999996	0.469	0.449	0.451	0.48100000000000004
brd-k28456706	Not Clinically Relevant	0.41200000000000003	0.41200000000000003	0.4	0.37200000000000005	0.426	0.397	0.418	0.385	0.387	0.439	0.392	0.43200000000000005	0.401	0.368	0.38799999999999996	0.39399999999999996	0.384	0.414	0.434	0.426
ml239	Not Clinically Relevant	0.41200000000000003	0.442	0.428	0.36	0.425	0.401	0.424	0.376	0.397	0.428	0.392	0.431	0.366	0.40700000000000003	0.37	0.39899999999999997	0.39299999999999996	0.41	0.428	0.445
chlorambucil	alkylates and cross-links DNA,interfering with DNA replication and damaging the DNA	0.408	0.408	0.385	0.366	0.4	0.413	0.424	0.36700000000000005	0.39899999999999997	0.42200000000000004	0.40299999999999997	0.433	0.39399999999999996	0.426	0.373	0.41600000000000004	0.405	0.38299999999999995	0.431	0.414
skepinone-l	Not Clinically Relevant	0.40299999999999997	0.42700000000000005	0.375	0.40299999999999997	0.402	0.41200000000000003	0.43	0.374	0.408	0.43700000000000006	0.39299999999999996	0.419	0.384	0.38799999999999996	-0.37	0.384	0.396	0.368	0.46	0.426
xl765	PI3K/mTOR inhibitor	0.401	0.38799999999999996	0.39299999999999996	0.39299999999999996	0.39399999999999996	0.405	0.40299999999999997	0.379	0.39	0.42700000000000005	0.38299999999999995	0.418	0.389	0.386	0.408	0.414	0.381	0.395	0.413	0.431
ml050	Not Clinically Relevant	0.401	0.395	0.389	0.385	0.387	0.41	0.41	0.35	0.405	0.402	0.374	0.418	0.35200000000000004	0.396	0.368	0.41	0.375	0.374	0.413	0.413
abt-199	Bcl2 inhibitor	0.4	0.354	0.345	0.35100000000000003	0.363	0.35	0.365	0.327	0.374	0.377	0.34700000000000003	0.353	0.36700000000000005	0.325	0.353	0.365	0.355	0.365	0.373	0.397
sotrastaurin	pan-PKCinhibitor	0.4	0.43	0.401	0.42200000000000004	0.40299999999999997	0.409	0.41600000000000004	-0.374	0.44299999999999995	0.434	0.39899999999999997	0.45399999999999996	-0.369	0.37799999999999995	-0.369	0.39899999999999997	-0.38799999999999996	0.392	0.423	0.41700000000000004
brd-k13999467	Not Clinically Relevant	0.39899999999999997	0.385	0.35	0.364	0.402	0.371	0.386	0.382	0.406	0.406	0.374	0.396	0.38799999999999996	0.366	0.358	0.391	0.373	0.353	0.39	0.392
barasertib	highly selectiveAurora Bkinase inhibitor	0.39899999999999997	0.44299999999999995	0.382	0.39299999999999996	0.434	0.418	0.424	0.37	0.43	0.457	0.382	0.46399999999999997	0.373	0.431	0.34	0.408	0.379	0.353	0.45799999999999996	0.431
tipifarnib-p1	Not Clinically Relevant	0.39899999999999997	0.406	0.374	0.364	0.389	0.4	0.40299999999999997	0.34700000000000003	0.4	0.40399999999999997	0.349	0.414	0.358	0.365	0.37200000000000005	0.401	0.345	0.371	0.402	0.39
talazoparib	Not Clinically Relevant	0.397	0.44	0.414	0.361	0.39299999999999996	0.36700000000000005	0.408	0.4	0.418	-0.38299999999999995	0.409	0.409	0.40299999999999997	0.38	0.382	0.41200000000000003	0.419	0.40399999999999997	0.41700000000000004	0.387
prima-1-met	Not Clinically Relevant	0.396	0.37	0.377	0.35	0.389	0.382	0.386	0.406	0.414	0.39799999999999996	0.397	0.387	0.369	0.37	0.387	0.402	0.40399999999999997	0.371	0.397	0.38299999999999995
avrainvillamide	Not Clinically Relevant	0.395	0.46	0.428	0.431	0.40399999999999997	0.41600000000000004	0.43700000000000006	0.385	0.444	0.456	0.41600000000000004	0.48	0.39	0.46	0.35	0.43700000000000006	0.425	0.40700000000000003	0.48	0.48200000000000004
cct036477	Not Clinically Relevant	0.39399999999999996	0.43700000000000006	0.409	0.408	0.389	0.387	0.442	0.377	0.433	0.431	0.429	0.43700000000000006	0.382	0.426	0.36700000000000005	0.41200000000000003	0.371	0.39399999999999996	0.44799999999999995	0.415
jw-55	Not Clinically Relevant	0.391	0.327	0.35	0.35	0.39399999999999996	0.363	0.37799999999999995	0.322	0.36700000000000005	0.33899999999999997	0.35	0.359	0.32899999999999996	0.371	0.33799999999999997	0.35700000000000004	0.382	0.34700000000000003	0.369	0.374
brd-k88742110	Not Clinically Relevant	0.39	0.42700000000000005	0.4	0.4	0.4	0.392	0.40700000000000003	0.35200000000000004	0.44	0.435	0.402	0.397	0.39399999999999996	0.4	0.368	0.391	0.36	0.402	0.4	0.439
compound 1541a	Not Clinically Relevant	0.389	0.39799999999999996	0.36	0.37	0.409	0.38	0.34700000000000003	0.325	0.377	0.405	0.37	0.365	0.35200000000000004	0.33799999999999997	0.332	0.36700000000000005	0.341	0.379	0.391	0.366
kin001-266	Not Clinically Relevant	0.38799999999999996	0.41100000000000003	-0.42	0.38799999999999996	-0.38299999999999995	0.391	0.39899999999999997	-0.35600000000000004	-0.396	-0.389	0.401	0.38799999999999996	-0.386	0.376	0.364	0.39799999999999996	-0.37799999999999995	-0.41600000000000004	0.41200000000000003	-0.424
foretinib	c-Met/VEGFR2 inhibitor	0.386	0.39	0.35600000000000004	0.35700000000000004	0.375	0.364	0.408	0.34299999999999997	0.373	0.405	0.369	0.39899999999999997	0.326	0.366	0.33899999999999997	0.391	0.35200000000000004	0.34299999999999997	0.409	0.382
brd-k19103580	Not Clinically Relevant	0.384	-0.33	-0.353	0.33	0.371	0.35200000000000004	-0.33899999999999997	-0.341	-0.35200000000000004	0.348	-0.342	0.366	-0.359	0.34700000000000003	0.355	0.363	-0.322	-0.35	0.35700000000000004	-0.36200000000000004
sb-505124	Not Clinically Relevant	0.384	0.43200000000000005	0.445	0.425	-0.37799999999999995	0.418	0.435	0.384	0.415	0.43	0.397	0.439	-0.39899999999999997	0.44	0.389	0.43200000000000005	0.409	0.424	0.43200000000000005	0.433
compound 7d-cis	Not Clinically Relevant	0.384	0.397	0.377	0.414	0.39299999999999996	0.382	0.397	0.341	0.41	0.42200000000000004	0.355	0.414	0.395	0.374	0.34299999999999997	0.381	0.34299999999999997	0.37200000000000005	0.424	0.418
iu1	Not Clinically Relevant	0.384	0.38299999999999995	0.368	0.391	0.39899999999999997	0.39799999999999996	0.382	0.35	0.385	0.414	0.379	0.42	0.363	0.39299999999999996	0.354	0.373	0.349	0.36200000000000004	0.414	0.389
brd-a71883111	Not Clinically Relevant	0.38299999999999995	0.39	0.375	0.371	0.435	0.38799999999999996	0.381	0.35100000000000003	0.39399999999999996	0.431	0.363	0.42700000000000005	0.374	0.368	0.354	0.43200000000000005	0.366	0.38299999999999995	0.40700000000000003	0.4
brd1835	Not Clinically Relevant	0.382	0.35200000000000004	0.35100000000000003	0.342	0.366	0.353	0.386	0.332	0.35700000000000004	0.377	0.327	0.37200000000000005	0.322	0.391	0.33299999999999996	0.371	0.349	0.344	0.376	0.36200000000000004
cytarabine hydrochloride	Not Clinically Relevant	0.381	0.375	0.324	0.326	0.377	0.33899999999999997	0.36	0.3	0.366	0.39899999999999997	0.348	0.382	0.35	0.33799999999999997	0.305	0.36200000000000004	0.311	0.332	0.38	0.344
epigallocatechin-3-monogallate	Not Clinically Relevant	0.381	0.395	0.375	0.363	0.38	0.39399999999999996	0.39399999999999996	0.321	0.377	0.41100000000000003	0.358	0.402	0.33299999999999996	0.38	0.353	0.414	0.36200000000000004	0.35200000000000004	0.41600000000000004	0.41100000000000003
brd-m00053801	Not Clinically Relevant	0.38	0.401	0.39299999999999996	0.379	0.368	0.37200000000000005	0.38799999999999996	0.371	0.39299999999999996	0.40399999999999997	0.389	0.405	0.401	0.354	0.377	0.40299999999999997	0.35200000000000004	0.365	0.41700000000000004	0.43200000000000005
nsc30930	Not Clinically Relevant	0.37799999999999995	0.358	0.377	0.32899999999999996	0.397	0.363	0.38	0.33	0.364	0.382	0.32899999999999996	0.37	0.345	0.369	0.327	0.355	0.327	0.35700000000000004	0.375	0.353
brd-k34485477	Not Clinically Relevant	0.37799999999999995	0.42200000000000004	0.425	0.389	0.424	0.376	0.406	0.40399999999999997	0.433	0.384	0.414	0.405	0.40700000000000003	0.39899999999999997	0.322	0.428	0.395	0.409	0.446	0.39799999999999996
compound 1b	Not Clinically Relevant	0.377	0.366	0.35700000000000004	0.354	0.405	0.39299999999999996	0.38299999999999995	0.355	0.368	-0.384	0.34700000000000003	-0.40299999999999997	0.371	0.384	0.35600000000000004	0.37200000000000005	0.35200000000000004	0.36700000000000005	-0.36700000000000005	0.37799999999999995
kw-2449	multi-kinase inhibitor, mostly forFlt3, modestly potent to FGFR1, Bcr-Abl and Aurora A;	0.376	0.395	0.32	0.331	0.36	0.33899999999999997	0.40299999999999997	0.318	0.35700000000000004	0.376	0.349	0.405	0.332	0.381	0.32	0.35700000000000004	0.34	0.31	0.408	0.37
elcpk	Not Clinically Relevant	0.375	0.35200000000000004	0.341	0.317	0.345	0.33399999999999996	0.363	0.316	0.386	0.364	0.379	0.366	0.37	0.32299999999999995	0.32799999999999996	0.342	0.34299999999999997	0.326	0.36200000000000004	0.35200000000000004
sr1001	Not Clinically Relevant	0.375	0.363	0.348	0.374	0.369	0.368	0.389	0.34299999999999997	0.369	0.39	0.363	0.406	0.361	0.39399999999999996	0.364	0.365	0.355	0.359	0.386	-0.389
lenvatinib	VEGFR inhibitor (VEGFR1,VEGFR2andVEGFR3)	0.374	0.379	0.34299999999999997	0.331	0.365	0.363	0.377	0.342	0.359	0.371	0.348	0.349	0.349	0.344	0.358	0.369	0.344	0.314	0.38299999999999995	0.385
necrostatin-7	Not Clinically Relevant	0.374	0.381	0.348	0.34	0.37799999999999995	0.35200000000000004	0.37200000000000005	0.319	0.36	0.37	0.34299999999999997	0.395	0.35	0.363	0.33399999999999996	0.37	0.33799999999999997	0.354	0.379	0.363
968	Not Clinically Relevant	0.373	0.35600000000000004	0.35	0.35100000000000003	0.349	0.36200000000000004	0.331	0.348	0.36	0.37	0.384	0.311	0.391	0.301	0.318	0.33299999999999996	0.348	0.335	0.35100000000000003	0.33399999999999996
alisertib	Aurora A kinase inhibitor	0.373	0.415	0.33799999999999997	0.336	0.371	0.38299999999999995	0.377	0.307	0.368	0.41600000000000004	0.361	0.419	0.34700000000000003	0.38	0.282	0.37799999999999995	0.344	0.314	0.4	0.37
sildenafil	Viagra, used to treat erectile dysfunction and pulmonary arterial hypertension	0.37200000000000005	0.315	0.295	0.317	0.33	0.295	0.32799999999999996	0.3	0.32799999999999996	0.331	0.314	0.33299999999999996	0.326	0.32899999999999996	0.302	0.33799999999999997	0.314	0.292	0.33799999999999997	0.33899999999999997
rg-108	Not Clinically Relevant	0.371	0.386	0.361	0.359	0.39399999999999996	0.382	0.385	0.336	0.371	0.40299999999999997	0.36700000000000005	0.4	0.364	0.365	0.31	0.368	0.35100000000000003	0.33299999999999996	0.405	0.39799999999999996
bms-270394	Not Clinically Relevant	0.371	0.375	0.365	0.332	0.396	0.37	0.401	0.34299999999999997	0.374	0.40299999999999997	0.35	0.386	0.335	0.355	0.34	0.40299999999999997	0.355	0.36700000000000005	0.37799999999999995	0.386
isoliquiritigenin	Not Clinically Relevant	0.371	0.40399999999999997	0.382	0.348	0.38299999999999995	0.39299999999999996	0.397	0.33399999999999996	0.445	0.401	0.36200000000000004	0.37	0.345	0.41600000000000004	0.39	0.38799999999999996	0.392	0.379	0.38	0.385
tacrolimus	FK-506, immunosuppressive drug usedafter allogeneic organ transplant	0.37	0.379	0.363	0.377	0.396	0.38	0.39	0.34600000000000003	0.379	0.413	0.35600000000000004	0.415	0.361	0.37799999999999995	0.348	0.413	0.374	0.355	0.41100000000000003	0.395
ac55649	Not Clinically Relevant	0.37	0.35600000000000004	0.336	0.315	0.373	0.344	0.379	0.33899999999999997	0.37200000000000005	0.395	0.32799999999999996	0.37799999999999995	0.34600000000000003	0.361	0.313	0.364	0.34299999999999997	0.32	0.384	0.35
pdmp	Not Clinically Relevant	0.36700000000000005	0.34700000000000003	0.325	0.312	0.342	0.348	0.32799999999999996	0.309	0.341	0.361	0.336	0.364	0.321	0.341	0.33	0.35700000000000004	0.299	0.31	0.34600000000000003	0.336
unc1215	Not Clinically Relevant	0.36700000000000005	-0.36700000000000005	0.4	-0.373	0.38799999999999996	-0.36200000000000004	-0.4	0.353	0.397	0.371	-0.38	0.35600000000000004	-0.37200000000000005	-0.359	0.33299999999999996	-0.374	-0.35600000000000004	0.39	-0.389	0.379
nvp-adw742	Not Clinically Relevant	0.364	0.37	0.319	0.322	0.33799999999999997	0.365	0.358	0.28800000000000003	0.345	0.385	0.321	0.354	0.32	0.325	0.311	0.345	0.304	0.306	0.355	0.34700000000000003
mst-312	Not Clinically Relevant	0.364	0.35600000000000004	0.34	0.32899999999999996	0.33399999999999996	0.35600000000000004	0.38	0.318	0.36700000000000005	0.395	0.36700000000000005	0.374	0.337	0.316	0.311	0.35200000000000004	0.32299999999999995	0.32	0.376	0.341
darinaparsin	organic arsenic compound composed of dimethylated arsenic linked to glutathione	0.363	0.4	0.34	0.33899999999999997	0.355	0.337	0.33299999999999996	0.307	0.376	0.354	0.35200000000000004	0.316	0.353	0.33799999999999997	0.33	0.33299999999999996	0.355	0.34600000000000003	0.363	0.369
sb-225002	Not Clinically Relevant	0.36	0.368	0.318	0.29600000000000004	0.331	0.33	0.355	0.27899999999999997	0.32899999999999996	0.37	0.33299999999999996	0.365	0.32299999999999995	0.317	0.28300000000000003	0.353	0.309	0.299	0.377	0.35100000000000003
brd-k92856060	Not Clinically Relevant	0.35700000000000004	0.39299999999999996	0.34700000000000003	0.32799999999999996	0.348	0.371	0.37799999999999995	0.307	0.36200000000000004	0.389	0.37799999999999995	0.349	0.327	0.38	0.326	0.34700000000000003	0.32	0.33	0.382	0.37200000000000005
npk76-ii-72-1	Not Clinically Relevant	0.35700000000000004	0.369	0.375	0.322	0.397	0.37200000000000005	0.391	0.326	0.35600000000000004	0.35200000000000004	0.375	0.389	0.321	0.40299999999999997	0.366	0.396	0.336	0.336	0.38299999999999995	0.37200000000000005
ski-ii	Not Clinically Relevant	0.35600000000000004	0.35100000000000003	0.34600000000000003	0.337	0.33899999999999997	0.345	0.374	0.322	0.35600000000000004	0.373	0.34700000000000003	0.374	0.33399999999999996	0.354	0.31	0.35	0.32	0.342	0.369	0.33299999999999996
pf-4800567 hydrochloride	Not Clinically Relevant	0.35600000000000004	0.386	0.359	-0.387	0.369	0.38	0.387	-0.35700000000000004	-0.386	0.45	0.33799999999999997	0.42200000000000004	0.37200000000000005	0.374	-0.353	0.35700000000000004	0.32799999999999996	0.332	0.41600000000000004	0.382
brd-k24690302	Not Clinically Relevant	0.35600000000000004	0.376	0.35600000000000004	0.381	0.37799999999999995	0.348	0.396	0.345	0.40399999999999997	0.408	0.36700000000000005	0.368	0.373	0.369	0.321	0.387	0.349	0.354	0.371	0.396
bibr-1532	Not Clinically Relevant	0.35600000000000004	0.345	0.327	0.312	0.344	0.33899999999999997	0.368	0.308	0.33899999999999997	0.384	0.32899999999999996	0.379	0.33	0.327	0.319	0.349	0.316	0.318	0.37799999999999995	0.341
jw-74	Not Clinically Relevant	0.35600000000000004	0.391	0.349	0.35100000000000003	0.365	0.366	0.35100000000000003	0.348	0.376	0.39	0.315	0.414	0.335	0.38	0.335	0.358	0.37	0.349	0.39799999999999996	0.395
nsc 74859	Not Clinically Relevant	0.355	0.34299999999999997	0.327	0.322	0.348	0.327	0.33299999999999996	0.32799999999999996	0.35600000000000004	0.35200000000000004	0.312	0.368	0.319	0.363	0.33	0.349	0.327	0.316	0.36	0.35100000000000003
azd4547	FGFR-1,2 and 3 inhibitor	0.355	0.355	0.28800000000000003	0.324	0.28300000000000003	0.326	0.35700000000000004	0.315	0.318	0.353	0.325	0.33299999999999996	0.31	0.341	0.345	0.311	0.314	0.293	0.34	0.327
nsc23766	Not Clinically Relevant	0.354	0.354	0.345	0.36200000000000004	0.34	0.341	0.348	0.311	0.342	0.376	0.33899999999999997	0.384	0.32299999999999995	0.324	0.302	0.33799999999999997	0.33299999999999996	0.34700000000000003	0.381	0.39
lbh-589	HDAC inhibitor	0.354	0.36700000000000005	0.325	0.315	0.325	0.33899999999999997	0.33899999999999997	-0.293	0.321	0.368	0.306	0.34	0.322	0.317	-0.28800000000000003	0.335	0.305	0.303	0.344	0.345
cil41	Not Clinically Relevant	0.354	0.377	0.363	0.35	0.358	0.368	0.349	0.318	0.38299999999999995	0.41700000000000004	0.325	0.358	0.34299999999999997	0.375	0.35	0.361	0.373	0.342	0.364	0.35
sz4ta2	Not Clinically Relevant	0.354	0.392	0.359	0.379	0.35200000000000004	0.373	0.354	0.32899999999999996	0.373	0.401	0.344	0.363	0.321	0.35600000000000004	-0.301	0.376	0.35200000000000004	0.331	0.41	0.397
mgcd-265	inhibitor ofc-MetandVEGFR1/2/3, as well as Ron and Tie2	0.353	0.337	0.312	0.33799999999999997	0.36200000000000004	0.331	0.344	0.304	0.35100000000000003	0.368	0.325	0.361	0.32899999999999996	0.324	0.322	0.332	0.321	0.322	0.369	0.35200000000000004
brd-k02251932	Not Clinically Relevant	0.353	0.325	0.33299999999999996	-0.308	0.368	0.33899999999999997	0.37200000000000005	0.311	0.34600000000000003	0.353	0.301	0.349	0.325	0.368	0.311	0.348	0.298	0.33	0.36200000000000004	0.33
brd-k11533227	Not Clinically Relevant	0.35200000000000004	0.35600000000000004	0.348	0.34	0.35100000000000003	0.325	0.373	0.337	0.375	0.36700000000000005	0.342	0.35200000000000004	0.345	0.32299999999999995	0.322	0.35	0.317	0.341	0.364	0.368
omacetaxine mepesuccinate	natural product, proteintranslationinhibitor, used for myeloid leukemia	0.35100000000000003	0.355	0.355	0.35700000000000004	0.33799999999999997	0.35	0.381	0.308	0.335	0.373	0.317	0.364	0.324	0.33299999999999996	0.292	0.34700000000000003	0.305	0.312	0.366	0.368
repligen 136	Not Clinically Relevant	0.35100000000000003	0.373	0.36	0.37	0.35700000000000004	0.375	0.371	-0.35	0.36700000000000005	0.387	0.349	0.384	0.336	0.38	-0.365	0.379	-0.337	-0.374	0.368	0.373
gw-843682x	Not Clinically Relevant	0.35	0.34299999999999997	0.294	0.282	0.313	0.35200000000000004	0.29600000000000004	0.257	0.28600000000000003	0.35700000000000004	0.294	0.348	0.3	0.307	0.273	0.325	0.297	0.27399999999999997	0.34600000000000003	0.337
px-12	thioredoxin-1 (Trx-1)inhibitor	0.349	0.392	0.35100000000000003	0.319	0.359	0.33799999999999997	0.369	0.299	0.344	0.39399999999999996	0.321	0.379	0.327	0.355	0.309	0.35700000000000004	0.32299999999999995	0.33299999999999996	0.382	0.389
ly-2183240	Not Clinically Relevant	0.348	0.39	0.316	0.32899999999999996	0.33799999999999997	0.34600000000000003	0.386	0.282	0.358	0.39299999999999996	0.361	0.377	0.327	0.344	0.27	0.35100000000000003	0.307	0.304	0.397	0.354
brd-k75293299	Not Clinically Relevant	0.348	0.34	0.32	0.297	0.344	0.322	0.317	0.297	0.355	0.317	0.29	0.306	0.29	0.29100000000000004	0.32299999999999995	0.349	0.301	0.293	0.318	0.32299999999999995
fsc231	Not Clinically Relevant	0.34700000000000003	-0.315	0.29600000000000004	-0.28600000000000003	0.342	0.335	0.326	0.284	0.35200000000000004	0.332	0.33799999999999997	-0.32	0.349	0.282	0.299	0.331	-0.32799999999999996	0.309	0.302	0.298
sitagliptin	used for Treating type 2 diabetes, works by increasing the amount of insulin released by your body	0.34700000000000003	0.368	0.374	0.34700000000000003	0.39799999999999996	0.37799999999999995	0.33299999999999996	0.327	0.384	0.40299999999999997	0.344	0.35200000000000004	0.35200000000000004	0.348	0.345	0.392	0.34299999999999997	0.354	0.35700000000000004	0.325
apicidin	Not Clinically Relevant	0.34700000000000003	0.366	0.342	0.33399999999999996	0.354	0.359	0.361	0.298	0.341	0.375	0.321	0.36200000000000004	0.324	0.33	0.287	0.345	0.31	0.322	0.35600000000000004	0.349
tg-100-115	PI3K/inhibitor	0.34600000000000003	0.337	0.34600000000000003	0.33799999999999997	0.327	0.348	0.34299999999999997	0.331	0.345	0.361	0.319	0.34700000000000003	0.33	0.336	0.358	0.33299999999999996	0.33899999999999997	0.335	0.349	0.36
isox	Not Clinically Relevant	0.34600000000000003	0.35600000000000004	0.309	0.319	0.337	0.332	0.354	0.28	0.32899999999999996	0.36	0.32	0.364	0.311	0.32899999999999996	0.271	0.32899999999999996	0.293	0.298	0.366	0.32799999999999996
ceranib-2	Not Clinically Relevant	0.34600000000000003	0.387	0.326	0.337	0.335	0.355	0.361	0.298	0.34600000000000003	0.401	0.35600000000000004	0.379	0.349	0.33399999999999996	0.276	0.35700000000000004	0.319	0.297	0.401	0.348
brd6340	Not Clinically Relevant	0.345	0.34700000000000003	0.317	0.336	0.345	0.319	0.36200000000000004	0.303	0.33899999999999997	0.374	0.308	0.359	0.33399999999999996	0.332	-0.309	0.33799999999999997	0.322	0.321	0.376	0.364
mdivi-1	Not Clinically Relevant	0.345	0.37200000000000005	0.337	0.35100000000000003	0.34700000000000003	0.342	0.369	0.327	0.348	0.37200000000000005	0.34299999999999997	0.364	0.337	0.35200000000000004	0.337	0.345	0.349	0.32899999999999996	0.371	0.374
tacedinaline	Not Clinically Relevant	0.345	0.375	0.308	0.316	0.32899999999999996	0.317	0.353	0.297	0.326	0.34600000000000003	0.331	0.36700000000000005	0.303	0.33399999999999996	0.314	0.34299999999999997	0.32799999999999996	0.29600000000000004	0.361	0.373
fingolimod	sphingosine-1-phosphate receptor modulator, sequesters lymphocytes in lymph nodes, mostly used for treating multiple sclerosis	0.344	0.359	0.35600000000000004	0.35600000000000004	0.369	0.341	0.353	0.318	0.366	0.375	0.34600000000000003	0.366	0.355	0.317	0.319	0.363	0.32899999999999996	0.354	0.376	0.38799999999999996
brd-k42260513	Not Clinically Relevant	0.344	0.369	0.387	0.4	0.349	-0.376	0.384	0.355	0.373	0.39	0.36700000000000005	0.409	0.35100000000000003	0.377	0.332	0.355	0.35100000000000003	0.382	0.409	0.425
brd-k61166597	Not Clinically Relevant	0.344	0.332	0.313	0.327	0.359	0.33799999999999997	0.32799999999999996	-0.28800000000000003	0.31	0.344	0.29	0.363	0.309	0.327	-0.282	0.335	0.294	0.299	0.34299999999999997	0.341
azd1480	JAK2inhibitor with some activity against JAK3 and Tyk2	0.344	0.391	0.303	0.32899999999999996	0.332	0.33899999999999997	0.365	0.325	0.304	0.391	0.33899999999999997	0.35600000000000004	0.302	0.344	0.301	0.32799999999999996	0.336	0.295	0.39899999999999997	0.369
pf-184	Not Clinically Relevant	0.34299999999999997	0.348	0.301	0.317	0.32799999999999996	0.32	0.342	0.301	0.319	0.37799999999999995	0.322	0.365	0.317	0.306	0.305	0.335	0.327	0.29	0.35700000000000004	0.317
elocalcitol	vitamin D receptor agonist	0.34299999999999997	0.318	0.33299999999999996	0.314	0.332	0.36200000000000004	0.35600000000000004	0.316	0.342	0.37200000000000005	0.324	0.374	0.32	0.34	0.311	0.35100000000000003	0.321	0.33399999999999996	0.34	0.35200000000000004
brd-k29313308	Not Clinically Relevant	0.341	0.377	0.35600000000000004	0.35700000000000004	0.369	-0.36700000000000005	0.373	-0.32299999999999995	0.369	0.39299999999999996	0.33299999999999996	0.391	-0.336	0.371	-0.312	0.373	-0.363	0.345	0.39	0.39299999999999996
ki8751	Not Clinically Relevant	0.34	0.35100000000000003	0.314	0.3	0.34600000000000003	0.33299999999999996	0.35	0.29600000000000004	0.335	0.377	0.314	0.368	0.307	0.34299999999999997	0.293	0.35100000000000003	0.318	0.29600000000000004	0.369	0.35700000000000004
nsc95397	Not Clinically Relevant	0.34	0.337	0.315	0.314	0.327	0.308	0.319	0.284	0.321	0.35	0.294	0.33899999999999997	0.318	0.318	0.294	0.335	0.308	0.304	0.337	0.368
kpt185	Not Clinically Relevant	0.33899999999999997	0.359	0.336	0.32	0.325	0.353	0.36200000000000004	0.293	0.342	0.384	0.311	0.397	0.315	0.33799999999999997	0.267	0.365	0.315	0.303	0.40399999999999997	0.369
brd-k80183349	Not Clinically Relevant	0.33799999999999997	0.312	0.295	0.309	0.32799999999999996	0.305	0.332	0.276	0.322	0.35200000000000004	0.302	0.344	0.295	0.3	0.282	0.311	0.299	0.289	0.316	0.327
nsc19630	Not Clinically Relevant	0.33799999999999997	0.359	0.35100000000000003	0.32299999999999995	0.312	0.34	0.36	0.26899999999999996	0.32	0.363	0.29100000000000004	0.37200000000000005	0.306	0.325	0.31	0.349	0.32899999999999996	0.318	0.368	0.386
brd-k41597374	Not Clinically Relevant	0.337	0.322	-0.326	0.335	0.344	-0.36700000000000005	-0.325	-0.312	-0.326	0.344	-0.312	0.361	-0.325	0.326	-0.305	-0.358	-0.32799999999999996	-0.32799999999999996	0.35200000000000004	0.34
hc-067047	Not Clinically Relevant	0.336	0.3	0.324	0.298	0.337	0.344	0.325	0.297	0.317	0.361	0.29	0.35	0.306	0.325	0.29100000000000004	0.35700000000000004	0.28300000000000003	0.316	0.342	0.34299999999999997
brd-k44224150	Not Clinically Relevant	0.336	0.311	0.341	0.3	0.35	0.33899999999999997	0.324	0.311	0.322	0.335	0.305	0.318	0.326	0.315	0.295	0.33799999999999997	0.34700000000000003	0.33799999999999997	0.311	0.316
ml006	Not Clinically Relevant	0.336	0.324	0.316	0.321	0.325	0.317	0.33799999999999997	0.285	0.358	0.35100000000000003	0.293	0.359	0.31	0.33299999999999996	0.303	0.324	0.292	0.319	0.327	0.34700000000000003
at-406	Not Clinically Relevant	0.335	0.32	0.33899999999999997	0.317	0.313	0.349	0.33	0.31	0.324	0.326	0.312	0.332	0.311	0.306	0.308	0.303	0.326	0.309	0.33899999999999997	0.33899999999999997
compound 23 citrate	Not Clinically Relevant	0.335	0.34	0.336	0.31	0.33299999999999996	0.314	0.33299999999999996	0.27399999999999997	0.33899999999999997	0.348	0.326	0.35100000000000003	0.315	0.299	0.287	0.35100000000000003	0.282	0.32	0.358	0.33899999999999997
isoevodiamine	Not Clinically Relevant	0.33399999999999996	0.348	0.305	0.305	0.332	0.336	0.34299999999999997	0.28	0.324	0.369	0.322	0.354	0.315	0.313	0.284	0.335	0.315	0.297	0.36200000000000004	0.33
brd-k51831558	Not Clinically Relevant	0.33399999999999996	0.379	0.366	0.368	0.373	0.34	0.395	0.354	0.405	0.425	0.37200000000000005	0.4	0.34700000000000003	0.37	0.35100000000000003	0.344	0.37200000000000005	0.385	0.406	0.37200000000000005
bms-754807	Not Clinically Relevant	0.33299999999999996	0.358	0.314	0.299	0.306	0.304	0.37200000000000005	0.29600000000000004	0.34700000000000003	0.342	0.305	0.341	0.32	0.332	0.294	0.33399999999999996	0.316	0.304	0.35200000000000004	0.35
brd-k84807411	Not Clinically Relevant	0.33299999999999996	0.335	0.33399999999999996	0.34600000000000003	0.369	0.318	0.317	0.335	0.36200000000000004	0.337	0.37799999999999995	0.316	0.341	0.307	0.34700000000000003	0.371	0.34600000000000003	0.331	0.36	0.33899999999999997
lomeguatrib	Inhibitor of MGMT, a DNA repair protein that confers resistance to alkylating agents such as Temozolomide, DTIC, Carmustine, etc.	0.33299999999999996	0.317	0.32	0.304	0.34600000000000003	0.318	0.33399999999999996	-0.312	0.349	0.358	0.297	0.36200000000000004	0.32299999999999995	0.318	-0.309	0.34600000000000003	0.32799999999999996	0.319	0.33899999999999997	0.358
necrostatin-1	Not Clinically Relevant	0.33299999999999996	0.33	0.325	0.305	0.337	0.342	0.322	0.303	0.34299999999999997	0.353	0.311	0.348	0.319	0.33399999999999996	0.32299999999999995	0.33399999999999996	0.324	0.313	0.344	0.349
bendamustine	alkylating agent	0.332	0.34299999999999997	0.33399999999999996	0.294	0.353	0.368	0.32	0.313	0.341	0.355	0.302	0.32299999999999995	0.312	0.33299999999999996	0.304	0.327	0.316	0.319	0.337	0.34
brd-k02492147	Not Clinically Relevant	0.332	0.28300000000000003	0.305	0.27699999999999997	0.341	0.313	0.312	0.272	0.314	0.32799999999999996	0.28800000000000003	0.341	0.281	0.3	0.297	0.35600000000000004	0.27	0.293	0.325	0.33399999999999996
cisplatin	Not Clinically Relevant	0.332	0.354	0.35100000000000003	0.35100000000000003	0.316	0.32799999999999996	-0.366	0.353	0.38	-0.34600000000000003	0.35	0.35600000000000004	0.33399999999999996	0.341	0.318	0.358	0.355	-0.345	0.36700000000000005	-0.364
brd-k04800985	Not Clinically Relevant	0.331	-0.303	-0.301	-0.28300000000000003	0.315	-0.27699999999999997	0.32799999999999996	0.289	0.324	-0.32799999999999996	-0.303	0.318	-0.298	0.318	-0.297	-0.332	-0.287	-0.298	-0.315	0.326
hyperforin	Active ingredient in St. John's Wort, blocks reuptake of of serotonin, norepinephrine, dopamine and GABA	0.33	0.305	-0.299	0.294	-0.335	0.298	0.311	-0.292	0.32799999999999996	0.34	-0.284	0.336	0.293	0.31	0.29	0.314	-0.29	-0.318	0.33399999999999996	0.33299999999999996
jw-480	Not Clinically Relevant	0.33	0.311	0.315	0.28800000000000003	0.33799999999999997	0.34600000000000003	0.325	0.297	0.34	0.331	0.299	0.303	0.293	0.332	0.307	0.341	0.305	0.324	0.32899999999999996	0.33899999999999997
plx-4032	BRAF (V600E) inhibitor	0.33	0.314	0.33799999999999997	0.297	0.324	0.348	0.355	0.316	0.336	0.324	0.331	0.322	0.299	0.301	0.299	0.344	0.302	0.315	0.321	0.341
belinostat	HDAC inhibitor (PXD101)	0.33	0.34299999999999997	0.33399999999999996	0.307	0.348	0.33799999999999997	0.366	0.289	0.33299999999999996	0.332	0.33399999999999996	0.361	0.306	0.34700000000000003	0.284	0.34700000000000003	0.294	0.32299999999999995	0.355	0.349
triazolothiadiazine	Not Clinically Relevant	0.32899999999999996	0.363	0.297	0.285	0.317	0.32799999999999996	0.326	0.268	0.319	0.349	0.31	0.344	0.297	0.304	0.26	0.327	0.29	0.28300000000000003	0.349	0.318
fqi-1	Not Clinically Relevant	0.32799999999999996	0.28800000000000003	0.26	0.285	0.281	0.28300000000000003	0.28800000000000003	0.252	0.298	0.282	0.29600000000000004	0.306	0.311	0.251	0.261	0.268	0.245	0.264	0.308	0.307
etp-46464	Not Clinically Relevant	0.32799999999999996	0.33299999999999996	0.29	0.307	0.29	0.292	0.32299999999999995	0.271	0.327	0.327	0.27399999999999997	0.33399999999999996	0.263	0.289	0.254	0.3	0.266	0.265	0.32899999999999996	0.325
teniposide	Topo II inhibitor	0.32799999999999996	0.303	0.267	0.276	0.31	0.26899999999999996	0.316	0.249	0.31	0.316	0.302	0.309	0.316	0.337	0.297	0.272	0.284	0.257	0.313	0.302
qs-11	Not Clinically Relevant	0.32799999999999996	0.34700000000000003	0.319	0.344	0.318	0.32899999999999996	0.322	0.32	0.363	0.309	0.327	0.278	0.321	0.3	0.297	0.293	0.298	0.33799999999999997	0.309	0.348
brivanib	multitargetedtyrosine kinase inhibitor, esp VEGFR and FGFR	0.327	0.308	0.298	0.303	0.316	0.31	0.345	0.308	0.354	0.36	0.307	0.32299999999999995	0.32899999999999996	0.32799999999999996	0.307	0.313	0.294	0.28800000000000003	0.33299999999999996	0.32299999999999995
vorinostat	HDAC inhibitor (SAHA)	0.327	0.324	0.31	0.31	-0.006	0.342	0.353	-0.3	0.324	0.324	0.321	0.36200000000000004	0.31	0.34	0.29	0.34600000000000003	-0.008	0.29	0.345	0.311
lrrk2-in-1	Not Clinically Relevant	0.327	0.365	0.29	0.307	0.327	0.32	0.331	0.262	0.313	0.355	0.29600000000000004	0.363	0.26899999999999996	0.318	0.287	0.34299999999999997	0.29100000000000004	0.275	0.35600000000000004	0.33
parbendazole	Not Clinically Relevant	0.326	0.354	0.295	0.278	0.317	0.313	0.332	0.261	0.31	0.34299999999999997	0.307	0.354	0.297	0.289	0.255	0.314	0.27899999999999997	0.27399999999999997	0.355	0.298
mi-2	Not Clinically Relevant	0.326	0.331	0.297	0.342	0.294	0.303	0.298	-0.299	0.314	0.34600000000000003	0.295	0.3	0.33899999999999997	0.27	-0.301	0.28300000000000003	-0.282	0.305	0.327	0.326
brd8899	Not Clinically Relevant	0.325	0.301	0.303	0.327	0.332	0.32899999999999996	0.341	0.294	0.34299999999999997	0.35200000000000004	0.289	0.33399999999999996	0.317	0.336	0.292	0.319	0.312	0.315	0.321	0.322
pyr-41	Not Clinically Relevant	0.325	0.298	0.297	0.295	0.32799999999999996	0.327	0.315	0.27399999999999997	0.322	0.32799999999999996	0.293	0.31	0.308	0.308	0.29100000000000004	0.31	0.3	0.29	0.294	0.32799999999999996
su11274	Not Clinically Relevant	0.325	0.318	0.29	0.261	0.317	0.307	0.307	0.263	0.308	0.33299999999999996	0.28600000000000003	0.316	0.3	0.319	0.262	0.3	0.305	0.3	0.312	0.31
hg-5-113-01	Not Clinically Relevant	0.32299999999999995	0.332	0.33399999999999996	0.289	0.31	0.321	0.33899999999999997	0.262	0.342	0.311	0.331	0.35700000000000004	0.308	0.37	0.304	0.335	0.276	-0.303	0.345	-0.32899999999999996
ml162	Not Clinically Relevant	0.32299999999999995	0.35700000000000004	0.319	0.28600000000000003	0.336	0.32299999999999995	0.363	0.322	0.354	0.359	0.316	0.353	0.32799999999999996	0.314	0.298	0.335	0.32	0.322	0.371	0.353
sgx-523	Metinhibitor	0.32299999999999995	0.33	0.335	0.302	0.318	0.298	0.34600000000000003	0.306	0.33899999999999997	0.34	0.325	0.332	0.307	0.322	0.304	0.322	0.306	0.304	0.358	0.298
nsc48300	Not Clinically Relevant	0.322	0.358	0.311	0.313	0.319	0.322	0.349	0.29	0.35100000000000003	0.36	0.31	0.34600000000000003	0.32299999999999995	0.317	0.298	0.344	0.312	0.299	0.365	0.332
gossypol	Natural product, may function to inhibit Bcl2 family members	0.322	0.308	0.293	0.265	0.336	0.336	0.299	-0.265	0.28	0.34	0.263	0.303	0.294	0.285	0.258	0.306	0.268	0.28	0.306	0.289
erastin	Not Clinically Relevant	0.321	0.33399999999999996	0.287	0.303	0.308	0.312	0.326	0.289	0.33399999999999996	0.341	0.289	0.335	0.305	0.314	0.273	0.32299999999999995	0.298	0.271	0.336	0.311
mi-1	Not Clinically Relevant	0.321	-0.317	-0.281	-0.302	-0.299	-0.28300000000000003	-0.33899999999999997	-0.307	-0.344	-0.33299999999999996	-0.282	0.33299999999999996	-0.308	-0.317	0.3	0.309	-0.29100000000000004	-0.28300000000000003	-0.327	-0.319
yk 4-279	Not Clinically Relevant	0.321	0.33399999999999996	0.3	0.287	0.306	0.3	0.321	0.272	0.301	0.353	0.31	0.327	0.302	0.287	0.273	0.309	0.289	0.28	0.34	0.306
cyclophosphamide	alkylating agent, nitrogen mustardfamily, works by disrupting the duplication ofDNAand the creation ofRNA (Cytoxan)	0.32	0.301	0.281	0.28600000000000003	0.342	0.315	0.327	0.26	-0.33299999999999996	-0.298	-0.312	0.305	0.309	0.312	0.276	0.315	0.313	0.297	-0.3	0.308
gmx-1778	Not Clinically Relevant	0.32	0.38	0.345	0.307	0.32	0.358	0.35200000000000004	0.26899999999999996	0.33899999999999997	0.379	0.317	0.377	0.298	0.344	0.258	0.32899999999999996	0.295	0.32	0.359	0.377
byl-719	PI3Kinhibitor with minimal effect on PI3K//	0.32	0.304	0.29	0.307	0.293	0.313	0.289	0.27899999999999997	0.28800000000000003	0.335	-0.28300000000000003	0.33299999999999996	-0.27899999999999997	0.28600000000000003	-0.27699999999999997	0.32899999999999996	0.311	-0.275	0.316	0.327
pandacostat	Not Clinically Relevant	0.32	0.318	0.319	0.3	0.32	0.341	0.33	-0.278	0.301	0.35600000000000004	0.29	0.359	0.315	0.316	-0.278	0.33	0.298	0.317	0.32799999999999996	0.321
daporinad	inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells	0.32	0.33899999999999997	0.312	0.278	0.306	0.32799999999999996	0.336	0.26	0.322	0.309	0.322	0.33399999999999996	0.28300000000000003	0.342	0.276	0.326	0.27899999999999997	0.31	0.341	0.318
ku-0063794	Not Clinically Relevant	0.319	0.316	0.27699999999999997	0.316	0.297	0.326	0.322	0.271	0.309	0.359	0.27699999999999997	0.318	0.276	0.302	0.287	0.297	0.253	0.27899999999999997	0.318	0.304
tivantinib	Met inhibitor	0.319	0.365	0.317	0.305	0.319	0.33899999999999997	0.324	0.242	0.29600000000000004	0.377	0.301	0.363	0.272	0.312	0.21600000000000003	0.325	0.27	0.28	0.385	0.312
vincristine	binds tubulin, disrupts microtubule dynamics	0.319	0.341	0.287	0.26899999999999996	0.287	0.327	0.3	0.23399999999999999	0.293	0.33899999999999997	0.29	0.316	0.28	0.285	0.252	0.287	0.255	0.265	0.335	0.309
pifithrin-mu	Not Clinically Relevant	0.319	0.34	0.317	0.304	0.34	-0.335	0.34299999999999997	-0.28800000000000003	0.326	0.342	0.299	0.344	0.306	0.35200000000000004	-0.271	0.337	0.299	0.318	0.35700000000000004	0.342
brd-k86535717	Not Clinically Relevant	0.318	0.33399999999999996	0.32799999999999996	0.256	0.341	0.272	0.32799999999999996	0.27	-0.35100000000000003	0.318	0.287	0.302	0.264	0.321	0.294	0.35	0.27699999999999997	0.316	0.344	0.326
manumycin a	Not Clinically Relevant	0.318	0.317	0.299	0.317	0.302	0.324	0.322	0.26	0.298	0.34700000000000003	0.295	0.325	0.28800000000000003	0.32799999999999996	0.273	0.313	0.281	0.302	0.331	0.315
nintedanib	tyrosine-kinase inhibitor, targeting VEGFR,FGFR andPDGFR	0.318	0.306	0.267	0.245	0.293	0.319	0.32	0.263	0.287	0.322	0.272	0.32299999999999995	0.298	0.31	0.298	0.297	0.315	0.266	0.285	0.299
bix-01294	Not Clinically Relevant	0.317	0.345	0.309	0.293	0.32799999999999996	0.321	0.336	0.287	0.324	0.34	0.315	0.33399999999999996	0.29100000000000004	0.29600000000000004	0.273	0.33299999999999996	0.29600000000000004	0.29100000000000004	0.326	0.35200000000000004
brd-k85133207	Not Clinically Relevant	0.317	0.281	0.263	0.268	0.324	-0.295	0.313	-0.285	0.322	0.303	0.275	0.304	0.29600000000000004	0.276	0.27899999999999997	-0.307	0.275	0.284	0.29600000000000004	0.294
am-580	Not Clinically Relevant	0.317	0.321	0.314	0.27399999999999997	0.326	0.321	0.325	0.263	0.319	0.335	0.273	0.341	0.278	0.314	0.249	0.314	0.292	0.28800000000000003	0.336	0.326
ro4929097	Notch (gamma secretase) inhibitor	0.317	0.292	0.306	0.306	0.304	0.325	0.32299999999999995	0.273	0.326	0.349	0.284	0.331	0.254	0.297	0.294	0.304	0.281	0.284	0.315	0.336
decitabine	Nucleoside analog, inhibitor of DNA methylation and DNA synthesis (Dacogen)	0.317	0.332	0.28600000000000003	0.282	0.336	0.303	0.32899999999999996	-0.27699999999999997	0.315	0.34600000000000003	0.31	0.33799999999999997	0.297	0.299	-0.272	0.319	-0.305	-0.29600000000000004	0.33799999999999997	0.321
itraconazole	Anti-fungal, hedgehog antagonist	0.316	0.331	0.336	0.349	0.344	0.34299999999999997	0.37	0.307	0.368	0.368	0.32799999999999996	0.369	0.327	0.349	-0.317	0.364	0.326	0.33399999999999996	0.364	0.373
fqi-2	Not Clinically Relevant	0.316	0.325	0.27899999999999997	0.281	0.3	0.303	0.316	0.251	0.284	0.348	0.307	0.335	0.304	0.28	0.253	0.302	0.266	0.267	0.354	0.315
fgin-1-27	Not Clinically Relevant	0.316	0.34299999999999997	0.336	0.319	0.361	0.33899999999999997	0.306	0.308	0.353	0.374	0.28600000000000003	0.327	0.27899999999999997	0.308	0.31	0.34700000000000003	0.342	0.307	0.326	0.32899999999999996
vorapaxar	thrombinreceptor (protease-activated receptor, PAR-1)antagonist based on the natural product himbacine	0.315	0.287	0.295	0.307	0.301	0.327	0.308	0.28300000000000003	0.298	0.32799999999999996	0.292	0.325	0.301	0.289	0.285	0.299	0.27899999999999997	0.298	0.297	0.304
brd-k70511574	Not Clinically Relevant	0.315	0.317	0.267	0.295	0.29100000000000004	0.302	0.304	0.25	0.29600000000000004	0.33299999999999996	0.311	0.319	0.294	0.28800000000000003	0.25	0.32	0.266	0.255	0.336	0.309
nvp-231	Not Clinically Relevant	0.314	0.285	0.263	0.254	0.285	0.27699999999999997	0.282	0.244	0.276	0.298	0.27399999999999997	0.293	0.28	0.271	0.23800000000000002	0.272	0.256	0.273	0.289	0.287
cay10576	Not Clinically Relevant	0.314	0.371	0.376	0.332	0.38299999999999995	0.381	0.36	0.353	0.363	0.381	0.34299999999999997	0.335	0.335	0.325	0.33399999999999996	0.364	0.35100000000000003	0.37	0.36	0.37
n9-isopropylolomoucine	Not Clinically Relevant	0.314	0.29100000000000004	0.28800000000000003	0.26899999999999996	0.29100000000000004	0.275	0.301	-0.27699999999999997	-0.297	0.297	0.287	0.317	-0.275	0.265	0.28300000000000003	0.297	0.285	0.29	0.302	-0.319
birb-796	Not Clinically Relevant	0.314	0.317	0.318	0.316	0.321	0.318	0.33	0.301	0.332	0.336	0.28300000000000003	0.361	0.294	0.337	0.29100000000000004	0.33299999999999996	0.28800000000000003	0.322	0.325	0.341
ml083	Not Clinically Relevant	0.312	0.311	0.306	0.313	0.324	0.322	0.35100000000000003	0.284	0.335	0.326	0.305	0.33899999999999997	0.294	0.312	0.285	0.33299999999999996	0.297	0.314	-0.32	0.34600000000000003
ml311	Not Clinically Relevant	0.312	0.317	0.272	0.295	0.297	0.315	0.318	0.256	0.302	0.349	0.28600000000000003	0.33799999999999997	0.267	0.27899999999999997	0.245	0.303	0.272	0.254	0.321	0.293
brd-k34222889	Not Clinically Relevant	0.312	0.325	0.273	0.276	0.29600000000000004	0.289	0.303	0.24100000000000002	0.303	0.33	0.28600000000000003	0.319	0.273	0.28	0.265	0.312	0.281	0.259	0.331	0.301
brd-k96970199	Not Clinically Relevant	0.311	0.293	0.273	0.266	0.33399999999999996	0.248	0.304	0.263	-0.34299999999999997	0.26899999999999996	0.27399999999999997	0.263	-0.265	0.24100000000000002	0.3	0.331	0.27399999999999997	0.258	0.289	-0.309
gsk1059615	PI3K///andmTOR inhibitor	0.31	0.297	0.302	0.297	0.32	0.324	0.305	0.26899999999999996	0.281	0.32799999999999996	0.29600000000000004	0.337	0.267	0.266	0.257	0.33	0.29	0.276	0.349	0.308
ciclopirox	antifungal agent for topical dermatologic treatment of superficial mycoses	0.31	0.311	0.272	0.27399999999999997	0.319	0.298	0.301	-0.257	0.31	0.337	0.28600000000000003	0.32	0.31	0.278	0.275	0.299	-0.27	0.27699999999999997	0.313	0.316
myriocin	Not Clinically Relevant	0.31	-0.272	-0.306	-0.275	0.335	0.35	0.292	0.294	0.35700000000000004	0.349	-0.28800000000000003	0.32899999999999996	-0.28800000000000003	0.3	0.316	0.319	0.295	-0.302	0.289	-0.308
brd-k16147474	Not Clinically Relevant	0.309	-0.32799999999999996	0.316	-0.315	0.325	-0.304	-0.32799999999999996	-0.302	0.35	0.336	0.3	0.331	0.289	0.327	0.312	-0.332	0.301	-0.299	0.332	-0.337
vx-680	VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C	0.309	0.385	0.38	0.36	0.307	0.395	0.3	0.302	0.38	0.341	0.415	0.379	0.40399999999999997	0.345	0.27399999999999997	0.308	0.322	0.369	0.38299999999999995	0.359
brd-k66453893	Not Clinically Relevant	0.308	0.316	0.267	0.276	0.293	0.301	0.285	0.249	0.293	0.319	0.27399999999999997	0.31	0.275	0.262	0.248	0.305	0.26	0.249	0.317	0.28300000000000003
brd-k66532283	Not Clinically Relevant	0.308	0.32299999999999995	0.32299999999999995	0.319	0.32299999999999995	0.311	0.32899999999999996	0.28600000000000003	0.335	0.33	0.315	0.335	0.302	0.302	0.29	0.324	0.281	0.315	0.33	0.337
pl-di	Not Clinically Relevant	0.308	0.336	0.304	0.285	0.308	0.285	0.317	-0.267	0.322	0.353	0.321	0.336	0.28800000000000003	0.302	0.27399999999999997	0.32799999999999996	0.28300000000000003	0.28800000000000003	0.33799999999999997	0.321
importazole	Not Clinically Relevant	0.308	0.27399999999999997	0.273	0.275	0.281	0.306	0.33	0.272	0.295	0.301	0.29100000000000004	0.319	0.26899999999999996	0.303	0.28	0.292	0.297	0.27699999999999997	0.29100000000000004	0.311
brd-k34099515	Not Clinically Relevant	0.308	0.299	0.22399999999999998	0.316	0.29	0.248	0.278	0.28	0.35200000000000004	0.27	0.28800000000000003	0.257	0.276	0.23600000000000002	0.281	0.28300000000000003	0.285	0.247	0.27	0.28800000000000003
kx2-391	Src inhibitor (peptidomimetic) that targets the peptide substrate site of Src	0.307	0.332	0.28	0.253	0.292	0.315	0.305	0.249	0.282	0.325	0.28800000000000003	0.325	0.276	0.27399999999999997	0.252	0.29100000000000004	0.262	0.265	0.33299999999999996	0.295
cil70	Not Clinically Relevant	0.306	0.34600000000000003	0.293	0.313	0.315	0.311	0.33	0.253	0.33299999999999996	0.344	0.305	0.304	0.314	0.345	0.282	0.319	0.318	0.3	0.318	0.316
brd-k30019337	Not Clinically Relevant	0.306	0.289	0.297	0.252	0.31	0.295	0.306	0.267	0.335	0.33	0.317	0.29	0.298	0.26	0.28800000000000003	0.38	0.27399999999999997	0.28800000000000003	0.358	0.28300000000000003
nsc-207895	Not Clinically Relevant	0.306	0.308	0.321	0.28800000000000003	0.28	0.27899999999999997	0.307	0.256	0.32	0.289	0.304	0.294	0.27899999999999997	0.303	0.278	0.285	0.311	0.303	0.299	0.324
ml312	Not Clinically Relevant	0.305	0.22699999999999998	0.282	0.237	0.306	0.273	0.235	0.26	0.282	0.287	0.27	0.261	0.253	0.244	0.276	0.275	0.23800000000000002	0.281	0.254	0.257
mps-1-in-1	Not Clinically Relevant	0.305	0.332	0.32299999999999995	0.28800000000000003	-0.319	0.327	0.34299999999999997	-0.28300000000000003	0.325	0.275	0.303	0.32299999999999995	0.311	0.33899999999999997	0.278	0.344	0.281	0.303	0.33299999999999996	0.306
tandutinib	FLT3antagonist, also inhibits PDGFR and c-Kit,	0.304	0.311	0.28600000000000003	0.27699999999999997	0.28600000000000003	0.299	0.344	0.289	0.32899999999999996	0.326	0.287	0.28800000000000003	0.272	0.281	0.29	0.278	0.272	0.284	0.306	0.315
zm447439	Not Clinically Relevant	0.304	0.28600000000000003	0.315	0.306	-0.27899999999999997	0.281	0.32799999999999996	-0.28800000000000003	0.3	0.29600000000000004	0.299	0.311	0.27699999999999997	0.313	0.259	0.299	0.284	0.297	0.311	0.304
npc-26	Not Clinically Relevant	0.302	0.276	-0.267	-0.281	-0.318	-0.304	-0.309	-0.292	-0.306	-0.318	-0.285	0.304	-0.297	-0.295	0.278	-0.285	-0.276	-0.266	-0.306	-0.301
cediranib	VEGFR inhibitor	0.302	0.35	0.292	0.305	0.295	0.301	0.33899999999999997	0.302	0.33299999999999996	0.34	0.316	0.302	0.305	0.315	0.303	0.312	0.318	0.29100000000000004	0.335	0.32
cay10618	Not Clinically Relevant	0.302	0.32	0.271	0.273	0.285	0.314	0.28800000000000003	0.231	0.281	0.326	0.27699999999999997	0.311	0.264	0.271	0.22699999999999998	0.281	0.265	0.268	0.305	0.302
brd-k90370028	Not Clinically Relevant	0.302	0.34600000000000003	0.315	0.314	0.313	0.326	0.332	0.298	0.318	0.397	0.297	0.35100000000000003	0.29	0.33799999999999997	0.284	0.319	0.314	0.302	0.34600000000000003	0.337
dacarbazine	alkylating agent, Dacarbazine works by methylating guanine at the O-6 and N-7 positions	0.302	0.284	0.267	0.29600000000000004	0.306	0.275	0.302	0.262	0.317	0.322	0.285	0.314	0.287	0.28	0.27699999999999997	0.304	0.287	0.255	0.297	0.285
gsk-3 inhibitor ix	Not Clinically Relevant	0.302	0.293	0.3	0.28300000000000003	0.331	0.327	0.317	0.29600000000000004	0.3	0.309	0.293	0.301	0.314	0.278	0.292	0.305	0.289	0.303	0.289	0.305
pitstop2	Not Clinically Relevant	0.301	0.305	0.276	0.322	0.28600000000000003	0.316	0.297	0.27	0.297	0.319	0.281	0.322	0.27399999999999997	0.305	0.29	0.312	0.299	0.265	0.3	0.313
brd1812	Not Clinically Relevant	0.301	0.308	0.292	0.27	0.301	0.318	0.294	0.23199999999999998	0.297	0.327	0.258	0.311	0.27699999999999997	0.282	0.254	0.298	0.248	0.273	0.299	0.316
brd-k17060750	Not Clinically Relevant	0.301	-0.318	0.285	0.292	0.3	-0.312	-0.319	0.27399999999999997	-0.301	-0.326	-0.27899999999999997	-0.313	-0.272	0.317	0.267	0.301	0.29	0.28	-0.294	0.315
tipifarnib-p2	Not Clinically Relevant	0.301	0.313	0.257	0.27399999999999997	0.27899999999999997	0.263	0.306	0.248	0.319	0.315	0.295	0.292	0.278	0.268	0.256	0.306	0.259	0.259	0.305	0.302
hli 373	Not Clinically Relevant	0.3	0.324	0.293	0.311	0.318	0.285	0.336	0.259	0.326	0.35100000000000003	0.301	0.331	0.3	0.282	0.27899999999999997	0.302	0.266	0.28800000000000003	0.321	0.325
pf-573228	Not Clinically Relevant	0.3	0.285	0.247	0.24600000000000002	0.265	0.27699999999999997	0.276	0.231	0.256	0.31	0.265	0.3	0.266	0.272	0.243	0.27699999999999997	0.26	0.249	0.293	0.272
ym201636	Not Clinically Relevant	0.3	0.35200000000000004	0.332	0.299	-0.35100000000000003	0.305	0.35	0.29100000000000004	0.321	0.287	0.327	0.324	0.299	0.348	0.311	0.33799999999999997	0.301	0.31	0.337	0.344
ml031	Not Clinically Relevant	0.3	0.322	0.305	0.303	0.29	0.341	0.345	0.251	0.326	0.33799999999999997	0.27699999999999997	0.325	0.268	0.32799999999999996	0.28	0.322	0.27	0.299	0.336	0.336
neopeltolide	Not Clinically Relevant	0.3	0.264	0.21	0.22699999999999998	0.27399999999999997	0.285	0.251	0.22	0.262	0.253	0.22899999999999998	0.214	0.244	0.225	0.225	0.23399999999999999	0.23199999999999998	0.251	0.21600000000000003	0.191
cucurbitacin i	Not Clinically Relevant	0.299	0.335	0.305	0.308	0.316	0.28300000000000003	0.33299999999999996	0.272	0.315	0.336	0.302	0.337	0.294	0.28600000000000003	0.255	0.306	0.284	0.304	0.34600000000000003	0.345
mitomycin	DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis	0.299	0.305	0.271	0.27399999999999997	0.32899999999999996	0.305	0.311	0.249	0.299	0.35	0.298	0.321	0.3	0.29	0.25	0.324	0.27899999999999997	0.28300000000000003	0.335	0.331
b02	Not Clinically Relevant	0.298	0.305	0.273	0.261	0.276	0.3	0.301	0.226	0.27699999999999997	0.316	0.259	0.299	0.257	0.271	0.252	0.293	0.268	0.264	0.308	0.29600000000000004
i-bet151	Not Clinically Relevant	0.298	0.27699999999999997	0.256	0.262	0.27	0.265	0.27899999999999997	0.24100000000000002	0.28	0.275	0.276	0.27399999999999997	0.256	0.25	0.239	0.253	0.233	0.262	0.278	0.28
necrosulfonamide	Not Clinically Relevant	0.298	0.364	0.297	0.313	0.304	0.304	0.304	-0.251	0.307	0.336	0.28	0.32899999999999996	0.28800000000000003	0.29	0.23600000000000002	0.311	0.294	0.29	0.342	0.336
neuronal differentiation inducer iii	Not Clinically Relevant	0.297	0.317	0.28	0.289	0.311	0.265	0.324	-0.267	0.32	0.316	0.28600000000000003	0.319	0.29600000000000004	0.28800000000000003	-0.24600000000000002	0.307	-0.28	0.284	0.315	0.304
ly-2157299	Not Clinically Relevant	0.29600000000000004	0.308	0.32299999999999995	-0.24600000000000002	0.285	0.271	0.292	0.27899999999999997	-0.308	0.264	0.27699999999999997	0.294	0.26	0.247	0.28	0.289	0.322	0.262	0.28600000000000003	0.294
qw-bi-011	Not Clinically Relevant	0.295	0.292	0.26	0.24	0.251	0.282	0.289	0.21899999999999997	0.314	0.28300000000000003	0.32	0.253	0.299	0.252	0.258	0.27399999999999997	0.214	0.28800000000000003	0.304	0.32799999999999996
pifithrin-alpha	Not Clinically Relevant	0.295	0.278	0.268	0.263	0.28800000000000003	0.289	0.297	0.264	0.313	0.28300000000000003	0.28300000000000003	0.27899999999999997	0.266	0.276	0.272	0.247	0.268	0.26899999999999996	0.273	0.28
cd-1530	Not Clinically Relevant	0.294	0.268	0.297	0.25	0.297	0.295	0.301	0.262	0.297	0.312	0.257	0.312	0.27	0.284	0.26	0.27399999999999997	0.276	0.281	0.306	0.305
gsk461364	Plk1inhibitor, less active against Plk2 and Plk3.	0.294	0.32	0.266	0.273	0.292	0.308	0.28	0.233	0.28300000000000003	0.33399999999999996	0.28300000000000003	0.33299999999999996	0.28800000000000003	0.302	0.252	0.28800000000000003	0.28600000000000003	0.248	0.33299999999999996	0.29
brd-a94377914	Not Clinically Relevant	0.294	0.29100000000000004	0.254	0.272	0.28	0.27699999999999997	0.3	-0.253	0.308	0.312	0.266	0.276	0.26899999999999996	0.278	0.23399999999999999	0.271	-0.256	0.25	0.252	0.272
trifluoperazine	antipsychotic, antiadrenergic and antidopaminergic. Blocks dopamine D1 and D2 receptors 	0.293	0.315	0.3	0.32299999999999995	0.312	-0.318	0.345	0.292	-0.33799999999999997	-0.32299999999999995	0.325	0.336	-0.313	-0.316	0.287	0.318	-0.307	0.299	0.335	0.318
cil55a	Not Clinically Relevant	0.293	0.297	0.28300000000000003	0.298	0.273	0.3	0.287	0.27899999999999997	0.32	0.292	0.29600000000000004	0.28800000000000003	0.275	0.281	0.295	0.293	0.28300000000000003	0.287	0.287	0.282
wz3105	Not Clinically Relevant	0.293	0.282	0.318	0.266	-0.327	0.32	0.322	-0.308	0.29100000000000004	0.28600000000000003	0.28300000000000003	0.309	0.27699999999999997	0.314	0.275	0.316	-0.271	0.28	0.306	0.316
bax channel blocker	Not Clinically Relevant	0.292	0.266	0.27	0.281	0.263	0.258	0.308	0.247	0.28600000000000003	0.276	0.275	0.307	0.253	0.262	0.26899999999999996	0.304	0.263	0.276	0.282	0.305
nakiterpiosin	Not Clinically Relevant	0.292	0.306	0.27	0.264	0.264	0.293	0.29100000000000004	0.248	0.281	0.312	0.28300000000000003	0.308	0.275	0.25	0.23399999999999999	0.287	0.244	0.243	0.33	0.276
alvocidib	Flavopiridol,CDK inhibitor, works against CDK1, 2, 4, 6 and 9	0.29100000000000004	0.252	0.308	0.281	0.282	0.317	0.28	0.228	0.295	0.302	0.267	0.26	0.262	0.23	0.218	0.28	0.213	0.278	0.331	0.282
brd-k35604418	Not Clinically Relevant	0.29100000000000004	0.317	0.28800000000000003	0.302	0.266	0.3	0.315	0.242	0.308	0.331	0.29600000000000004	0.315	0.27	0.3	0.253	0.292	0.268	0.258	0.324	0.28800000000000003
stf-31	Not Clinically Relevant	0.29	0.336	0.29	0.287	0.297	0.322	0.311	0.244	0.294	0.33899999999999997	0.29	0.34600000000000003	0.278	0.309	0.222	0.29100000000000004	0.267	0.272	0.327	0.324
pi-103	Not Clinically Relevant	0.29	0.284	0.29	0.24600000000000002	-0.005	0.28600000000000003	0.304	0.022000000000000002	0.28600000000000003	0.289	0.27899999999999997	0.27899999999999997	0.264	0.278	0.258	0.29600000000000004	0.285	0.276	0.29600000000000004	0.29
curcumin	Natural Product, component of turmeric, may function as HDAC inhibitor	0.289	0.307	0.27	0.28300000000000003	0.264	0.302	0.292	0.251	0.281	0.322	0.28300000000000003	0.303	0.278	0.257	0.248	0.278	0.252	0.252	0.32	0.27899999999999997
zg-10	Not Clinically Relevant	0.289	0.302	0.278	0.263	0.28300000000000003	0.299	0.315	0.264	0.304	0.273	0.27399999999999997	0.32899999999999996	0.287	0.313	0.31	0.297	0.278	-0.27699999999999997	0.324	-0.312
rigosertib	ON-01910, Plk-1 inhibitor	0.289	0.326	0.272	0.294	0.278	0.304	0.298	0.255	0.287	0.307	0.301	0.321	0.26899999999999996	0.281	0.256	0.306	0.271	0.256	0.326	0.298
ku-60019	Not Clinically Relevant	0.289	0.275	0.252	0.275	0.289	0.267	0.28600000000000003	-0.26	-0.294	0.28800000000000003	0.255	0.28800000000000003	0.276	0.275	0.27699999999999997	0.292	0.27399999999999997	-0.262	0.302	0.27899999999999997
fluorouracil	antimetabolite	0.287	0.293	-0.261	0.254	0.29100000000000004	0.28600000000000003	0.29100000000000004	-0.273	-0.27699999999999997	0.31	-0.266	0.324	0.264	0.27899999999999997	-0.273	0.284	-0.28	-0.257	0.294	0.282
thalidomide	interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma	0.287	0.321	0.305	0.308	0.276	0.287	0.302	0.287	0.287	0.348	0.25	0.306	0.264	0.326	0.255	0.28600000000000003	0.29	0.276	0.28800000000000003	0.293
tgx-221	Not Clinically Relevant	0.287	0.268	0.273	0.273	0.303	0.278	0.299	0.26899999999999996	0.302	0.298	0.263	0.28800000000000003	0.27899999999999997	-0.268	0.28300000000000003	0.285	0.261	0.276	0.29100000000000004	0.287
silmitasertib	casein kinase 2 inhibitor	0.287	0.261	0.263	0.275	0.281	0.304	0.267	0.249	0.281	0.302	0.248	0.298	0.28300000000000003	0.259	0.254	0.28600000000000003	0.262	0.264	0.284	0.28300000000000003
gdc-0941	Pictilisib, potent inhibitor ofPI3K/, with modest selectivity against p110 (11-fold) and p110	0.287	0.272	0.244	0.271	0.273	0.265	0.287	0.243	0.275	0.287	0.24100000000000002	0.285	0.23600000000000002	0.266	0.237	0.293	0.265	0.24	0.266	0.267
nvp-bez235	PI3K/mTOR inhibitor	0.287	0.275	0.24600000000000002	0.266	0.248	0.285	0.26	0.23800000000000002	0.255	0.309	0.243	0.311	0.221	0.266	0.22699999999999998	0.271	0.249	0.215	0.295	0.281
ch-55	Not Clinically Relevant	0.28600000000000003	0.294	0.299	0.27	0.3	0.29	0.304	0.245	0.284	0.317	0.257	0.324	0.253	0.28800000000000003	0.255	0.315	0.275	0.28	0.312	0.301
tw-37	Not Clinically Relevant	0.28600000000000003	0.256	0.24100000000000002	0.198	0.249	0.26	0.26	0.20600000000000002	0.251	0.27399999999999997	0.22399999999999998	0.256	0.243	0.24600000000000002	0.214	0.245	0.23600000000000002	0.226	0.271	0.253
momelotinib	JAK1 and JAK2 inhibitor	0.28600000000000003	0.27699999999999997	0.237	0.278	0.299	0.28	0.289	0.258	0.278	0.295	0.262	0.272	0.29600000000000004	0.261	0.267	0.28800000000000003	0.28300000000000003	0.251	0.28600000000000003	0.254
osi-027	Not Clinically Relevant	0.28600000000000003	0.28600000000000003	0.272	0.265	-0.016	0.276	0.28800000000000003	0.0	0.276	0.276	0.27899999999999997	0.29600000000000004	0.25	0.276	0.252	0.292	0.259	0.276	0.295	0.284
cd-437	Not Clinically Relevant	0.285	0.29100000000000004	0.268	0.23800000000000002	0.29100000000000004	0.289	0.282	0.253	0.28300000000000003	0.324	0.264	0.287	0.271	0.272	0.23800000000000002	0.299	0.28300000000000003	0.26	0.297	0.284
salermide	Not Clinically Relevant	0.284	0.253	0.273	0.257	0.289	0.26899999999999996	0.267	0.248	0.27399999999999997	0.29600000000000004	0.23399999999999999	0.287	0.249	0.253	0.239	0.285	0.253	0.25	0.276	0.29
gsk525762a	Not Clinically Relevant	0.284	0.268	0.233	0.235	0.264	-0.259	0.257	-0.23399999999999999	0.267	0.268	0.23800000000000002	0.26	0.27399999999999997	-0.257	0.23800000000000002	0.22899999999999998	-0.22899999999999998	0.252	0.267	0.248
brd-k37390332	Not Clinically Relevant	0.28300000000000003	0.29600000000000004	0.29	0.314	0.293	0.29600000000000004	0.336	0.278	0.327	0.305	0.303	0.303	0.28600000000000003	0.311	0.28	0.303	0.299	0.302	0.302	0.301
mk-1775	Wee1 kinase inhibitor	0.28300000000000003	0.27899999999999997	0.256	0.264	0.271	0.29100000000000004	0.255	0.231	0.267	0.32	0.25	0.298	0.262	0.242	0.21899999999999997	0.271	0.23399999999999999	0.24	0.276	0.287
gant-61	Not Clinically Relevant	0.28300000000000003	0.26899999999999996	0.254	0.256	0.275	0.287	0.276	0.247	0.27899999999999997	0.271	0.267	0.276	0.268	0.264	0.26899999999999996	0.28800000000000003	0.258	0.26899999999999996	0.267	0.284
bardoxolone methyl	Not Clinically Relevant	0.282	0.285	0.27699999999999997	0.293	0.272	0.303	0.29100000000000004	0.245	0.27	0.322	0.295	0.29600000000000004	0.261	0.273	0.24	0.28800000000000003	0.259	0.271	0.313	0.287
tamatinib	(R4060) inhibitor of IgE and IgG-mediated activation of Fc receptor signaling. Primary target is Syk	0.282	0.248	0.231	0.263	0.3	0.27399999999999997	0.27699999999999997	0.259	0.292	0.295	0.242	0.318	0.27	0.271	0.258	0.287	0.24600000000000002	0.24100000000000002	0.29	0.282
cerulenin	Not Clinically Relevant	0.282	0.299	0.27399999999999997	0.26899999999999996	0.262	0.303	0.298	-0.22899999999999998	0.29	0.313	0.249	0.313	0.247	0.285	0.25	0.306	0.237	0.244	0.317	0.308
dinaciclib	CDK inhibitor, esp CDK1, 2, 5, and 9	0.281	0.258	0.303	0.293	0.254	0.29600000000000004	0.272	0.198	0.262	0.278	0.24	0.257	0.24	0.248	0.20199999999999999	0.265	0.19899999999999998	0.257	0.294	0.27699999999999997
brd-k96431673	Not Clinically Relevant	0.281	0.314	0.275	-0.266	0.307	-0.28	0.27899999999999997	0.244	0.301	0.293	0.27899999999999997	0.29	0.252	0.257	0.264	0.315	0.264	0.271	0.292	0.275
merck60	Not Clinically Relevant	0.281	0.298	0.26899999999999996	0.294	0.29100000000000004	0.295	0.285	-0.26899999999999996	0.29100000000000004	0.314	0.268	0.33	0.255	0.29100000000000004	-0.259	0.297	-0.262	0.26899999999999996	0.312	0.303
ko-143	Not Clinically Relevant	0.281	0.292	0.287	0.293	0.285	0.293	0.284	0.24100000000000002	-0.285	0.318	-0.262	0.294	0.27	0.29100000000000004	0.266	0.27699999999999997	0.23399999999999999	0.27399999999999997	0.29	0.298
3-cl-ahpc	Not Clinically Relevant	0.28	0.262	0.249	0.225	0.26	0.28300000000000003	0.26899999999999996	0.243	0.257	0.31	0.267	0.272	0.266	0.243	0.249	0.271	0.254	0.25	0.295	0.26899999999999996
cimetidine	(Tagamet) Antacid and antihistamine	0.28	0.336	0.303	0.263	0.28800000000000003	0.28300000000000003	0.332	0.266	0.33	0.316	0.299	0.318	0.265	0.297	0.27	0.332	0.273	0.275	0.32799999999999996	0.304
purmorphamine	Not Clinically Relevant	0.27899999999999997	0.275	0.265	0.263	0.259	0.261	0.28600000000000003	0.235	0.271	0.302	0.252	0.28300000000000003	0.247	0.267	0.264	0.27	0.249	0.253	0.295	0.301
cx-5461	Not Clinically Relevant	0.27899999999999997	0.282	0.295	0.23800000000000002	0.293	0.272	0.282	0.233	0.273	0.251	0.262	0.303	0.237	0.29600000000000004	0.27	0.29	0.239	0.272	0.28300000000000003	0.267
narciclasine	Not Clinically Relevant	0.27899999999999997	0.268	0.27899999999999997	0.287	0.265	0.285	0.28300000000000003	0.225	0.27399999999999997	0.295	0.268	0.308	0.264	0.228	0.223	0.312	0.23600000000000002	0.252	0.316	0.27699999999999997
brd9876	Not Clinically Relevant	0.27899999999999997	0.248	0.23199999999999998	0.228	0.24100000000000002	0.21100000000000002	0.265	0.21600000000000003	0.262	0.27699999999999997	0.23800000000000002	0.251	0.242	0.24100000000000002	0.222	0.24600000000000002	0.222	0.235	0.252	0.262
srt-1720	Not Clinically Relevant	0.278	0.29600000000000004	0.278	0.261	0.28800000000000003	0.289	0.278	0.231	0.275	0.319	0.244	0.287	0.256	0.262	0.23600000000000002	0.27899999999999997	0.275	0.253	0.294	0.27699999999999997
az-3146	Not Clinically Relevant	0.278	0.263	0.239	0.235	0.276	0.254	0.26899999999999996	0.22899999999999998	0.265	0.292	0.248	0.295	0.255	0.272	0.24100000000000002	0.26	0.22399999999999998	0.235	0.27899999999999997	0.275
clofarabine	purinenucleosideantimetabolite	0.278	0.257	0.226	0.25	0.261	0.272	0.28300000000000003	0.237	0.265	0.287	0.268	0.271	0.265	0.249	0.22399999999999998	0.285	0.22699999999999998	0.239	0.292	0.24100000000000002
tigecycline	antibioticused to treat a number ofbacterial infections	0.278	0.24600000000000002	0.244	0.231	0.245	0.254	0.23399999999999999	0.205	0.27399999999999997	0.247	0.242	0.24600000000000002	0.23199999999999998	0.256	0.257	0.23399999999999999	0.245	0.251	0.23600000000000002	0.255
nsc632839	Not Clinically Relevant	0.27699999999999997	0.312	0.267	0.252	0.27899999999999997	0.294	0.29600000000000004	0.21899999999999997	0.284	0.312	0.257	0.315	0.256	0.275	0.22699999999999998	0.28	0.258	0.239	0.32	0.313
cr-1-31b	Not Clinically Relevant	0.27699999999999997	0.282	0.287	0.258	0.247	0.28300000000000003	0.267	-0.261	0.278	0.293	0.267	0.27699999999999997	0.272	0.22899999999999998	-0.24600000000000002	0.266	0.231	0.27	0.289	0.284
pf-3758309	Not Clinically Relevant	0.276	0.302	0.281	0.295	0.276	0.29100000000000004	0.303	0.226	0.272	0.358	0.27399999999999997	0.32899999999999996	0.23199999999999998	0.28600000000000003	0.209	0.289	0.261	0.245	0.335	0.29
ml258	Not Clinically Relevant	0.276	-0.258	-0.252	0.253	-0.27699999999999997	0.251	0.273	-0.235	-0.27699999999999997	0.28600000000000003	-0.23199999999999998	0.282	0.253	0.254	-0.257	-0.28	-0.258	-0.243	-0.27399999999999997	-0.28
triptolide	diterpenoidepoxidefrom thunder god vine, may act on the XBP helicase that is a part of the TFIIH transcription factor complex	0.276	0.282	0.254	-0.278	0.281	0.276	0.278	-0.251	-0.298	0.271	-0.263	0.27899999999999997	0.27	0.271	-0.261	0.26899999999999996	-0.23	-0.253	0.284	-0.268
jq-1	Not Clinically Relevant	0.275	0.284	0.245	0.24600000000000002	0.281	0.24600000000000002	0.263	0.226	0.276	0.285	0.263	0.272	0.272	0.24100000000000002	0.217	0.247	0.22899999999999998	0.251	0.27699999999999997	0.268
sb-525334	Not Clinically Relevant	0.275	0.303	0.28	0.243	0.27	0.28300000000000003	0.318	-0.25	0.293	0.3	0.23600000000000002	0.318	0.23600000000000002	0.306	0.245	0.301	0.294	0.263	0.306	0.299
chm-1	Not Clinically Relevant	0.27399999999999997	0.316	0.237	0.237	0.28300000000000003	0.278	0.285	0.22	0.28600000000000003	0.309	0.273	0.306	0.267	0.26	0.201	0.267	0.23600000000000002	0.237	0.307	0.28
unc0638	Not Clinically Relevant	0.273	0.292	0.29	0.282	0.312	0.26899999999999996	0.326	0.262	0.292	0.278	0.303	0.29	0.264	0.282	0.28800000000000003	0.308	0.266	0.27399999999999997	0.29600000000000004	0.306
sch-79797	Not Clinically Relevant	0.273	0.27899999999999997	0.23800000000000002	0.27399999999999997	0.259	0.255	0.272	0.235	0.257	0.301	0.261	0.29600000000000004	0.27	0.254	0.223	0.264	0.233	0.23199999999999998	0.3	0.29
phloretin	Not Clinically Relevant	0.272	0.263	0.23199999999999998	0.252	0.27	0.28300000000000003	0.275	0.22899999999999998	0.256	0.29100000000000004	0.23399999999999999	0.28600000000000003	0.249	0.261	0.222	0.261	0.23	0.233	0.28300000000000003	0.259
prl-3 inhibitor i	Not Clinically Relevant	0.271	0.28800000000000003	0.255	0.251	0.263	0.27	0.297	0.239	0.26899999999999996	0.306	0.255	0.272	0.24600000000000002	0.287	0.267	0.26	0.235	0.24	0.276	0.266
gw-405833	Not Clinically Relevant	0.27	0.24600000000000002	0.255	0.233	0.266	0.266	0.252	0.205	0.243	0.289	0.25	0.284	0.252	0.222	0.218	0.267	-0.226	0.255	0.268	0.253
niclosamide	used to treattapeworm infestations,  inhibits glucose uptake, oxidative phosphorylation, and anaerobic metabolism in the tapeworm	0.27	0.295	0.302	0.249	0.248	0.325	0.33	0.271	0.307	0.33	0.293	0.287	0.284	0.289	0.265	0.309	0.249	0.304	0.324	0.297
ciclosporin	nan	0.26899999999999996	0.268	0.244	0.256	0.27899999999999997	0.25	0.276	0.228	-0.262	0.271	0.258	0.273	0.271	0.267	0.209	0.28	0.235	0.281	0.27399999999999997	0.28800000000000003
cyanoquinoline 11	Not Clinically Relevant	0.26899999999999996	-0.27399999999999997	0.29600000000000004	0.263	-0.251	0.27899999999999997	-0.275	-0.265	-0.29600000000000004	0.289	-0.281	0.26	0.268	0.233	-0.272	0.268	-0.271	0.293	0.244	0.265
sch-529074	Not Clinically Relevant	0.26899999999999996	0.278	0.265	0.259	0.273	-0.25	0.299	0.226	0.29	0.28	0.284	0.28600000000000003	0.254	-0.264	0.233	0.27	-0.251	0.265	0.27899999999999997	0.293
cal-101	Idelalisib,  PI3K/p110 inhibitor	0.26899999999999996	0.278	0.26	0.268	0.272	0.273	0.28300000000000003	0.267	0.285	0.292	0.272	0.281	0.263	0.256	0.273	0.28800000000000003	0.267	0.253	0.303	0.27
ar-42	Not Clinically Relevant	0.267	0.271	0.28	0.252	0.319	0.307	0.326	0.253	0.292	0.248	0.297	0.306	0.251	0.325	0.27	0.32899999999999996	0.254	0.266	0.295	0.273
cil56	Not Clinically Relevant	0.266	0.262	0.27899999999999997	0.257	0.28800000000000003	0.301	0.282	0.253	0.306	0.309	0.272	0.265	0.275	0.27	0.23	0.289	0.271	0.258	0.285	0.27699999999999997
r428	Not Clinically Relevant	0.266	0.27399999999999997	0.258	0.25	0.245	0.281	0.276	0.251	0.278	0.263	0.25	0.265	0.233	0.256	0.262	0.261	0.259	0.233	0.276	0.29600000000000004
brd-k45681478	Not Clinically Relevant	0.266	0.268	0.262	0.272	0.26899999999999996	0.249	0.297	-0.242	0.293	0.275	0.256	0.28	0.235	0.275	0.244	0.265	0.255	0.262	0.287	0.28600000000000003
prochlorperazine	dopamine (D2) receptor antagonist, used for treatment ofnauseaandvertigo.	0.266	0.271	0.249	0.249	0.263	0.251	0.28800000000000003	0.21600000000000003	0.276	0.265	0.266	0.259	0.243	0.247	0.23	0.255	0.243	0.23600000000000002	0.259	0.268
leptomycin b	Not Clinically Relevant	0.265	0.255	0.248	0.243	0.248	0.266	0.266	0.225	0.272	0.29100000000000004	0.255	0.299	0.25	0.245	0.21100000000000002	0.263	0.23399999999999999	0.23399999999999999	0.28300000000000003	0.253
ql-x-138	Not Clinically Relevant	0.264	0.273	0.28600000000000003	0.245	-0.313	0.293	0.313	-0.25	0.273	0.24100000000000002	0.295	0.278	0.242	0.308	0.24600000000000002	0.29100000000000004	0.242	0.27699999999999997	0.282	0.28800000000000003
bleomycin a2	InducesDNAstrand breaks, inhibits incorporation ofthymidineinto DNA strands.	0.262	0.253	0.245	0.261	0.253	0.278	0.26899999999999996	0.237	0.276	0.298	0.249	0.273	0.25	0.257	0.256	0.27399999999999997	0.247	0.263	0.262	0.253
semagacestat	Notch (gamma secretase) inhibitor	0.262	0.27699999999999997	0.257	0.243	0.293	0.27899999999999997	0.272	0.253	0.263	0.275	0.24600000000000002	0.28800000000000003	0.24600000000000002	0.26899999999999996	0.276	0.276	0.294	0.262	0.28800000000000003	0.281
ml320	Not Clinically Relevant	0.262	0.24100000000000002	0.21899999999999997	0.19699999999999998	0.27399999999999997	0.214	0.242	0.225	0.245	0.254	0.222	0.249	0.233	0.228	0.215	0.237	0.243	0.207	0.244	0.235
sb-743921	kinesin spindle protein (KSP)inhibitor	0.261	0.27699999999999997	0.265	0.24	0.258	0.275	0.259	0.223	0.26	0.292	0.255	0.278	0.25	0.239	0.226	0.263	0.228	0.251	0.285	0.26
nvp-bsk805	Not Clinically Relevant	0.261	0.26899999999999996	0.243	0.24600000000000002	0.266	0.257	0.276	0.231	0.264	0.275	0.276	0.27	0.243	0.252	0.243	0.261	0.226	0.23399999999999999	0.28	0.268
cay10603	Not Clinically Relevant	0.261	0.266	0.254	0.24600000000000002	-0.308	0.284	0.28600000000000003	0.237	0.27699999999999997	0.23199999999999998	0.3	0.295	0.24100000000000002	0.305	0.278	0.306	0.243	0.252	0.28	0.265
smer-3	Not Clinically Relevant	0.26	0.252	0.23199999999999998	0.256	0.256	0.258	0.28600000000000003	0.217	0.284	0.289	0.239	0.308	0.247	0.266	0.23	0.263	0.198	0.243	0.285	0.24600000000000002
gsk2636771	PI3K beta inhibitor, >900-fold selectivity over PI3K/PI3K and >10-fold over PI3K. 	0.26	0.271	0.254	0.271	0.244	0.249	0.289	0.27399999999999997	0.29	0.258	0.284	0.27	0.266	0.24100000000000002	0.249	0.262	0.228	0.253	0.282	0.27
sirolimus	rapamycin, mTOR inhibitor	0.26	0.231	0.23199999999999998	0.214	0.243	0.24	0.248	0.201	0.22899999999999998	0.258	0.207	0.261	0.2	0.22699999999999998	0.204	0.242	0.215	0.22	0.24100000000000002	0.24600000000000002
cytochalasin b	Not Clinically Relevant	0.259	0.28300000000000003	0.22899999999999998	0.25	0.276	0.23800000000000002	0.265	0.272	0.29100000000000004	0.297	0.28600000000000003	0.285	0.255	0.23800000000000002	0.27399999999999997	0.255	0.259	0.23600000000000002	0.29100000000000004	0.256
fluvastatin	HMG-CoA reductase inhibitor,	0.259	0.294	0.27	0.239	0.27399999999999997	0.26899999999999996	0.29	0.265	0.307	0.29600000000000004	0.289	0.27699999999999997	0.28800000000000003	0.252	0.265	0.262	0.256	0.26	0.294	0.26899999999999996
cay10594	Not Clinically Relevant	0.259	0.251	0.265	0.244	0.261	0.257	0.257	0.225	0.263	0.272	0.252	-0.261	0.249	-0.251	0.228	0.249	0.23	0.263	0.25	0.266
pf-750	Not Clinically Relevant	0.258	0.235	0.24600000000000002	0.235	0.261	0.262	0.258	-0.217	0.245	0.28300000000000003	0.22399999999999998	0.278	0.244	0.249	0.24600000000000002	0.28300000000000003	0.243	0.257	0.267	0.28300000000000003
methylstat	Not Clinically Relevant	0.258	0.268	0.265	0.268	0.254	0.271	0.261	0.20600000000000002	0.27399999999999997	0.295	0.24100000000000002	0.307	0.233	0.268	0.22699999999999998	0.292	0.235	0.242	0.308	0.305
obatoclax	Not Clinically Relevant	0.258	0.24600000000000002	0.23399999999999999	0.23199999999999998	0.248	0.264	0.249	0.19899999999999998	0.25	0.271	0.26899999999999996	0.253	0.247	0.20800000000000002	0.212	0.233	0.222	0.24100000000000002	0.242	0.256
mk-0752	Notch (gamma secretase) inhibitor	0.258	0.253	0.225	0.237	0.266	0.258	0.276	0.237	0.27699999999999997	0.287	0.249	0.272	0.22399999999999998	0.25	0.222	0.26899999999999996	0.233	0.244	0.258	0.27399999999999997
prima-1	Not Clinically Relevant	0.258	0.301	0.26	0.242	0.26899999999999996	0.23600000000000002	0.27699999999999997	0.231	0.278	0.299	0.24600000000000002	0.299	0.23600000000000002	0.278	0.225	0.27399999999999997	0.24	0.244	0.289	0.287
ci-976	Not Clinically Relevant	0.258	0.247	0.247	0.226	0.244	0.251	0.248	0.23800000000000002	0.245	0.242	0.23199999999999998	0.25	0.247	0.255	0.245	0.263	0.22699999999999998	0.22899999999999998	0.26	0.27899999999999997
brd-k27224038	Not Clinically Relevant	0.257	0.245	0.24600000000000002	0.23600000000000002	0.272	0.24100000000000002	0.255	0.265	0.28600000000000003	0.243	0.29600000000000004	-0.256	0.299	-0.22	0.293	0.285	0.27699999999999997	0.261	0.29100000000000004	0.27899999999999997
blebbistatin	Not Clinically Relevant	0.257	0.27	0.281	0.254	0.268	0.242	0.259	0.235	0.285	0.23	0.249	0.265	0.273	0.239	0.26	0.278	0.254	0.267	0.27	0.243
brd-k78574327	Not Clinically Relevant	0.257	0.308	0.28600000000000003	0.254	0.299	0.302	0.29600000000000004	0.264	0.34299999999999997	0.313	0.303	0.276	0.264	0.266	0.278	0.371	0.266	0.271	0.311	0.257
wz4002	Not Clinically Relevant	0.257	0.263	0.267	0.29100000000000004	0.261	0.267	0.256	-0.22899999999999998	0.261	0.287	0.22899999999999998	0.294	0.24	0.235	0.243	0.267	0.23399999999999999	0.254	0.27699999999999997	0.266
brd-a02303741	Not Clinically Relevant	0.257	0.253	0.23600000000000002	0.244	0.257	0.257	0.251	0.23	0.242	0.259	0.248	0.252	0.239	0.257	0.237	0.247	0.253	0.23	0.251	0.261
unc0321	Not Clinically Relevant	0.256	0.22399999999999998	0.225	0.225	0.244	0.24600000000000002	0.243	0.235	0.263	0.27399999999999997	0.23	0.262	0.239	0.228	0.23600000000000002	0.22899999999999998	0.21899999999999997	0.218	0.24100000000000002	0.251
ex-527	SIRT1 inhibitor	0.256	0.249	0.22899999999999998	0.251	0.235	0.22899999999999998	0.259	0.212	0.27	0.273	0.237	0.244	0.22899999999999998	0.261	0.223	0.231	0.222	0.22399999999999998	0.251	0.267
sr-ii-138a	Not Clinically Relevant	0.255	0.275	0.254	0.24600000000000002	0.252	0.261	0.26	-0.22699999999999998	0.251	0.295	0.23399999999999999	0.27899999999999997	0.23600000000000002	0.23	-0.24	0.265	0.222	0.233	0.272	0.28300000000000003
wp1130	Not Clinically Relevant	0.254	0.239	0.235	0.212	0.23600000000000002	0.249	0.25	-0.21100000000000002	0.22699999999999998	0.278	0.22399999999999998	0.251	0.205	0.242	0.24	0.245	0.22899999999999998	0.222	0.257	0.251
hbx-41108	Not Clinically Relevant	0.254	0.268	0.22899999999999998	0.225	0.235	0.24	0.254	-0.20199999999999999	0.265	0.251	0.22899999999999998	0.27399999999999997	0.209	0.239	-0.21899999999999997	0.25	-0.212	0.248	0.267	0.259
le-135	Not Clinically Relevant	0.253	0.24100000000000002	0.21899999999999997	0.24100000000000002	0.247	0.24600000000000002	0.257	0.22399999999999998	0.233	0.261	0.21899999999999997	0.257	0.247	0.23800000000000002	0.192	0.23199999999999998	0.215	0.235	0.257	0.254
palmostatin b	Not Clinically Relevant	0.253	0.23600000000000002	0.225	0.249	0.23	0.259	0.259	0.23	0.223	0.252	0.243	0.28	0.23199999999999998	0.21100000000000002	0.217	0.244	0.23399999999999999	0.212	0.242	0.263
brd-k41334119	Not Clinically Relevant	0.253	0.228	0.235	0.212	0.272	0.257	0.25	0.255	0.302	0.258	0.263	0.263	0.251	0.231	0.28800000000000003	0.299	0.244	0.256	0.281	0.247
ku 0060648	Not Clinically Relevant	0.252	0.22899999999999998	0.214	0.245	0.207	0.222	0.233	0.213	0.214	0.248	0.21899999999999997	0.23199999999999998	0.19699999999999998	0.205	0.213	0.226	0.209	0.21100000000000002	0.23399999999999999	0.233
dexamethasone	syntheticcorticosteroid, used to reduce inflammation	0.252	0.23399999999999999	0.239	0.217	0.259	0.275	0.26	0.231	0.23600000000000002	0.243	0.223	0.258	0.233	0.244	0.24100000000000002	0.23800000000000002	0.233	0.23	0.23399999999999999	0.265
regorafenib	VEGFR2-TIE2 inhibitor	0.252	0.255	0.254	0.23	0.261	0.249	0.27699999999999997	0.222	0.272	0.276	0.23	0.257	0.233	0.252	0.23199999999999998	0.273	0.24	0.257	0.265	0.271
pyrazolanthrone	Not Clinically Relevant	0.251	0.257	-0.239	0.239	0.281	0.266	0.278	-0.248	-0.27399999999999997	0.27699999999999997	0.23199999999999998	0.285	0.225	0.249	-0.245	-0.27	-0.23	-0.245	0.275	-0.275
brd-k14844214	Not Clinically Relevant	0.25	-0.23800000000000002	0.258	0.242	-0.259	-0.26899999999999996	0.24100000000000002	0.242	0.261	-0.252	-0.21899999999999997	-0.266	0.231	-0.249	0.253	-0.27399999999999997	0.22699999999999998	-0.258	-0.244	-0.26
agk-2	Not Clinically Relevant	0.25	0.268	0.259	0.271	0.265	0.305	0.275	-0.23199999999999998	0.28	0.289	-0.251	0.281	0.254	0.27	0.26	0.256	0.237	0.249	0.278	0.27
tg-101348	JAK2inhibitor	0.247	0.25	0.20800000000000002	0.233	0.237	0.21100000000000002	0.262	0.23800000000000002	0.243	0.257	0.235	0.237	0.248	0.23399999999999999	0.23199999999999998	0.24	0.244	0.198	0.255	0.245
ouabain	Not Clinically Relevant	0.247	0.27899999999999997	0.284	0.284	0.271	0.3	0.31	0.24600000000000002	0.293	0.325	0.267	0.28600000000000003	0.273	0.285	0.239	0.28600000000000003	0.23399999999999999	0.268	0.307	0.285
cudc-101	Not Clinically Relevant	0.24600000000000002	0.235	0.263	0.22699999999999998	-0.308	0.27899999999999997	0.275	-0.24600000000000002	0.26899999999999996	0.22899999999999998	0.26	0.273	0.265	0.299	0.239	0.272	0.217	0.265	0.243	-0.26
oligomycin a	Not Clinically Relevant	0.24600000000000002	0.248	0.22	0.218	-0.24600000000000002	0.256	0.239	0.20199999999999999	0.244	0.285	0.21100000000000002	0.237	0.22399999999999998	0.239	0.18899999999999997	0.242	0.215	0.209	0.26	0.23800000000000002
wz8040	Not Clinically Relevant	0.245	-0.276	0.247	0.253	0.259	0.251	-0.26899999999999996	-0.226	-0.278	0.27399999999999997	-0.239	0.261	0.255	0.248	0.231	0.266	0.23	0.257	0.248	-0.27399999999999997
vandetanib	VEGFR, EGFR and RET inhibitor	0.244	-0.225	-0.207	0.21100000000000002	0.252	0.226	-0.247	0.203	-0.22899999999999998	0.23199999999999998	-0.209	0.22	0.212	-0.218	-0.212	0.22399999999999998	0.21100000000000002	-0.21600000000000003	-0.223	-0.242
gsk690693	Not Clinically Relevant	0.243	0.253	0.294	-0.23800000000000002	-0.322	0.255	0.281	-0.261	0.273	-0.23399999999999999	0.268	0.255	-0.263	0.27399999999999997	0.23600000000000002	0.273	0.25	0.258	0.27699999999999997	0.27399999999999997
betulinic acid	Not Clinically Relevant	0.243	-0.237	-0.25	-0.23	-0.254	-0.242	-0.255	-0.226	-0.244	-0.268	-0.215	-0.25	-0.23	-0.24	-0.23600000000000002	-0.254	-0.21899999999999997	-0.243	-0.248	-0.262
kh-cb19	Not Clinically Relevant	0.242	0.275	0.292	0.28	0.265	0.302	0.272	0.237	0.27	0.29600000000000004	0.275	0.308	0.239	0.266	0.23	0.319	0.264	0.28800000000000003	0.289	0.303
brd-k01737880	Not Clinically Relevant	0.24100000000000002	0.22399999999999998	0.271	0.248	0.24100000000000002	0.228	0.23800000000000002	-0.212	0.233	0.23399999999999999	0.268	0.247	0.281	-0.16399999999999998	0.18600000000000003	0.24	0.209	0.215	0.332	0.259
ml210	Not Clinically Relevant	0.24100000000000002	0.28300000000000003	0.242	0.20800000000000002	0.22	0.245	0.27	0.231	0.27	0.262	0.25	0.258	0.253	0.243	0.21	0.239	0.23399999999999999	0.231	0.272	0.248
jw-7-24-1	Not Clinically Relevant	0.23800000000000002	0.26	0.282	0.261	-0.31	0.264	0.28	-0.259	-0.254	0.24100000000000002	0.285	0.28800000000000003	-0.22699999999999998	0.28	0.259	0.293	0.258	-0.26899999999999996	0.275	-0.29100000000000004
at7867	Not Clinically Relevant	0.237	0.297	0.244	0.26	0.248	0.228	0.268	0.256	0.262	0.293	0.256	0.267	0.23	0.225	0.247	0.26	0.268	0.21899999999999997	0.28600000000000003	0.251
dbeq	Not Clinically Relevant	0.235	0.268	0.221	0.23399999999999999	0.23399999999999999	0.243	0.23800000000000002	0.209	0.231	0.247	0.228	0.252	0.239	0.22899999999999998	0.221	0.247	0.203	0.222	0.263	0.285
genentech cpd 10	Not Clinically Relevant	0.23399999999999999	0.26899999999999996	0.285	0.225	-0.243	0.253	0.29100000000000004	0.22899999999999998	0.25	0.247	0.27899999999999997	0.267	0.242	0.308	0.271	0.297	0.244	0.247	0.28300000000000003	0.255
1s,3r-rsl-3	Not Clinically Relevant	0.23199999999999998	0.258	0.23	0.19	0.213	0.242	0.243	0.221	0.24600000000000002	0.256	0.237	0.235	0.22899999999999998	0.217	0.221	0.244	0.242	0.212	0.256	0.253
brd-k30748066	Not Clinically Relevant	0.231	0.171	0.256	0.239	0.21600000000000003	0.264	0.217	0.131	0.19	0.19399999999999998	0.20600000000000002	0.228	0.198	0.192	0.121	0.285	0.21100000000000002	0.23199999999999998	0.18600000000000003	0.179
stemregenin 1	Not Clinically Relevant	0.231	0.213	0.21	0.217	0.22899999999999998	-0.22899999999999998	0.23800000000000002	-0.212	-0.226	0.258	0.196	0.23600000000000002	0.21899999999999997	0.21100000000000002	-0.22899999999999998	-0.226	-0.212	0.214	0.23399999999999999	0.225
aew541	Not Clinically Relevant	0.228	0.252	0.192	0.25	0.201	0.182	0.256	0.203	0.282	0.256	0.245	0.26	0.22399999999999998	0.231	0.213	0.245	-0.20600000000000002	0.205	0.228	0.237
mln2480	TAK-580, pan-Raf kinase inhibitor	0.228	0.253	0.233	0.26899999999999996	0.218	0.242	0.294	-0.182	0.255	0.244	0.23600000000000002	0.265	0.192	0.249	0.18100000000000002	-0.244	0.237	0.218	0.253	0.249
lovastatin	HMG-CoA reductase inhibitor,	0.228	0.231	0.225	0.21	0.21600000000000003	0.22399999999999998	0.253	0.2	0.23	0.245	0.225	0.221	0.22	0.203	0.204	0.22399999999999998	0.185	0.198	0.254	-0.222
brd4132	Not Clinically Relevant	0.228	0.22	0.20600000000000002	0.182	0.244	0.226	0.23399999999999999	0.213	0.222	0.249	0.21899999999999997	0.228	0.225	0.193	0.20800000000000002	0.22699999999999998	0.21600000000000003	0.221	0.23600000000000002	0.243
wiki4	Not Clinically Relevant	0.225	0.272	0.263	0.23399999999999999	-0.27699999999999997	0.228	0.255	0.22	0.264	-0.237	0.231	0.27399999999999997	0.252	0.24600000000000002	0.21899999999999997	0.235	0.247	-0.268	0.258	-0.266
sns-032	CDK inhibitor, esp CDK2 , 7 and 9 	0.21899999999999997	0.207	0.212	0.20199999999999999	-0.204	0.221	0.21899999999999997	-0.225	-0.228	0.23800000000000002	-0.198	0.215	-0.196	-0.201	-0.213	0.21600000000000003	-0.19699999999999998	0.2	0.226	-0.209
myricetin	Not Clinically Relevant	0.20600000000000002	0.237	0.213	0.21899999999999997	0.22	0.233	0.251	0.188	0.225	0.24100000000000002	0.201	0.26	0.22	0.237	-0.19399999999999998	0.22	0.223	0.222	0.21899999999999997	0.235
mitomycin-c	DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis	0.201	0.207	0.22399999999999998	-0.214	-0.203	0.222	0.237	-0.172	0.23	-0.222	0.21	0.252	-0.203	0.226	0.2	0.213	-0.21	-0.21100000000000002	0.22	-0.235
fulvestrant	selective estrogen receptor degrader(SERD)	0.19899999999999998	0.253	0.262	0.24600000000000002	0.23800000000000002	0.27699999999999997	0.25	0.235	0.259	0.261	0.23600000000000002	0.226	0.222	0.242	0.24	0.267	0.215	0.242	0.263	0.267
thz-2-102-1	Not Clinically Relevant	0.18899999999999997	0.215	0.21600000000000003	0.18100000000000002	-0.267	0.245	0.261	-0.21100000000000002	0.21100000000000002	0.182	0.20199999999999999	0.231	-0.212	0.273	0.191	0.256	0.195	-0.221	0.228	-0.233
etoposide	Topo II inhibitor	0.068	0.294	0.28	0.046	0.036000000000000004	0.272	0.304	0.235	0.28600000000000003	0.061	0.282	0.29	0.043	0.265	0.239	0.297	0.264	0.026000000000000002	0.298	0.033
serdemetan	(JNJ-26854165) Mdm2antagonist, stabilizes p53	0.037000000000000005	0.049	0.03	0.03	0.036000000000000004	0.035	0.040999999999999995	0.013999999999999999	0.034	0.054000000000000006	0.032	0.052000000000000005	0.022000000000000002	0.039	0.026000000000000002	0.048	0.022000000000000002	0.017	0.045	0.043
topotecan	Topo I inhibitor	0.036000000000000004	0.268	0.057	0.25	0.026000000000000002	0.27	0.28600000000000003	0.027999999999999997	0.26899999999999996	0.305	0.28	0.275	0.266	0.257	0.054000000000000006	0.266	0.026000000000000002	0.055	0.272	0.272
doxorubicin	Topo II inhibitor, DNA intercalator	0.027999999999999997	0.044000000000000004	0.018000000000000002	0.01	0.027999999999999997	0.027999999999999997	0.031	0.024	0.009000000000000001	0.019	0.03	0.022000000000000002	0.027000000000000003	0.023	0.015	0.015	0.013999999999999999	0.005	0.040999999999999995	0.004
raf265	inhibitor ofC-Raf/B-Raf/B-Raf V600E	0.013000000000000001	0.023	0.017	0.027999999999999997	0.008	0.036000000000000004	0.040999999999999995	0.011000000000000001	0.032	0.009000000000000001	0.01	0.027999999999999997	0.012	0.044000000000000004	0.018000000000000002	0.012	0.018000000000000002	-0.001	0.025	0.021
gemcitabine	Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis	0.012	0.01	-0.019	0.013000000000000001	0.017	0.001	-0.003	0.006	-0.008	0.016	0.006999999999999999	0.005	0.026000000000000002	-0.01	0.002	-0.006999999999999999	-0.024	-0.011000000000000001	0.006999999999999999	-0.024
entinostat	HDAC inhibitor	0.008	0.28800000000000003	-0.02	0.012	0.027999999999999997	0.289	0.298	-0.27699999999999997	0.28600000000000003	0.008	0.252	0.29600000000000004	0.27699999999999997	0.282	0.001	0.312	-0.008	0.28	0.021	0.008
bi-2536	Plk1inhibitor, less active against Plk2 and Plk3.	0.006	0.011000000000000001	-0.02	-0.003	-0.002	0.01	-0.023	-0.024	-0.02	0.006	-0.011000000000000001	0.013999999999999999	-0.032	0.012	-0.025	-0.022000000000000002	-0.015	-0.016	0.001	-0.028999999999999998
sn-38	Topo I inhibitor, active metabolite of irinotecan but 1000 times more active	0.003	0.33399999999999996	-0.013000000000000001	-0.005	0.002	0.303	0.0	0.28600000000000003	-0.003	0.017	0.33299999999999996	0.33799999999999997	0.001	-0.013999999999999999	0.28300000000000003	0.002	0.302	-0.005	-0.004	-0.012
pha-793887	CDK inhibitor, esp CDK2, CDK5 and CDK7	-0.003	0.29100000000000004	-0.053	0.271	-0.083	0.312	0.316	-0.065	-0.024	0.301	0.278	0.316	-0.040999999999999995	0.298	0.256	0.307	-0.048	-0.07	0.324	-0.052000000000000005
mk-2206	Akt1/2/3 inhibitor	-0.004	-0.039	-0.035	-0.024	-0.021	-0.001	-0.017	-0.037000000000000005	-0.032	-0.002	-0.035	-0.017	-0.037000000000000005	-0.012	0.002	-0.012	-0.040999999999999995	-0.044000000000000004	-0.02	-0.016
l-685458	Not Clinically Relevant	-0.005	-0.294	-0.294	0.052000000000000005	0.006	-0.301	-0.302	-0.28800000000000003	-0.295	0.013000000000000001	-0.278	0.037000000000000005	-0.27899999999999997	-0.297	-0.29	-0.305	-0.292	-0.293	-0.282	-0.304
pik-93	Not Clinically Relevant	-0.006999999999999999	-0.001	-0.003	-0.003	-0.055999999999999994	0.31	0.304	-0.017	-0.027999999999999997	0.013000000000000001	0.278	0.302	-0.026000000000000002	0.275	0.268	0.314	-0.012	-0.026000000000000002	0.304	-0.031
tamoxifen	ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes	-0.011000000000000001	-0.022000000000000002	-0.02	-0.021	-0.011000000000000001	0.012	-0.026000000000000002	-0.026000000000000002	-0.03	0.021	-0.038	0.011000000000000001	-0.019	-0.012	-0.016	-0.017	-0.021	-0.039	-0.023	-0.021
azd7762	Chk1/ Chk2 inhibitor	-0.018000000000000002	-0.022000000000000002	-0.012	-0.022000000000000002	-0.022000000000000002	-0.005	-0.032	-0.02	-0.027000000000000003	0.006999999999999999	-0.013999999999999999	0.002	-0.021	-0.027000000000000003	-0.026000000000000002	-0.017	-0.022000000000000002	-0.027000000000000003	-0.002	-0.024
zstk474	PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3K	-0.02	-0.025	-0.03	-0.025	-0.052000000000000005	-0.008	-0.033	-0.037000000000000005	-0.036000000000000004	-0.012	-0.03	-0.013000000000000001	-0.04	-0.04	-0.02	-0.024	-0.034	-0.05	-0.02	-0.034
cabozantinib	MET, AXL, VEGFR and RET inhibitor	-0.023	-0.040999999999999995	-0.059000000000000004	-0.06	-0.04	-0.031	-0.043	-0.02	-0.049	-0.040999999999999995	-0.046	-0.053	-0.06	-0.048	-0.03	-0.027999999999999997	-0.040999999999999995	-0.07	-0.040999999999999995	-0.049
bms-536924	Not Clinically Relevant	-0.027000000000000003	-0.048	-0.068	-0.068	-0.04	0.31	-0.05	-0.057999999999999996	-0.064	-0.013000000000000001	-0.061	0.348	-0.064	0.324	-0.047	-0.055	-0.066	-0.067	-0.051	-0.052000000000000005
docetaxel	inhibits microtubule dynamics; semi-synthetic analogue ofpaclitaxel	-0.031	-0.004	-0.022000000000000002	-0.040999999999999995	-0.013999999999999999	-0.013000000000000001	-0.055	-0.04	-0.051	0.002	-0.034	-0.011000000000000001	-0.043	-0.038	-0.05	-0.038	-0.025	-0.023	-0.011000000000000001	-0.042
azd8055	mTORinhibitor	-0.037000000000000005	-0.048	-0.065	-0.046	-0.066	-0.01	-0.052000000000000005	-0.068	-0.057	-0.032	-0.048	-0.037000000000000005	-0.059000000000000004	-0.040999999999999995	-0.04	-0.043	-0.055999999999999994	-0.071	-0.045	-0.06
nutlin-3	Mdm2antagonist, stabilizes p53 	-0.039	-0.013000000000000001	-0.009000000000000001	-0.013000000000000001	-0.016	-0.028999999999999998	0.001	-0.037000000000000005	0.006	-0.013999999999999999	0.001	-0.008	-0.02	-0.023	-0.024	-0.038	-0.25	-0.011000000000000001	0.006	-0.006
pazopanib	KIT,FGFR,PDGFRandVEGFR inhibitor	-0.042	-0.07200000000000001	-0.113	-0.096	-0.067	-0.081	-0.096	-0.1	-0.096	-0.055999999999999994	-0.1	-0.092	-0.081	-0.09300000000000001	-0.077	-0.09300000000000001	-0.09300000000000001	-0.11599999999999999	-0.091	-0.10300000000000001
piperlongumine	Not Clinically Relevant	-0.043	-0.031	-0.064	-0.044000000000000004	-0.306	-0.298	-0.048	-0.27399999999999997	-0.059000000000000004	-0.03	-0.044000000000000004	-0.043	-0.044000000000000004	-0.049	-0.278	-0.045	-0.063	-0.06	-0.032	-0.053
sunitinib	VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3	-0.043	-0.06	-0.07	-0.047	-0.051	-0.04	-0.062	-0.065	-0.057	-0.053	-0.044000000000000004	-0.053	-0.077	-0.053	-0.049	-0.063	-0.07200000000000001	-0.068	-0.049	-0.078
methotrexate	antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins	-0.044000000000000004	0.043	0.057	0.23199999999999998	-0.276	0.25	0.256	-0.059000000000000004	0.24600000000000002	0.23	0.218	0.063	-0.04	0.258	0.032	0.073	-0.22399999999999998	-0.22	0.244	-0.23600000000000002
temozolomide	alkylating agent	-0.044000000000000004	-0.068	-0.085	-0.078	-0.062	0.318	-0.066	-0.07	-0.052000000000000005	-0.048	-0.08199999999999999	-0.057999999999999996	-0.044000000000000004	-0.073	-0.054000000000000006	-0.038	-0.076	-0.081	-0.078	-0.061
tpca-1	Not Clinically Relevant	-0.045	0.335	-0.067	0.306	-0.079	0.309	0.33899999999999997	-0.064	-0.065	-0.034	0.326	0.336	-0.057999999999999996	0.32	0.29600000000000004	0.32799999999999996	-0.062	-0.077	0.341	-0.066
pevonedistat	(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)	-0.045	-0.077	-0.094	-0.087	-0.06	-0.06	-0.083	-0.057999999999999996	-0.073	-0.057999999999999996	-0.071	-0.063	-0.071	-0.064	-0.063	-0.057999999999999996	-0.096	-0.09300000000000001	-0.068	-0.07400000000000001
nvp-tae684	Not Clinically Relevant	-0.047	-0.048	-0.09	-0.069	-0.047	-0.055	-0.081	-0.062	-0.07400000000000001	-0.042	-0.065	-0.040999999999999995	-0.061	-0.061	-0.07400000000000001	-0.085	-0.073	-0.086	-0.084	-0.071
ku-55933	Not Clinically Relevant	-0.047	-0.07	-0.08	-0.068	-0.054000000000000006	-0.042	-0.057999999999999996	-0.046	-0.057	-0.054000000000000006	-0.077	-0.037000000000000005	-0.055	-0.057999999999999996	-0.039	-0.052000000000000005	-0.066	-0.064	-0.07400000000000001	-0.07
mg-132	Not Clinically Relevant	-0.05	-0.017	-0.04	-0.011000000000000001	-0.054000000000000006	-0.052000000000000005	-0.034	-0.038	-0.052000000000000005	-0.049	-0.023	-0.046	-0.055999999999999994	-0.045	-0.055999999999999994	-0.048	-0.054000000000000006	-0.04	-0.038	-0.044000000000000004
bms-345541	Not Clinically Relevant	-0.052000000000000005	0.28600000000000003	0.302	0.282	-0.07200000000000001	0.302	0.316	-0.27899999999999997	0.29600000000000004	-0.039	0.27699999999999997	0.316	-0.04	0.298	0.046	0.306	-0.261	-0.046	0.302	-0.052000000000000005
temsirolimus	Not Clinically Relevant	-0.066	-0.079	-0.08	-0.08199999999999999	-0.084	-0.055	-0.076	-0.076	-0.077	-0.075	-0.067	-0.06	-0.08900000000000001	-0.067	-0.079	-0.05	-0.09	-0.084	-0.054000000000000006	-0.07400000000000001
chir-99021	Not Clinically Relevant	-0.069	-0.084	-0.092	-0.07400000000000001	-0.071	-0.09699999999999999	-0.1	-0.076	-0.083	-0.081	-0.084	-0.079	-0.07	-0.09300000000000001	-0.055	-0.085	-0.08199999999999999	-0.096	-0.094	-0.086
bexarotene	retinoidthat selectively activatesretinoid X receptors(RXRs), induces cell differentiation and apoptosis	-0.077	-0.06	-0.078	-0.092	-0.07400000000000001	-0.052000000000000005	-0.073	-0.096	-0.084	-0.07	-0.08199999999999999	-0.048	-0.066	-0.069	-0.079	-0.040999999999999995	-0.047	-0.05	-0.084	-0.059000000000000004
osi-930	inhibitor ofKit,KDRandCSF-1R; also potent to Flt-1, c-Raf and Lck	-0.08	-0.016	-0.073	-0.064	-0.341	-0.027000000000000003	-0.34600000000000003	-0.311	-0.038	-0.052000000000000005	-0.06	-0.039	-0.094	-0.016	-0.325	-0.336	-0.316	-0.294	-0.055	-0.092
azd6482	PI3Kinhibitor, less active against PI3K, PI3K and PI3K	-0.08	-0.102	-0.111	-0.10400000000000001	-0.078	-0.079	-0.094	-0.066	-0.111	-0.08900000000000001	-0.094	-0.094	-0.10400000000000001	-0.10300000000000001	-0.07	-0.106	-0.085	-0.1	-0.107	-0.109
dabrafenib	Braf (V600E) inhibitor	-0.087	-0.51	-0.06	-0.049	-0.488	-0.466	-0.057	-0.475	-0.051	-0.496	-0.052000000000000005	-0.526	-0.08199999999999999	-0.494	-0.084	-0.496	-0.47200000000000003	-0.068	-0.532	-0.527
tretinoin	Retinoid	-0.096	-0.084	-0.083	0.48100000000000004	-0.067	0.494	-0.079	-0.10300000000000001	-0.105	-0.055999999999999994	0.494	0.52	-0.099	0.484	-0.081	0.516	-0.098	-0.096	-0.087	-0.094
pac-1	Not Clinically Relevant	-0.1	-0.098	-0.128	-0.131	-0.08800000000000001	0.37	-0.11199999999999999	-0.342	-0.131	-0.094	-0.132	-0.10400000000000001	-0.11599999999999999	0.349	-0.11	0.369	-0.12300000000000001	-0.127	-0.115	-0.11800000000000001
paclitaxel	disrupts microtubule dynamics	-0.115	0.044000000000000004	-0.11599999999999999	0.040999999999999995	-0.10300000000000001	0.059000000000000004	0.006999999999999999	-0.10400000000000001	-0.106	-0.10400000000000001	-0.106	0.043	-0.11	-0.106	-0.113	-0.096	-0.10400000000000001	-0.1	0.044000000000000004	-0.121
parthenolide	Not Clinically Relevant	-0.122	-0.102	-0.125	-0.107	-0.12	-0.125	-0.11800000000000001	-0.11900000000000001	-0.131	-0.122	-0.354	-0.124	-0.36	-0.107	-0.336	-0.122	-0.366	-0.124	-0.113	-0.122
bosutinib	BCR-Abl, Src, Lyn and Hck inhibitor	-0.138	-0.384	-0.38	-0.38	-0.10400000000000001	-0.109	-0.391	-0.354	-0.39399999999999996	-0.37799999999999995	-0.385	-0.376	-0.136	-0.387	-0.354	-0.13	-0.355	-0.376	-0.402	-0.39299999999999996
sorafenib	VEGFR,PDGFRandRaf (c-Raf) inhibitor	-0.141	-0.135	-0.156	-0.011000000000000001	-0.13699999999999998	-0.12	-0.151	-0.147	-0.151	-0.156	-0.12	-0.151	-0.14	-0.145	-0.139	-0.14300000000000002	-0.153	-0.157	-0.14800000000000002	-0.153
crizotinib	ALK, ROS1 and MET inhibitor	-0.14400000000000002	-0.099	-0.16399999999999998	-0.145	-0.136	-0.136	-0.134	-0.42	-0.139	-0.128	-0.133	-0.111	-0.166	-0.125	-0.151	-0.11699999999999999	-0.446	-0.14400000000000002	-0.135	-0.174
linifanib	RTK inhibitor,targets VEGFR, PDGFR,KDR, andCSF-1R	-0.18	-0.204	-0.215	-0.17800000000000002	-0.456	-0.15	-0.19	-0.505	-0.428	-0.16899999999999998	-0.44799999999999995	-0.153	-0.47600000000000003	-0.168	-0.441	-0.20199999999999999	-0.49700000000000005	-0.455	-0.201	-0.18899999999999997
brd-k71935468	Not Clinically Relevant	-0.18	-0.16699999999999998	-0.156	-0.179	-0.203	-0.172	-0.20600000000000002	0.165	-0.195	-0.179	-0.16399999999999998	-0.215	-0.174	-0.203	0.18	-0.191	-0.17	-0.174	-0.185	-0.20800000000000002
quizartinib	Flt3 inhibitor	-0.192	-0.188	-0.22699999999999998	0.45	-0.179	0.434	0.49700000000000005	-0.2	-0.21	-0.135	-0.152	0.451	-0.20199999999999999	0.444	0.44	0.456	-0.198	-0.205	-0.213	-0.21899999999999997
sepantronium bromide	YM155 (Sepantronium Bromide), survivinsuppressant	-0.20600000000000002	-0.209	-0.233	0.198	-0.21899999999999997	0.21100000000000002	-0.213	-0.19699999999999998	-0.23800000000000002	-0.217	-0.221	0.249	-0.198	0.22899999999999998	0.18899999999999997	-0.243	-0.217	-0.243	0.218	-0.255
bafilomycin a1	Not Clinically Relevant	-0.209	-0.242	-0.2	-0.228	-0.242	-0.2	-0.21600000000000003	-0.237	-0.259	-0.196	-0.222	-0.185	-0.198	0.245	-0.231	-0.215	-0.243	-0.22699999999999998	-0.22899999999999998	-0.23
ipa-3	Not Clinically Relevant	-0.215	-0.22899999999999998	-0.249	-0.23	-0.3	-0.198	-0.26	-0.256	-0.256	-0.23600000000000002	0.23199999999999998	-0.226	-0.251	-0.239	-0.23199999999999998	-0.212	-0.223	-0.254	-0.239	-0.273
sid 26681509	Not Clinically Relevant	-0.21899999999999997	0.22	0.19699999999999998	0.209	-0.221	-0.205	0.221	-0.193	0.213	0.24600000000000002	0.198	0.242	0.204	-0.23	0.20600000000000002	-0.21600000000000003	0.192	0.205	0.24	0.221
brd-k33514849	Not Clinically Relevant	-0.21899999999999997	-0.182	0.201	-0.22	-0.19	-0.243	0.191	-0.196	-0.198	-0.198	0.195	0.203	-0.225	0.20600000000000002	-0.20800000000000002	-0.217	-0.21	-0.17600000000000002	0.239	-0.228
vinorelbine	Not Clinically Relevant	-0.225	-0.252	-0.265	-0.255	-0.23600000000000002	-0.249	-0.292	-0.21100000000000002	-0.254	-0.253	-0.242	-0.281	-0.24100000000000002	-0.27399999999999997	-0.237	-0.256	-0.244	-0.27699999999999997	-0.26	-0.317
brd-k97651142	Not Clinically Relevant	-0.226	-0.237	-0.233	-0.21600000000000003	-0.245	-0.23399999999999999	-0.243	-0.25	-0.244	0.263	-0.20800000000000002	-0.27	-0.20800000000000002	-0.22899999999999998	-0.214	-0.254	-0.212	-0.23399999999999999	-0.249	-0.235
ym-155	YM155 (Sepantronium Bromide), survivinsuppressant	-0.22699999999999998	0.261	0.256	0.266	-0.251	0.276	0.267	0.23600000000000002	0.255	0.254	0.237	0.252	0.226	0.256	0.225	0.245	0.257	0.249	0.255	-0.281
brd-k63431240	Not Clinically Relevant	-0.22899999999999998	-0.245	-0.21899999999999997	0.187	-0.256	-0.20600000000000002	-0.242	-0.21100000000000002	-0.24	-0.226	-0.215	-0.248	-0.21600000000000003	-0.20600000000000002	-0.20600000000000002	-0.231	-0.223	-0.20600000000000002	-0.235	-0.258
azd0530	kinase inhibitor, with selectivity againstSrc andBcr-Abl	-0.231	-0.24	-0.21600000000000003	-0.235	-0.198	-0.218	-0.245	-0.209	-0.233	-0.257	-0.239	-0.23199999999999998	-0.22399999999999998	-0.23199999999999998	-0.247	-0.25	-0.214	-0.19699999999999998	-0.26	-0.251
phenformin	Anti-diabetic AMPK Activator - mTOR Inhibitor- Autophagy inducer	-0.231	-0.242	-0.233	-0.248	-0.272	0.237	-0.272	-0.26	-0.255	-0.243	-0.237	-0.254	-0.237	-0.26899999999999996	-0.20600000000000002	-0.267	-0.22899999999999998	-0.29600000000000004	-0.257	-0.267
dacinostat	Not Clinically Relevant	-0.23399999999999999	-0.228	-0.226	-0.226	-0.284	0.27	0.278	-0.259	-0.244	-0.248	0.23	0.24600000000000002	-0.22899999999999998	0.282	0.212	0.29100000000000004	-0.256	-0.266	0.251	-0.257
tw 37	Not Clinically Relevant	-0.23399999999999999	0.275	-0.267	0.22	-0.221	-0.22899999999999998	-0.25	0.245	-0.26899999999999996	-0.252	0.249	0.24600000000000002	-0.24600000000000002	0.25	-0.23199999999999998	-0.273	0.27899999999999997	-0.248	-0.26	-0.265
17-aag	Not Clinically Relevant	-0.23600000000000002	-0.265	-0.264	-0.235	-0.214	-0.231	-0.255	-0.226	-0.29100000000000004	-0.255	-0.24100000000000002	-0.217	-0.251	-0.278	-0.223	-0.248	-0.251	-0.231	-0.24600000000000002	-0.271
ql-xii-47	Not Clinically Relevant	-0.237	0.266	0.244	-0.23	-0.262	0.233	0.23	-0.228	0.248	-0.218	0.23	0.24600000000000002	-0.20199999999999999	0.252	0.191	0.23399999999999999	0.22	0.24600000000000002	0.24100000000000002	-0.24600000000000002
neratinib	Her2 and EGFR inhibitor	-0.239	-0.293	-0.253	-0.22399999999999998	-0.23800000000000002	-0.276	-0.289	-0.268	-0.289	-0.257	-0.273	-0.233	-0.237	-0.257	-0.254	-0.235	-0.243	-0.259	-0.258	-0.251
brd8958	Not Clinically Relevant	-0.24	0.24600000000000002	-0.23199999999999998	-0.23600000000000002	-0.231	-0.248	-0.266	-0.237	-0.242	-0.264	0.218	-0.247	-0.223	-0.248	-0.231	-0.257	-0.257	-0.213	-0.239	-0.247
tae684	Not Clinically Relevant	-0.243	0.24	-0.22699999999999998	0.24	-0.218	-0.218	-0.242	-0.245	0.244	-0.26	-0.22699999999999998	0.245	-0.226	-0.255	-0.23800000000000002	-0.24100000000000002	-0.258	-0.226	-0.247	-0.237
austocystin d	Not Clinically Relevant	-0.243	-0.281	-0.26899999999999996	-0.225	0.243	-0.27699999999999997	-0.278	-0.272	-0.302	-0.272	-0.26899999999999996	-0.235	-0.245	-0.23	-0.275	-0.22699999999999998	-0.265	-0.27899999999999997	-0.273	0.249
avicin d	Not Clinically Relevant	-0.245	-0.237	-0.248	-0.266	-0.23399999999999999	-0.235	-0.218	-0.195	-0.231	-0.252	-0.23	-0.249	-0.233	-0.233	-0.203	-0.239	-0.222	-0.257	-0.247	-0.28600000000000003
brd-k48477130	Not Clinically Relevant	-0.245	-0.282	-0.257	-0.294	-0.271	-0.261	-0.262	-0.244	-0.27	-0.305	-0.276	-0.271	-0.263	-0.275	-0.221	-0.267	-0.23199999999999998	-0.252	-0.29	-0.28
tl-1-85	Not Clinically Relevant	-0.24600000000000002	-0.259	-0.27899999999999997	-0.23199999999999998	-0.354	-0.2	-0.261	-0.3	-0.27	-0.242	-0.255	-0.22699999999999998	-0.27399999999999997	-0.23199999999999998	-0.252	-0.264	-0.29	-0.319	-0.262	-0.28
mln2238	Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (5) site of the 20S proteasome 	-0.248	-0.233	-0.22699999999999998	0.263	-0.275	-0.223	-0.24	-0.222	-0.255	0.262	0.24	-0.29	0.19699999999999998	-0.257	-0.21600000000000003	-0.272	-0.222	-0.228	-0.259	-0.24600000000000002
zd-6474	VEGFR, EGFR and RET inhibitor	-0.248	-0.27399999999999997	-0.253	-0.228	-0.23800000000000002	-0.23	-0.262	-0.24	-0.254	-0.28600000000000003	-0.242	-0.266	-0.237	-0.253	-0.249	-0.24	-0.243	-0.237	-0.273	-0.267
brefeldin a	Not Clinically Relevant	-0.249	-0.249	-0.253	0.225	-0.22699999999999998	-0.275	-0.27	-0.243	-0.254	-0.23600000000000002	-0.245	-0.242	-0.23199999999999998	-0.253	-0.231	-0.235	-0.22899999999999998	-0.247	-0.255	-0.23399999999999999
brd-k09344309	Not Clinically Relevant	-0.25	-0.233	-0.254	-0.24	-0.319	-0.257	-0.231	-0.19699999999999998	-0.275	0.19	-0.265	-0.285	-0.215	-0.248	-0.23800000000000002	-0.301	-0.24100000000000002	-0.254	-0.278	-0.256
lestauritinib	Not Clinically Relevant	-0.252	-0.264	-0.27699999999999997	-0.265	-0.285	-0.239	-0.284	-0.247	-0.282	-0.27899999999999997	-0.258	-0.278	-0.256	-0.27399999999999997	-0.23800000000000002	-0.3	-0.263	-0.27899999999999997	-0.27699999999999997	-0.308
sb590885	Not Clinically Relevant	-0.253	-0.254	-0.276	-0.256	-0.244	-0.28	-0.272	-0.248	-0.26	-0.27399999999999997	-0.26	-0.281	-0.264	-0.258	-0.266	-0.263	-0.247	-0.261	-0.276	-0.278
valdecoxib	NSAID used in the treatment of osteoarthritis, rheumatoid arthritis	-0.255	-0.231	-0.239	-0.233	-0.27699999999999997	-0.275	-0.261	-0.258	-0.257	0.261	-0.253	-0.252	-0.253	0.22399999999999998	-0.23	-0.271	-0.24100000000000002	-0.247	-0.24	-0.24100000000000002
bec	Not Clinically Relevant	-0.255	-0.225	-0.22399999999999998	-0.175	-0.29100000000000004	-0.215	-0.22899999999999998	-0.209	-0.282	-0.21899999999999997	-0.209	-0.19	-0.222	-0.239	-0.212	-0.271	-0.22699999999999998	-0.223	-0.254	-0.20199999999999999
spautin-1	Not Clinically Relevant	-0.255	-0.263	-0.245	0.225	-0.275	-0.265	-0.267	-0.26	-0.257	-0.25	-0.23399999999999999	-0.26899999999999996	-0.243	-0.258	-0.23	-0.265	-0.253	-0.247	-0.243	-0.266
snx-2112	Not Clinically Relevant	-0.256	-0.016	-0.242	-0.023	-0.298	0.255	0.027999999999999997	-0.24600000000000002	-0.27399999999999997	-0.003	-0.22899999999999998	-0.004	-0.021	0.027999999999999997	-0.222	0.027000000000000003	-0.22899999999999998	-0.259	-0.018000000000000002	-0.259
ng-25	Not Clinically Relevant	-0.257	-0.258	-0.26899999999999996	-0.254	-0.358	-0.203	-0.258	-0.298	-0.266	-0.237	-0.24100000000000002	-0.228	-0.263	0.24	-0.23	-0.23800000000000002	-0.276	-0.3	-0.251	-0.268
brd-k94991378	Not Clinically Relevant	-0.257	0.239	0.243	0.22	-0.264	-0.245	0.254	0.248	0.24600000000000002	-0.263	0.212	-0.301	0.247	-0.23800000000000002	0.242	-0.28	0.237	0.239	-0.233	0.263
col-3	matrix metalloproteinase (MMP) inhibitor	-0.258	-0.249	-0.287	-0.228	-0.23600000000000002	-0.258	-0.262	-0.294	-0.273	-0.261	-0.289	-0.249	-0.263	0.209	-0.23399999999999999	-0.257	-0.24600000000000002	-0.273	-0.271	-0.233
vu0155056	Not Clinically Relevant	-0.258	-0.285	0.253	0.249	0.281	0.284	-0.298	0.23399999999999999	-0.326	-0.295	0.263	0.292	-0.252	-0.295	0.263	-0.28	-0.23800000000000002	0.271	0.28	-0.311
brd-a05715709	Not Clinically Relevant	-0.258	-0.304	-0.265	-0.308	-0.27699999999999997	-0.276	-0.298	-0.265	-0.276	-0.324	-0.27399999999999997	0.275	-0.28800000000000003	-0.308	-0.24600000000000002	-0.27	-0.26	-0.257	-0.301	-0.28300000000000003
jq1	Not Clinically Relevant	-0.259	-0.26899999999999996	-0.275	-0.265	-0.252	-0.237	-0.284	-0.237	-0.264	-0.245	-0.242	-0.27399999999999997	-0.221	-0.231	-0.23399999999999999	-0.245	-0.23399999999999999	-0.26899999999999996	-0.273	-0.275
brd-a86708339	Not Clinically Relevant	-0.261	0.314	0.252	0.258	0.29	0.249	0.28300000000000003	-0.255	0.255	0.315	0.247	0.293	0.239	0.257	-0.23399999999999999	0.267	-0.275	0.242	0.308	0.285
marinopyrrole a	Not Clinically Relevant	-0.261	0.278	0.27	0.287	-0.272	0.27699999999999997	0.26	-0.26899999999999996	0.285	0.28600000000000003	0.27	0.272	-0.294	0.26	-0.23	0.24600000000000002	-0.254	-0.251	0.289	0.289
5-fluorouracil	antimetabolite	-0.261	0.307	0.282	0.239	-0.299	0.297	0.312	-0.28	0.278	0.24600000000000002	0.254	0.304	-0.247	0.322	0.223	0.315	-0.278	-0.276	0.28	-0.273
bcl-lzh-4	Not Clinically Relevant	-0.261	-0.303	-0.304	-0.314	-0.273	-0.33899999999999997	-0.309	-0.287	-0.29	-0.36700000000000005	-0.29100000000000004	-0.335	-0.297	-0.32899999999999996	-0.256	-0.289	-0.271	-0.272	-0.315	-0.309
canertinib	pan-ErbB inhibitor for EGFR and ErbB2,  no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.	-0.261	-0.289	-0.268	-0.26	0.253	-0.253	-0.276	-0.24100000000000002	-0.298	-0.271	-0.265	0.255	-0.251	-0.24600000000000002	-0.258	0.259	-0.239	-0.28300000000000003	-0.257	-0.272
khs101	Not Clinically Relevant	-0.262	-0.242	-0.22899999999999998	-0.195	-0.284	-0.25	-0.242	-0.254	-0.261	-0.254	-0.257	-0.23600000000000002	-0.242	-0.231	-0.26	-0.264	-0.247	-0.254	-0.251	-0.263
camptothecin	Not Clinically Relevant	-0.262	0.3	0.27	-0.257	-0.25	0.258	0.309	0.251	0.293	-0.27699999999999997	0.26899999999999996	0.302	-0.25	0.312	0.285	0.305	0.267	-0.253	0.304	-0.295
yk-4-279	Not Clinically Relevant	-0.262	-0.307	-0.314	-0.295	-0.287	-0.27	-0.326	-0.27899999999999997	-0.312	-0.307	-0.282	-0.287	-0.307	-0.266	-0.282	-0.27899999999999997	-0.298	-0.313	-0.28800000000000003	-0.316
ver-155008	Not Clinically Relevant	-0.264	-0.264	-0.256	-0.242	-0.268	-0.264	-0.284	-0.253	-0.26	-0.272	-0.23800000000000002	-0.27699999999999997	-0.257	-0.259	-0.247	-0.28300000000000003	-0.243	-0.243	-0.26	-0.304
elesclomol	Not Clinically Relevant	-0.265	-0.275	-0.262	-0.266	-0.272	-0.252	-0.29600000000000004	-0.27399999999999997	-0.321	-0.275	-0.254	-0.28	-0.262	-0.26	-0.275	-0.275	-0.29100000000000004	-0.263	-0.28	-0.298
tki258	Not Clinically Relevant	-0.266	-0.261	-0.24100000000000002	0.237	-0.245	-0.23399999999999999	0.24	-0.24600000000000002	0.252	-0.289	-0.264	-0.247	0.259	-0.244	-0.261	-0.256	-0.242	-0.233	-0.271	-0.239
gsk-j4	Not Clinically Relevant	-0.267	0.254	0.231	-0.263	-0.3	-0.225	0.19899999999999998	-0.28300000000000003	0.19399999999999998	-0.245	0.226	0.24100000000000002	0.253	0.276	-0.223	-0.226	-0.23800000000000002	0.245	0.276	0.251
epothilone b	Not Clinically Relevant	-0.268	-0.27	-0.26899999999999996	-0.27699999999999997	-0.247	-0.23399999999999999	-0.299	-0.225	-0.271	-0.272	-0.252	-0.259	-0.254	-0.253	-0.242	-0.282	-0.27699999999999997	-0.295	-0.249	-0.3
c6-ceramide	Not Clinically Relevant	-0.268	-0.258	-0.249	-0.28	-0.278	-0.26	-0.295	-0.251	-0.308	-0.28300000000000003	-0.264	0.28	-0.249	-0.28300000000000003	-0.267	-0.265	-0.263	-0.258	-0.278	-0.28300000000000003
tosedostat	inhibitor of the M1 family of aminopeptidases	-0.27	-0.256	-0.247	-0.25	-0.282	0.267	-0.255	-0.272	-0.292	0.27699999999999997	-0.23199999999999998	0.261	-0.24	-0.263	-0.268	0.254	-0.24100000000000002	-0.263	0.258	0.258
lapatinib	HER2/EGFR inhibitor	-0.27	-0.321	-0.28600000000000003	-0.29	-0.10400000000000001	-0.298	-0.332	-0.268	-0.319	-0.298	-0.318	-0.10099999999999999	-0.27899999999999997	-0.295	-0.27399999999999997	-0.307	-0.28800000000000003	-0.285	-0.307	-0.306
azd7545	Not Clinically Relevant	-0.271	-0.255	-0.251	0.242	-0.289	-0.27	0.258	-0.264	-0.285	0.281	-0.255	-0.268	0.251	-0.254	-0.253	-0.28600000000000003	-0.253	-0.258	-0.273	-0.26899999999999996
vinblastine	disrupts microtubule dynamics; vinca alkaloid, chemical analogue of vincristine	-0.271	-0.27399999999999997	-0.293	-0.27	-0.29100000000000004	-0.254	-0.306	-0.249	-0.3	-0.278	-0.271	-0.271	-0.263	-0.28	-0.272	-0.305	-0.276	-0.299	-0.287	-0.317
omipalisib	Not Clinically Relevant	-0.272	-0.263	-0.287	-0.266	-0.33399999999999996	0.289	-0.297	-0.304	-0.308	-0.27899999999999997	-0.264	-0.305	-0.281	-0.28300000000000003	-0.249	-0.281	-0.27699999999999997	-0.304	-0.28	-0.32299999999999995
dmog	Not Clinically Relevant	-0.272	-0.254	-0.27899999999999997	-0.285	-0.306	-0.27399999999999997	-0.276	-0.22899999999999998	-0.27699999999999997	-0.262	-0.254	-0.252	-0.264	-0.271	-0.235	-0.27	-0.249	-0.282	-0.255	-0.29
bay-61-3606	Not Clinically Relevant	-0.273	-0.28800000000000003	-0.276	-0.275	-0.293	-0.256	-0.28800000000000003	-0.287	-0.28800000000000003	-0.276	-0.27	-0.28	-0.3	-0.261	-0.248	-0.282	-0.276	-0.3	-0.29	-0.304
brd-k55116708	Not Clinically Relevant	-0.27399999999999997	-0.264	-0.257	0.225	-0.299	-0.258	-0.272	-0.22	-0.266	-0.282	-0.244	-0.268	-0.245	-0.256	-0.23	-0.29	-0.237	-0.24600000000000002	-0.272	-0.294
gsk650394	Not Clinically Relevant	-0.275	-0.301	-0.299	-0.281	-0.247	-0.255	-0.293	-0.263	-0.303	-0.289	-0.27	-0.264	-0.275	-0.258	-0.242	-0.265	-0.297	-0.312	-0.295	-0.3
cp466722	Not Clinically Relevant	-0.275	-0.275	-0.272	-0.237	-0.332	0.255	0.257	-0.29	-0.278	-0.27	0.268	0.268	-0.26	0.276	0.24600000000000002	0.261	-0.28	-0.262	-0.254	-0.26899999999999996
brd-k48334597	Not Clinically Relevant	-0.275	-0.273	0.29600000000000004	-0.245	0.27	-0.273	0.24600000000000002	0.244	-0.303	0.258	0.251	-0.251	0.23800000000000002	0.257	0.225	-0.252	-0.263	0.267	0.257	-0.28
thz-2-49	Not Clinically Relevant	-0.276	-0.293	-0.29	-0.259	-0.341	-0.23600000000000002	-0.29600000000000004	-0.28	-0.292	-0.267	-0.271	-0.271	-0.29	-0.26	-0.259	-0.285	-0.267	-0.297	-0.272	-0.304
brd-k71781559	Not Clinically Relevant	-0.27699999999999997	-0.298	0.276	-0.275	0.3	-0.308	-0.322	0.263	-0.314	-0.316	0.27	-0.324	-0.27399999999999997	-0.294	-0.257	-0.32799999999999996	-0.249	0.284	-0.29600000000000004	-0.304
seliciclib	Not Clinically Relevant	-0.278	-0.318	-0.303	-0.321	-0.275	-0.29100000000000004	-0.32299999999999995	-0.28600000000000003	-0.324	-0.316	-0.29	-0.319	-0.32799999999999996	-0.292	-0.285	-0.308	-0.272	-0.284	-0.324	-0.335
gw843682x	Not Clinically Relevant	-0.28	-0.27699999999999997	-0.289	-0.24	-0.3	-0.294	-0.306	-0.262	-0.292	-0.304	-0.278	-0.294	-0.301	-0.272	-0.252	-0.294	-0.282	-0.252	-0.307	-0.325
nelarabine	purinenucleosideanalog, which causes inhibition ofDNA synthesisand cytotoxicity	-0.281	-0.275	-0.275	-0.26	-0.28800000000000003	-0.27	-0.292	-0.23600000000000002	-0.27	-0.29600000000000004	-0.26	-0.28800000000000003	-0.278	-0.264	-0.24100000000000002	-0.287	-0.257	-0.272	-0.282	-0.312
bx796	Not Clinically Relevant	-0.28300000000000003	-0.29	-0.304	-0.272	-0.258	-0.245	-0.304	-0.252	-0.293	-0.295	0.26	0.267	-0.253	-0.262	0.231	-0.287	-0.266	-0.29	-0.314	-0.301
fedratinib	JAK2inhibitor	-0.284	0.3	-0.324	0.284	-0.33899999999999997	0.29600000000000004	0.326	-0.317	-0.33399999999999996	-0.28	0.326	0.299	-0.309	0.336	0.303	0.313	-0.305	-0.325	0.325	-0.322
sj-172550	Not Clinically Relevant	-0.284	-0.278	-0.28600000000000003	-0.275	-0.317	-0.282	-0.262	-0.249	-0.289	-0.287	-0.254	-0.289	-0.302	-0.251	-0.281	-0.275	-0.257	-0.29600000000000004	-0.28800000000000003	-0.29100000000000004
cid-5951923	Not Clinically Relevant	-0.284	-0.263	-0.266	-0.27399999999999997	-0.284	-0.259	-0.301	-0.247	-0.28300000000000003	-0.297	-0.26	-0.278	-0.265	-0.276	-0.264	-0.292	-0.264	-0.266	-0.29	-0.29100000000000004
simvastatin	HMG-CoA reductase inhibitor,	-0.28600000000000003	0.255	-0.267	0.24600000000000002	-0.278	-0.284	-0.26899999999999996	0.275	0.273	0.297	0.254	0.278	0.257	-0.271	0.254	-0.262	0.249	0.264	0.275	-0.272
pfi-1	Not Clinically Relevant	-0.28800000000000003	-0.28300000000000003	-0.331	-0.267	-0.284	-0.264	-0.32799999999999996	-0.263	-0.321	-0.28800000000000003	-0.293	-0.302	-0.28300000000000003	-0.307	-0.261	-0.278	-0.268	-0.321	-0.295	-0.325
pd-0325901	Not Clinically Relevant	-0.29100000000000004	-0.289	-0.26	-0.23399999999999999	-0.247	-0.258	-0.281	-0.253	-0.271	-0.28600000000000003	-0.257	-0.263	-0.28	-0.23199999999999998	-0.278	-0.24100000000000002	-0.263	-0.23399999999999999	-0.28600000000000003	-0.27899999999999997
saracatinib	kinase inhibitor, with selectivity againstSrc andBcr-Abl	-0.292	-0.3	-0.292	-0.284	-0.276	-0.28600000000000003	-0.336	-0.27399999999999997	-0.31	-0.298	-0.297	-0.292	-0.267	-0.28800000000000003	-0.26899999999999996	-0.308	-0.276	-0.28600000000000003	-0.31	-0.304
shikonin	Not Clinically Relevant	-0.293	-0.29	-0.298	-0.336	-0.313	-0.275	-0.293	-0.273	-0.318	-0.298	-0.28800000000000003	-0.303	-0.26	-0.285	-0.26	-0.303	-0.27	-0.316	-0.28800000000000003	-0.358
pyrimethamine	Not Clinically Relevant	-0.294	-0.36	-0.33799999999999997	-0.318	-0.317	-0.304	-0.354	-0.26899999999999996	-0.35100000000000003	-0.361	-0.327	-0.34700000000000003	-0.303	-0.312	-0.27399999999999997	-0.355	-0.306	-0.312	-0.353	-0.349
thapsigargin	Not Clinically Relevant	-0.295	-0.317	-0.316	-0.322	-0.272	-0.305	-0.337	-0.26899999999999996	-0.317	-0.33799999999999997	-0.297	-0.325	-0.316	-0.327	-0.317	-0.317	-0.313	-0.32799999999999996	-0.32299999999999995	-0.38
at-7519	Not Clinically Relevant	-0.29600000000000004	-0.266	-0.295	-0.268	-0.381	0.29600000000000004	0.305	-0.319	-0.282	-0.265	-0.257	0.304	-0.29600000000000004	0.293	0.22899999999999998	0.29600000000000004	-0.281	-0.302	0.261	-0.327
erlotinib	EGFR inhibitor (Tarceva)	-0.29600000000000004	-0.341	-0.325	-0.317	-0.302	-0.32799999999999996	-0.36200000000000004	-0.29600000000000004	-0.344	-0.326	-0.326	-0.341	-0.306	-0.32899999999999996	-0.317	-0.331	-0.298	-0.318	-0.349	-0.36200000000000004
ifosfamide	alkylating agent, nitrogen mustardfamily, works by disrupting the duplication ofDNAand the creation ofRNA	-0.297	-0.303	-0.28600000000000003	-0.29	-0.293	-0.268	-0.307	-0.262	-0.32899999999999996	0.289	-0.28600000000000003	-0.27699999999999997	-0.302	0.301	-0.303	-0.306	-0.278	-0.275	-0.285	-0.284
azacitidine	Nucleoside analog, inhibitor of DNA methylation and DNA/RNA synthesis (Vidaza)	-0.298	-0.301	-0.281	-0.28300000000000003	-0.335	-0.319	-0.32899999999999996	-0.294	-0.316	-0.324	-0.273	-0.319	-0.281	-0.316	-0.28300000000000003	-0.32899999999999996	-0.31	-0.282	-0.305	-0.301
plx4720	Not Clinically Relevant	-0.298	-0.301	-0.263	-0.281	-0.293	-0.285	0.34	-0.273	0.349	-0.36	0.312	-0.308	-0.306	-0.317	-0.289	-0.301	-0.284	-0.27399999999999997	-0.28600000000000003	-0.297
pd-0332991	CDK4/6 inhibitor	-0.298	-0.259	-0.267	-0.23199999999999998	-0.33	-0.247	-0.285	-0.297	-0.264	-0.285	-0.24600000000000002	-0.278	-0.253	-0.29600000000000004	-0.265	-0.255	-0.281	-0.268	-0.249	-0.235
ml334 diastereomer	Not Clinically Relevant	-0.298	-0.28	-0.295	-0.293	-0.304	-0.27699999999999997	-0.29	-0.268	-0.281	-0.319	-0.282	-0.289	-0.265	-0.282	-0.276	-0.304	-0.293	-0.278	-0.313	-0.312
gdc-0879	Not Clinically Relevant	-0.3	-0.293	-0.289	-0.271	-0.317	-0.298	-0.284	-0.271	-0.315	-0.32	-0.259	-0.309	-0.285	-0.27699999999999997	-0.284	-0.313	-0.28300000000000003	-0.28600000000000003	-0.289	-0.3
as605240	Not Clinically Relevant	-0.3	-0.322	-0.318	-0.307	-0.298	-0.293	-0.319	-0.317	-0.33399999999999996	-0.315	-0.301	-0.28800000000000003	-0.304	-0.29100000000000004	-0.29100000000000004	-0.305	-0.318	-0.314	-0.299	-0.332
kin001-244	Not Clinically Relevant	-0.3	-0.312	-0.319	-0.28600000000000003	-0.337	-0.276	-0.315	-0.28600000000000003	-0.335	-0.306	0.276	-0.303	-0.307	-0.293	0.27	0.295	-0.285	-0.32	-0.31	-0.332
pd318088	Not Clinically Relevant	-0.301	-0.312	-0.305	-0.259	-0.294	-0.294	-0.313	-0.293	-0.31	-0.298	-0.263	-0.304	-0.28	-0.292	-0.27	-0.287	-0.285	-0.289	-0.311	-0.32299999999999995
irinotecan	aka CPT-11, inhibitor of Topo I	-0.301	0.245	-0.258	0.273	-0.319	0.28300000000000003	0.24600000000000002	-0.29100000000000004	0.23600000000000002	0.284	0.263	0.254	0.258	0.243	-0.243	0.251	-0.29600000000000004	-0.257	0.22899999999999998	0.26
pf2341066	ALK, ROS1 and MET inhibitor	-0.301	0.27699999999999997	-0.251	0.285	-0.29	0.265	0.292	-0.294	0.29100000000000004	-0.311	0.265	0.301	-0.255	-0.297	-0.28600000000000003	-0.298	-0.294	-0.245	0.281	-0.281
way-362450	Not Clinically Relevant	-0.302	-0.287	-0.268	-0.28600000000000003	-0.305	-0.299	-0.324	-0.292	-0.301	-0.322	-0.259	-0.28800000000000003	-0.285	-0.284	-0.295	-0.306	-0.267	-0.266	-0.28300000000000003	-0.307
embelin	Not Clinically Relevant	-0.304	-0.342	-0.34700000000000003	-0.326	-0.309	-0.298	-0.35600000000000004	-0.295	-0.33899999999999997	-0.32799999999999996	-0.322	-0.311	-0.315	-0.32	-0.315	-0.335	-0.325	-0.35200000000000004	-0.315	-0.359
aa-cocf3	Not Clinically Relevant	-0.304	-0.284	-0.284	0.27	-0.314	-0.318	-0.308	-0.297	-0.299	-0.324	-0.251	-0.31	0.265	0.27899999999999997	-0.287	-0.285	-0.27899999999999997	-0.285	-0.299	-0.297
osu-03012	Not Clinically Relevant	-0.304	-0.28300000000000003	-0.307	-0.308	-0.306	-0.284	-0.311	-0.272	-0.307	-0.299	-0.27699999999999997	-0.29100000000000004	-0.318	-0.278	-0.3	-0.31	-0.29	-0.33399999999999996	-0.298	-0.331
erismodegib	Hedgehog (Smoothened) antagonist (LDE225)	-0.306	-0.317	-0.281	-0.275	-0.314	-0.304	-0.311	-0.287	-0.299	-0.327	-0.266	-0.318	-0.31	-0.287	-0.284	-0.319	-0.29100000000000004	-0.281	-0.314	-0.322
i-bet-762	Not Clinically Relevant	-0.306	0.29	-0.299	0.27699999999999997	-0.379	0.281	0.304	-0.345	-0.314	-0.276	0.304	0.309	-0.297	0.32	0.285	0.324	-0.3	-0.313	0.316	-0.324
fumonisin b1	Not Clinically Relevant	-0.306	-0.302	-0.261	-0.25	-0.281	0.26899999999999996	-0.29100000000000004	0.263	-0.29600000000000004	-0.28600000000000003	-0.29600000000000004	-0.298	-0.29100000000000004	-0.281	-0.29600000000000004	-0.29600000000000004	-0.267	-0.27899999999999997	-0.295	-0.306
pluripotin	Not Clinically Relevant	-0.306	-0.28	-0.278	0.278	-0.28300000000000003	0.282	-0.299	-0.26899999999999996	-0.292	-0.326	0.275	0.305	0.272	-0.273	-0.271	0.305	0.28300000000000003	0.267	0.301	-0.285
jq12	Not Clinically Relevant	-0.308	-0.314	-0.306	-0.303	-0.29	-0.281	-0.32299999999999995	-0.28800000000000003	-0.315	-0.301	-0.293	-0.301	-0.321	-0.27899999999999997	-0.28	-0.321	-0.29600000000000004	-0.326	-0.325	-0.34600000000000003
brd-k64610608	Not Clinically Relevant	-0.308	-0.31	-0.267	-0.313	-0.312	-0.28600000000000003	0.319	-0.276	-0.3	-0.32	-0.309	-0.325	-0.289	-0.308	-0.264	-0.29600000000000004	-0.284	-0.273	-0.306	-0.297
bleomycin	InducesDNAstrand breaks, inhibits incorporation ofthymidineinto DNA strands.	-0.31	-0.318	-0.35700000000000004	-0.348	-0.289	-0.316	-0.35700000000000004	-0.273	-0.35200000000000004	-0.345	-0.314	-0.34299999999999997	-0.292	-0.326	-0.29	-0.309	-0.33	-0.37	-0.324	-0.34700000000000003
brd-k50799972	Not Clinically Relevant	-0.311	-0.306	-0.298	-0.271	-0.309	-0.292	-0.313	-0.26	-0.342	-0.321	-0.28600000000000003	-0.318	-0.289	-0.305	-0.28	-0.304	-0.276	-0.307	-0.299	-0.331
brd-k27986637	Not Clinically Relevant	-0.311	-0.309	-0.273	-0.26899999999999996	-0.27699999999999997	-0.304	-0.28600000000000003	-0.271	-0.358	-0.311	-0.28800000000000003	-0.28	-0.252	-0.28300000000000003	-0.258	-0.303	-0.3	-0.284	-0.282	-0.297
istradefylline	adenosine A2A receptor antagonist, useful in the treatment of Parkinson's disease	-0.312	-0.32899999999999996	-0.29100000000000004	-0.325	-0.314	0.284	-0.31	-0.302	-0.322	-0.317	-0.27699999999999997	0.32799999999999996	-0.35	0.305	-0.321	-0.316	-0.308	-0.29	-0.327	-0.368
lbw242	Not Clinically Relevant	-0.315	0.292	0.32	0.316	-0.311	0.32299999999999995	0.312	-0.301	0.336	0.33299999999999996	0.309	-0.335	-0.32799999999999996	-0.32799999999999996	-0.312	0.325	-0.321	0.321	-0.302	0.318
gsk4112	Not Clinically Relevant	-0.316	-0.324	-0.298	-0.27	-0.327	-0.289	-0.314	-0.281	-0.304	-0.324	-0.292	-0.321	-0.312	-0.284	-0.285	-0.326	-0.29100000000000004	-0.3	-0.322	-0.32899999999999996
pictilisib	Pictilisib, potent inhibitor ofPI3K/, with modest selectivity against p110 (11-fold) and p110	-0.316	-0.307	-0.33399999999999996	-0.325	-0.32	-0.28	-0.337	-0.27899999999999997	-0.34	-0.312	-0.315	-0.31	-0.315	-0.297	-0.267	-0.321	-0.32299999999999995	-0.32299999999999995	-0.34299999999999997	-0.354
vaf-347	Not Clinically Relevant	-0.317	-0.305	-0.301	-0.293	-0.278	-0.295	-0.28600000000000003	-0.297	-0.301	-0.292	-0.266	-0.308	-0.29600000000000004	-0.264	-0.276	-0.28300000000000003	-0.317	-0.28300000000000003	-0.28300000000000003	-0.319
ic-87114	Not Clinically Relevant	-0.318	-0.34700000000000003	-0.348	-0.29100000000000004	-0.353	-0.35100000000000003	-0.342	-0.312	-0.33299999999999996	-0.359	0.297	-0.371	-0.31	-0.34299999999999997	-0.315	-0.368	-0.312	-0.32899999999999996	-0.325	-0.364
at13387	Selective potent Hsp90 inhibitor	-0.319	-0.289	-0.27	0.271	-0.285	-0.27699999999999997	-0.294	-0.295	-0.308	0.327	-0.28600000000000003	0.298	-0.305	-0.262	-0.307	-0.292	-0.265	-0.264	-0.303	-0.32
ml029	Not Clinically Relevant	-0.319	-0.312	0.287	0.293	-0.304	-0.315	-0.33	-0.294	-0.317	0.32899999999999996	-0.27399999999999997	0.337	0.27899999999999997	0.32899999999999996	-0.31	-0.309	-0.297	-0.276	0.33	0.34700000000000003
brd-k29086754	Not Clinically Relevant	-0.319	0.37200000000000005	0.364	0.33899999999999997	0.405	0.345	0.318	0.332	0.368	0.354	0.33799999999999997	0.32899999999999996	0.35100000000000003	0.35	0.345	0.34600000000000003	0.371	0.344	0.34299999999999997	-0.322
luminespib	Not Clinically Relevant	-0.32	-0.322	-0.32899999999999996	-0.32299999999999995	-0.303	-0.297	-0.353	-0.276	-0.34700000000000003	-0.34299999999999997	-0.315	-0.32899999999999996	-0.307	-0.307	-0.295	-0.32299999999999995	-0.331	-0.35100000000000003	-0.32899999999999996	-0.373
ponatinib	Bcr-ablinhibitor	-0.32	-0.342	-0.34	-0.33	-0.348	-0.298	-0.316	-0.32899999999999996	-0.32899999999999996	-0.335	-0.32299999999999995	-0.32299999999999995	-0.342	-0.293	-0.315	-0.312	-0.344	-0.36200000000000004	-0.34	-0.366
xmd8-92	Not Clinically Relevant	-0.321	-0.326	-0.322	-0.247	-0.312	-0.31	-0.33	-0.249	-0.33299999999999996	-0.317	-0.287	-0.31	-0.29	-0.292	-0.299	-0.308	-0.258	-0.361	-0.315	-0.35
zibotentan	Not Clinically Relevant	-0.321	-0.336	-0.364	-0.355	-0.315	-0.303	-0.37200000000000005	-0.331	-0.349	-0.321	-0.35200000000000004	-0.342	-0.29	-0.326	-0.29600000000000004	-0.324	-0.307	-0.34	-0.349	-0.363
azd6244	MEK1inhibitor	-0.321	-0.315	-0.28600000000000003	-0.265	-0.276	-0.282	-0.348	-0.307	-0.32799999999999996	-0.35100000000000003	-0.313	-0.324	-0.316	-0.297	-0.31	-0.282	-0.292	-0.268	-0.313	-0.302
ipr-456	Not Clinically Relevant	-0.322	-0.314	-0.306	-0.32899999999999996	-0.335	-0.33899999999999997	0.35200000000000004	-0.284	-0.355	-0.342	0.289	-0.33799999999999997	-0.285	-0.33	-0.31	-0.341	-0.301	-0.313	0.32299999999999995	-0.34
a-443654	Not Clinically Relevant	-0.322	-0.35100000000000003	-0.36	-0.305	-0.313	-0.298	-0.354	-0.292	-0.33299999999999996	-0.35600000000000004	-0.34700000000000003	-0.32899999999999996	-0.33299999999999996	-0.301	-0.31	-0.348	-0.326	-0.32299999999999995	-0.349	-0.381
cmk	Not Clinically Relevant	-0.324	-0.331	-0.32799999999999996	-0.297	-0.326	-0.29100000000000004	-0.33	-0.289	-0.358	-0.326	-0.308	-0.312	-0.316	-0.327	-0.294	-0.311	-0.368	-0.313	-0.319	-0.34700000000000003
palbociclib	CDK4/6 inhibitor	-0.325	-0.301	-0.335	-0.314	-0.314	-0.305	-0.34	-0.26899999999999996	-0.337	-0.344	-0.307	-0.309	-0.315	-0.315	-0.327	-0.344	-0.306	-0.342	-0.345	-0.36
cytarabine	antimetabolite, causes DNA damage,  inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis	-0.325	-0.313	-0.321	-0.316	-0.33299999999999996	-0.29	-0.335	-0.321	-0.34700000000000003	-0.336	-0.315	-0.295	-0.32	-0.313	-0.312	-0.33399999999999996	-0.327	-0.337	-0.332	-0.34299999999999997
jnk-9l	Not Clinically Relevant	-0.326	-0.33399999999999996	-0.361	-0.392	-0.337	-0.34	-0.373	-0.318	-0.37	-0.36	-0.36200000000000004	-0.349	-0.349	-0.348	-0.34299999999999997	-0.365	-0.34600000000000003	-0.375	-0.369	-0.413
brd-k09587429	Not Clinically Relevant	-0.327	-0.332	-0.322	-0.322	-0.331	-0.34	-0.34	-0.321	-0.348	-0.34600000000000003	-0.331	-0.33399999999999996	-0.348	-0.33299999999999996	-0.309	-0.345	-0.32899999999999996	-0.324	-0.337	-0.36
cct-018159	Not Clinically Relevant	-0.327	-0.319	-0.35	-0.32	-0.297	-0.276	-0.337	-0.28800000000000003	-0.336	-0.312	-0.313	-0.297	-0.31	-0.295	-0.301	-0.31	-0.315	-0.327	-0.342	-0.353
gsk269962a	Not Clinically Relevant	-0.32799999999999996	-0.337	-0.381	-0.33899999999999997	-0.313	-0.326	-0.34600000000000003	-0.312	-0.358	-0.348	-0.33	-0.348	-0.324	-0.321	-0.294	-0.359	-0.325	-0.38	-0.345	-0.374
imatinib	Bcr-abl,c-kitandPDGFRinhibitor	-0.32799999999999996	0.049	-0.31	0.312	-0.324	-0.29	0.045	-0.29600000000000004	0.047	-0.324	0.034	-0.324	-0.299	-0.294	-0.294	-0.316	-0.306	-0.303	-0.317	-0.322
s-trityl-l-cysteine	Not Clinically Relevant	-0.32899999999999996	-0.32299999999999995	-0.36	-0.27899999999999997	-0.353	-0.316	-0.35700000000000004	-0.315	-0.34299999999999997	-0.342	-0.322	-0.325	-0.32899999999999996	-0.3	-0.28600000000000003	-0.335	-0.308	-0.3	-0.33299999999999996	-0.36200000000000004
obatoclax mesylate	Not Clinically Relevant	-0.32899999999999996	-0.344	-0.34600000000000003	-0.34600000000000003	-0.35200000000000004	-0.29600000000000004	-0.38299999999999995	-0.305	-0.371	-0.33899999999999997	-0.32299999999999995	-0.33399999999999996	-0.331	-0.344	-0.325	-0.33799999999999997	-0.33899999999999997	-0.366	-0.34	-0.39799999999999996
midostaurin	Not Clinically Relevant	-0.331	-0.354	-0.361	-0.33299999999999996	-0.312	-0.33299999999999996	-0.39799999999999996	-0.313	-0.35200000000000004	-0.361	-0.32899999999999996	-0.344	-0.33799999999999997	-0.33799999999999997	-0.31	-0.373	-0.33899999999999997	-0.355	-0.36200000000000004	-0.386
tipifarnib	Not Clinically Relevant	-0.331	-0.353	-0.36	-0.354	-0.33299999999999996	-0.32299999999999995	-0.374	-0.32299999999999995	-0.355	-0.35	-0.337	-0.353	-0.342	-0.32899999999999996	-0.326	-0.35	-0.34600000000000003	-0.377	-0.35	-0.385
nilotinib	inhibits the kinasesBCR-ABL,[26]KIT,LCK,EPHA3,EPHA8,DDR1,DDR2,PDGFRB,MAPK11andZAK	-0.331	-0.295	-0.083	-0.293	-0.317	-0.294	-0.083	-0.307	-0.069	-0.32	-0.078	-0.075	-0.053	-0.29	-0.069	-0.306	-0.29100000000000004	-0.293	-0.067	-0.078
a-804598	Not Clinically Relevant	-0.33399999999999996	-0.29	-0.298	-0.273	-0.299	-0.306	-0.308	-0.293	-0.33299999999999996	-0.292	-0.29600000000000004	-0.293	-0.304	-0.254	-0.3	-0.29	-0.276	-0.29	-0.292	-0.316
pf-562271	Not Clinically Relevant	-0.336	-0.36	-0.365	-0.337	-0.33	-0.32799999999999996	-0.387	-0.322	-0.341	-0.341	-0.327	-0.321	-0.33399999999999996	-0.321	-0.324	-0.382	-0.331	-0.355	-0.358	-0.371
dactolisib	PI3K/mTOR inhibitor	-0.336	-0.32899999999999996	-0.34700000000000003	-0.326	-0.313	-0.325	-0.381	-0.276	-0.38	-0.35700000000000004	-0.327	-0.35	-0.309	-0.326	-0.292	-0.337	-0.322	-0.349	-0.33899999999999997	-0.371
bortezomib	proteasome inhibitor (Velcade)	-0.336	-0.344	-0.114	-0.079	-0.348	-0.324	-0.10099999999999999	-0.29	-0.105	-0.09300000000000001	-0.092	-0.359	-0.091	-0.32299999999999995	-0.292	-0.358	-0.10800000000000001	-0.10400000000000001	-0.09	-0.34600000000000003
sr8278	Not Clinically Relevant	-0.337	-0.272	-0.297	-0.213	-0.28300000000000003	-0.313	-0.281	-0.31	-0.261	-0.29	-0.265	0.23800000000000002	-0.33299999999999996	-0.243	-0.273	-0.341	-0.299	-0.268	-0.28600000000000003	-0.337
ql-viii-58	Not Clinically Relevant	-0.33799999999999997	-0.371	-0.361	-0.363	-0.35	-0.331	-0.385	-0.305	-0.38799999999999996	-0.355	-0.355	-0.36700000000000005	-0.361	-0.361	-0.313	-0.369	-0.355	-0.371	-0.384	-0.40299999999999997
pf-543	Not Clinically Relevant	-0.33799999999999997	-0.312	-0.311	-0.302	-0.32899999999999996	-0.32	-0.309	-0.322	-0.317	-0.332	-0.309	-0.324	-0.327	-0.331	-0.306	-0.316	-0.32	-0.318	-0.32299999999999995	-0.33
sgc0946	Not Clinically Relevant	-0.341	-0.331	-0.355	-0.37	-0.336	-0.32899999999999996	-0.37200000000000005	-0.322	-0.336	-0.34	-0.358	-0.366	-0.335	-0.341	-0.337	-0.354	-0.317	-0.345	-0.345	-0.33899999999999997
bleomycin (50 um)	Not Clinically Relevant	-0.342	-0.34700000000000003	-0.342	-0.321	-0.34299999999999997	-0.335	-0.401	0.32899999999999996	-0.366	-0.35600000000000004	-0.34700000000000003	-0.353	-0.33399999999999996	-0.32299999999999995	-0.312	-0.35700000000000004	-0.34	-0.35100000000000003	-0.359	-0.36700000000000005
brd-k52037352	Not Clinically Relevant	-0.342	-0.36200000000000004	-0.36200000000000004	-0.342	-0.353	-0.361	-0.38299999999999995	-0.354	-0.376	-0.386	-0.358	-0.35600000000000004	-0.33899999999999997	-0.373	-0.301	-0.371	-0.342	-0.33799999999999997	-0.374	-0.392
ibrutinib	BTK kinase inhibitor	-0.344	-0.34700000000000003	-0.33399999999999996	-0.32	-0.31	-0.34700000000000003	-0.355	-0.337	-0.36200000000000004	-0.33399999999999996	-0.35700000000000004	0.341	-0.321	-0.305	-0.33	-0.335	-0.34	-0.32799999999999996	-0.341	-0.344
brd-k33199242	Not Clinically Relevant	-0.344	-0.309	-0.301	-0.284	-0.363	-0.319	-0.324	-0.299	-0.32	-0.33299999999999996	-0.29600000000000004	-0.337	-0.311	-0.314	-0.293	-0.364	-0.325	-0.302	-0.32799999999999996	-0.331
(5z)-7-oxozeaenol	Not Clinically Relevant	-0.345	-0.365	-0.375	-0.36200000000000004	-0.33799999999999997	-0.33799999999999997	-0.376	-0.311	-0.386	-0.37200000000000005	-0.341	-0.35700000000000004	-0.348	-0.335	-0.32	-0.36700000000000005	-0.322	-0.35700000000000004	-0.38299999999999995	-0.39399999999999996
abiraterone	steroidal CYP17A1 inhibitorandandrogensynthesisinhibitor	-0.34600000000000003	-0.3	-0.315	-0.272	-0.359	-0.309	-0.336	-0.294	-0.33899999999999997	-0.26899999999999996	-0.32899999999999996	-0.266	-0.289	-0.22399999999999998	-0.311	-0.324	-0.308	-0.318	-0.318	-0.37200000000000005
rita	Not Clinically Relevant	-0.34700000000000003	0.35600000000000004	0.32	-0.331	-0.342	-0.354	0.353	-0.301	0.36200000000000004	-0.379	-0.321	0.349	-0.321	0.32899999999999996	-0.315	0.33899999999999997	-0.33799999999999997	-0.33299999999999996	0.34600000000000003	0.34600000000000003
cbb-1007	Not Clinically Relevant	-0.348	-0.335	-0.311	-0.318	-0.349	-0.298	-0.358	-0.32	-0.35100000000000003	-0.371	-0.32299999999999995	-0.33799999999999997	-0.319	-0.35200000000000004	-0.33399999999999996	-0.325	-0.322	-0.304	-0.368	-0.368
trametinib	MEK inhibitor (MEK1 and MEK2)	-0.349	-0.36200000000000004	-0.35700000000000004	-0.32	-0.336	-0.353	-0.379	-0.342	-0.33299999999999996	-0.349	-0.342	-0.355	-0.336	-0.34600000000000003	-0.354	-0.359	-0.33299999999999996	-0.324	-0.38	-0.37799999999999995
tgx221	Not Clinically Relevant	-0.349	-0.382	-0.38299999999999995	-0.344	-0.335	-0.405	-0.415	-0.324	-0.379	-0.38299999999999995	-0.342	-0.405	-0.32899999999999996	-0.395	-0.36700000000000005	-0.41600000000000004	-0.358	-0.375	-0.384	-0.384
tanespimycin	HSP90inhibitor	-0.349	-0.381	-0.38	-0.34600000000000003	-0.35600000000000004	-0.369	-0.395	-0.33799999999999997	-0.39	-0.35	-0.392	-0.353	-0.33	-0.38299999999999995	-0.366	-0.406	-0.36	-0.365	-0.386	-0.377
wh-4-023	Not Clinically Relevant	-0.35	-0.371	-0.37	-0.321	-0.35100000000000003	-0.35700000000000004	-0.42100000000000004	-0.321	-0.368	-0.363	-0.38	-0.375	-0.35200000000000004	-0.36700000000000005	-0.324	-0.40399999999999997	-0.35200000000000004	-0.35200000000000004	-0.38799999999999996	-0.38
pd0325901	Not Clinically Relevant	-0.35	-0.354	-0.363	-0.33299999999999996	-0.34299999999999997	-0.37200000000000005	-0.365	-0.314	-0.348	-0.349	-0.371	-0.35100000000000003	-0.34299999999999997	-0.337	-0.377	-0.389	-0.353	-0.35600000000000004	-0.385	-0.34700000000000003
procarbazine	alkylating agent	-0.35	-0.31	-0.314	-0.31	-0.325	-0.331	-0.348	-0.307	-0.344	-0.345	-0.316	-0.342	-0.31	-0.313	-0.308	-0.337	-0.304	-0.331	-0.32899999999999996	-0.345
xmd11-85h	Not Clinically Relevant	-0.35100000000000003	-0.38799999999999996	-0.37799999999999995	-0.337	-0.358	-0.35100000000000003	-0.391	-0.324	-0.39299999999999996	-0.363	-0.35100000000000003	-0.39	-0.355	-0.373	-0.32299999999999995	-0.36700000000000005	-0.34600000000000003	-0.37799999999999995	-0.387	-0.395
masitinib	tyrosine-kinase inhibitorused in the treatment ofmast cell tumorsin animals, specifically dogs	-0.35100000000000003	-0.096	-0.107	-0.092	-0.35	0.326	0.341	-0.318	-0.096	-0.092	0.324	0.35200000000000004	-0.09	0.092	0.314	0.09699999999999999	-0.32799999999999996	-0.114	-0.08800000000000001	-0.113
hg6-64-1	Not Clinically Relevant	-0.35200000000000004	-0.37799999999999995	-0.374	-0.38299999999999995	-0.35700000000000004	-0.34700000000000003	-0.371	-0.324	-0.36200000000000004	-0.37200000000000005	-0.344	-0.37200000000000005	-0.366	-0.34700000000000003	-0.32799999999999996	-0.354	-0.371	-0.385	-0.369	-0.39899999999999997
bicalutamide	antiandrogen, used to treat prostate cancer	-0.353	-0.39399999999999996	-0.41100000000000003	-0.36	-0.325	-0.359	-0.37799999999999995	-0.342	-0.374	-0.364	-0.395	-0.34600000000000003	-0.368	-0.34600000000000003	-0.34600000000000003	-0.363	-0.38799999999999996	-0.397	-0.413	-0.40299999999999997
etomoxir	agonist ofPPAR, inhibitor ofcarnitine palmitoyltransferase-1(CPT-1)	-0.355	-0.33899999999999997	-0.332	-0.33399999999999996	-0.35100000000000003	-0.33899999999999997	-0.35700000000000004	-0.327	-0.36700000000000005	-0.349	-0.313	-0.363	-0.33	-0.348	-0.337	-0.35700000000000004	-0.305	-0.327	-0.344	-0.369
veliparib	PARP inhibitor.	-0.355	-0.33299999999999996	-0.336	-0.34700000000000003	-0.34	-0.34	-0.361	-0.316	-0.33799999999999997	-0.348	-0.326	-0.08	-0.33799999999999997	-0.33799999999999997	-0.332	-0.358	-0.336	-0.32299999999999995	-0.36	-0.361
pd 153035	Not Clinically Relevant	-0.355	-0.33899999999999997	-0.348	0.35200000000000004	0.336	-0.341	-0.37799999999999995	-0.34600000000000003	-0.377	-0.34600000000000003	-0.34700000000000003	0.331	-0.322	-0.319	-0.326	0.342	-0.315	-0.336	-0.34700000000000003	-0.376
lenalidomide	derivativeofthalidomide, which interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma	-0.35700000000000004	-0.386	-0.39399999999999996	-0.35700000000000004	-0.408	-0.355	-0.39399999999999996	-0.414	-0.413	-0.386	-0.41700000000000004	-0.42200000000000004	-0.364	-0.371	-0.38	-0.385	-0.392	-0.373	-0.409	-0.41600000000000004
dasatinib	BCR-Abl,Src,c-Kit inhibitor	-0.35700000000000004	-0.364	-0.354	-0.313	-0.358	-0.353	-0.41	-0.331	-0.365	-0.359	-0.341	-0.364	-0.337	-0.35600000000000004	-0.316	-0.38799999999999996	-0.342	-0.34	-0.376	-0.377
brd9647	Not Clinically Relevant	-0.36	-0.312	-0.322	-0.335	-0.35200000000000004	-0.35100000000000003	-0.335	-0.341	-0.34700000000000003	-0.34600000000000003	-0.33399999999999996	-0.344	-0.337	-0.33	-0.33299999999999996	-0.35	-0.327	-0.34700000000000003	-0.317	-0.365
aica ribonucleotide	Not Clinically Relevant	-0.361	-0.37	-0.373	-0.32	-0.375	0.316	-0.35700000000000004	-0.365	-0.359	-0.317	-0.317	0.34600000000000003	-0.33	0.337	-0.284	0.336	-0.341	-0.36	-0.33299999999999996	-0.374
fh535	Not Clinically Relevant	-0.361	-0.373	-0.373	-0.38	-0.361	-0.365	-0.381	-0.322	-0.385	-0.374	-0.355	-0.381	-0.363	-0.363	-0.337	-0.386	-0.35	-0.391	-0.38299999999999995	-0.39899999999999997
as601245	Not Clinically Relevant	-0.361	-0.386	-0.381	-0.36700000000000005	-0.341	-0.342	-0.395	-0.324	-0.384	-0.359	-0.37200000000000005	-0.37	-0.35100000000000003	-0.34299999999999997	-0.355	-0.376	-0.364	-0.392	-0.365	-0.392
isonicotinohydroxamic acid	Not Clinically Relevant	-0.363	-0.327	-0.335	-0.374	-0.36200000000000004	-0.33399999999999996	-0.35600000000000004	-0.31	-0.35200000000000004	-0.35200000000000004	-0.358	-0.368	-0.342	-0.327	-0.306	-0.359	-0.315	-0.35700000000000004	-0.364	-0.369
kin001-270	Not Clinically Relevant	-0.363	0.40299999999999997	-0.408	0.349	-0.40700000000000003	0.342	0.41600000000000004	-0.36	-0.4	0.375	0.39899999999999997	0.366	-0.363	0.41700000000000004	0.379	0.386	0.365	-0.42100000000000004	0.414	-0.39
enzastaurin	Not Clinically Relevant	-0.363	-0.366	-0.37200000000000005	-0.353	-0.37	-0.324	-0.36200000000000004	-0.349	-0.38	-0.353	-0.344	-0.341	-0.341	-0.324	-0.304	-0.354	-0.35600000000000004	-0.38	-0.37200000000000005	-0.373
zebularine	Not Clinically Relevant	-0.365	-0.379	-0.371	-0.33399999999999996	-0.40299999999999997	-0.369	-0.389	-0.34299999999999997	-0.369	-0.382	-0.34299999999999997	-0.366	-0.349	-0.374	-0.348	-0.384	-0.371	-0.382	-0.38	-0.39799999999999996
akt inhibitor viii	Not Clinically Relevant	-0.36700000000000005	-0.38799999999999996	-0.376	-0.36	-0.37200000000000005	-0.33299999999999996	-0.38299999999999995	-0.359	-0.37	-0.36700000000000005	-0.342	-0.36	-0.358	-0.369	-0.306	-0.355	-0.385	-0.371	-0.374	-0.37799999999999995
lfm-a13	Not Clinically Relevant	-0.369	-0.369	-0.385	-0.387	-0.359	-0.35200000000000004	-0.436	-0.337	-0.375	-0.376	-0.37799999999999995	-0.376	-0.386	-0.381	-0.36	-0.39	-0.36700000000000005	-0.369	-0.402	-0.386
brd-k49290616	Not Clinically Relevant	-0.371	0.42	0.41	0.392	-0.39799999999999996	0.371	0.358	0.348	-0.424	0.405	-0.37	0.396	-0.375	0.37799999999999995	0.336	-0.40399999999999997	0.376	0.38299999999999995	-0.386	-0.413
bms-509744	Not Clinically Relevant	-0.37200000000000005	-0.387	-0.392	-0.374	-0.358	-0.374	-0.406	-0.305	-0.4	-0.408	-0.376	-0.41600000000000004	-0.37	-0.40399999999999997	-0.34	-0.41700000000000004	-0.389	-0.39899999999999997	-0.401	-0.419
salubrinal	Not Clinically Relevant	-0.37200000000000005	-0.35600000000000004	-0.336	-0.33899999999999997	-0.348	-0.322	-0.402	-0.365	-0.369	-0.384	-0.353	-0.35700000000000004	-0.37200000000000005	-0.322	-0.327	-0.369	-0.332	-0.348	-0.374	-0.41200000000000003
a-770041	Not Clinically Relevant	-0.373	-0.406	-0.397	-0.349	-0.39899999999999997	-0.366	-0.41700000000000004	-0.36700000000000005	-0.418	-0.391	-0.41	-0.409	-0.374	-0.363	-0.358	-0.439	-0.382	-0.39	-0.41	-0.391
eht-1864	Not Clinically Relevant	-0.373	-0.41	-0.415	-0.397	-0.371	-0.36	-0.439	-0.35200000000000004	-0.42	-0.385	-0.387	-0.433	-0.377	-0.41200000000000003	-0.373	-0.401	-0.381	-0.39899999999999997	-0.428	-0.397
nvp-bhg712	Not Clinically Relevant	-0.379	-0.37	-0.385	-0.373	-0.426	-0.306	-0.382	-0.419	-0.381	-0.37	-0.36200000000000004	-0.359	-0.397	-0.34	-0.326	-0.35700000000000004	-0.4	-0.423	-0.386	-0.387
sl0101	Not Clinically Relevant	-0.382	-0.395	-0.419	-0.41100000000000003	-0.386	-0.4	-0.46799999999999997	-0.37799999999999995	-0.43799999999999994	-0.396	-0.40399999999999997	-0.384	-0.396	-0.40700000000000003	-0.391	-0.41100000000000003	-0.374	-0.41	-0.43200000000000005	-0.40299999999999997
gefitinib	EGFR inhibitor (Iressa)	-0.384	-0.4	-0.39399999999999996	-0.40399999999999997	-0.14	-0.365	-0.40299999999999997	-0.37	-0.402	-0.382	-0.396	-0.384	-0.374	-0.363	-0.39	-0.389	-0.384	-0.386	-0.39799999999999996	-0.40700000000000003
selumetinib	MEK1inhibitor	-0.391	-0.42200000000000004	-0.406	-0.386	-0.396	-0.395	-0.413	-0.375	-0.40399999999999997	-0.386	-0.39	-0.419	-0.38	-0.38	-0.374	-0.418	-0.396	-0.397	-0.42200000000000004	-0.434
sb-431542	Not Clinically Relevant	-0.392	-0.375	-0.35600000000000004	-0.32799999999999996	-0.358	-0.363	-0.369	-0.365	-0.392	-0.36	-0.368	0.37799999999999995	-0.386	-0.353	-0.374	-0.371	0.341	-0.36200000000000004	-0.37200000000000005	-0.402
pf-4708671	Not Clinically Relevant	-0.392	-0.40399999999999997	-0.401	-0.40700000000000003	-0.387	-0.368	-0.41	-0.35700000000000004	-0.414	-0.358	-0.41100000000000003	-0.392	-0.381	-0.382	-0.365	-0.39899999999999997	-0.402	-0.395	-0.39899999999999997	-0.415
avagacestat	Not Clinically Relevant	-0.395	-0.418	-0.433	-0.39899999999999997	-0.409	-0.355	-0.433	-0.382	-0.41100000000000003	-0.408	-0.41700000000000004	-0.371	-0.374	-0.376	-0.391	-0.439	-0.396	-0.415	-0.424	-0.429
panobinostat	HDAC inhibitor	-0.397	-0.313	-0.335	0.253	-0.402	-0.28600000000000003	-0.281	-0.38	-0.304	-0.337	-0.316	-0.31	-0.335	-0.325	-0.325	-0.304	-0.369	-0.32	-0.293	-0.309
refametinib	Not Clinically Relevant	-0.39899999999999997	-0.392	-0.39299999999999996	-0.349	-0.382	-0.385	-0.41	-0.355	-0.385	-0.376	-0.39899999999999997	-0.39399999999999996	-0.377	-0.37799999999999995	-0.401	-0.43799999999999994	-0.35700000000000004	-0.369	-0.424	-0.413
cct007093	Not Clinically Relevant	-0.4	-0.426	-0.418	-0.401	-0.42100000000000004	-0.37799999999999995	-0.431	-0.384	-0.452	-0.397	-0.44299999999999995	-0.40399999999999997	-0.409	-0.387	-0.41200000000000003	-0.441	-0.41600000000000004	-0.439	-0.447	-0.425
selisistat	SIRT1 inhibitor	-0.401	-0.40399999999999997	-0.43799999999999994	-0.402	-0.42100000000000004	-0.424	-0.42	-0.385	-0.434	-0.41100000000000003	-0.41100000000000003	-0.425	-0.391	-0.401	-0.4	-0.446	-0.39399999999999996	-0.42	-0.41600000000000004	-0.42
birinapant	SMAC mimetic, mostly to cIAP1, less potent against XIAP.	-0.401	-0.377	-0.342	-0.35200000000000004	-0.418	-0.379	-0.38299999999999995	-0.364	-0.376	-0.37	-0.34299999999999997	-0.40299999999999997	-0.379	-0.375	-0.373	-0.389	-0.37	-0.361	-0.392	-0.39399999999999996
o-6-benzylguanine	guanine analog, binds the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) resulting in inhibition of AGT-mediated DNA repair	-0.402	-0.408	-0.41	-0.395	-0.41200000000000003	0.406	-0.406	-0.391	-0.396	-0.445	0.364	-0.424	0.387	-0.405	-0.381	-0.402	-0.368	-0.39799999999999996	-0.40299999999999997	-0.444
xmd15-27	Not Clinically Relevant	-0.40299999999999997	-0.41100000000000003	-0.425	-0.414	-0.428	0.402	-0.431	-0.397	-0.433	-0.42100000000000004	-0.39299999999999996	-0.406	-0.406	-0.39899999999999997	-0.374	0.42700000000000005	-0.41200000000000003	-0.434	-0.441	-0.433
gsk1904529a	Not Clinically Relevant	-0.40299999999999997	-0.409	-0.397	-0.40700000000000003	-0.39399999999999996	-0.41200000000000003	-0.46	-0.387	-0.426	-0.41200000000000003	-0.461	-0.41600000000000004	-0.409	-0.414	-0.384	-0.4	-0.41	-0.426	-0.442	-0.426
xmd8-85	Not Clinically Relevant	-0.40399999999999997	-0.413	-0.429	-0.4	-0.401	-0.36700000000000005	-0.426	-0.353	-0.449	-0.43	-0.391	-0.39899999999999997	-0.395	-0.39299999999999996	-0.369	-0.42200000000000004	-0.376	-0.414	-0.41200000000000003	-0.47200000000000003
tivozanib	VEGFR inhibitor	-0.405	-0.098	-0.109	-0.107	-0.406	-0.086	-0.10800000000000001	-0.134	-0.109	-0.096	-0.099	-0.08900000000000001	-0.127	-0.113	-0.1	-0.419	-0.106	-0.1	-0.11199999999999999	-0.115
pha-665752	Not Clinically Relevant	-0.408	-0.41200000000000003	-0.446	-0.414	-0.426	-0.42200000000000004	-0.47	-0.385	-0.434	-0.47100000000000003	-0.42	-0.45399999999999996	-0.428	-0.44299999999999995	-0.397	-0.44	-0.45	-0.41700000000000004	-0.44799999999999995	-0.43
fr-180204	Not Clinically Relevant	-0.409	-0.433	-0.456	-0.391	-0.424	-0.37799999999999995	-0.434	-0.445	-0.444	-0.39799999999999996	-0.44	-0.4	-0.42	-0.385	-0.348	-0.389	-0.423	-0.434	-0.46	-0.433
cgp-082996	Not Clinically Relevant	-0.413	-0.42700000000000005	-0.43700000000000006	-0.396	-0.419	-0.426	-0.455	-0.382	-0.44799999999999995	-0.44299999999999995	-0.449	-0.439	-0.436	-0.41600000000000004	-0.415	-0.44299999999999995	-0.431	-0.444	-0.455	-0.455
jw-7-52-1	Not Clinically Relevant	-0.418	-0.442	-0.44299999999999995	-0.4	-0.434	-0.389	-0.462	-0.39299999999999996	-0.43700000000000006	-0.452	-0.434	-0.41700000000000004	-0.435	-0.406	-0.386	-0.444	-0.449	-0.43799999999999994	-0.43200000000000005	-0.48100000000000004
kin001-236	Not Clinically Relevant	-0.418	-0.43799999999999994	-0.43700000000000006	-0.406	-0.43799999999999994	0.38799999999999996	-0.44299999999999995	-0.441	-0.435	-0.42	0.42700000000000005	-0.4	-0.405	-0.43	0.377	0.39	-0.426	-0.418	-0.45399999999999996	-0.43799999999999994
doramapimod	Not Clinically Relevant	-0.419	-0.39899999999999997	-0.444	-0.409	-0.42	-0.423	-0.45299999999999996	-0.408	-0.40700000000000003	-0.4	-0.431	-0.419	-0.397	-0.401	-0.405	-0.406	-0.414	-0.43	-0.433	-0.414
fmk	Not Clinically Relevant	-0.42100000000000004	-0.41100000000000003	-0.41200000000000003	-0.433	-0.41100000000000003	-0.433	-0.42700000000000005	-0.425	-0.445	-0.455	-0.391	-0.419	-0.41700000000000004	-0.418	-0.375	-0.425	-0.413	-0.42700000000000005	-0.43700000000000006	-0.431
stf-62247	Not Clinically Relevant	-0.424	-0.38799999999999996	-0.406	-0.40299999999999997	-0.43799999999999994	-0.395	-0.41	-0.44299999999999995	-0.42100000000000004	-0.40700000000000003	-0.41	-0.39799999999999996	-0.41	-0.4	-0.39299999999999996	-0.392	-0.39299999999999996	-0.414	-0.424	-0.42700000000000005
afatinib	EGFR and ErbB2 inhibitor	-0.426	-0.44799999999999995	-0.45	-0.43799999999999994	-0.419	-0.428	-0.45399999999999996	-0.42	-0.45799999999999996	-0.43	-0.466	-0.43799999999999994	-0.43700000000000006	-0.428	-0.444	-0.442	-0.44299999999999995	-0.447	-0.466	-0.44799999999999995
nu7441	Not Clinically Relevant	-0.42700000000000005	-0.424	-0.45799999999999996	-0.428	-0.428	-0.402	-0.48	-0.40700000000000003	-0.456	-0.424	-0.42200000000000004	-0.425	-0.414	-0.44	-0.41700000000000004	-0.449	-0.405	-0.442	-0.457	-0.46299999999999997
tak-715	Not Clinically Relevant	-0.428	-0.457	-0.475	-0.451	-0.485	-0.449	-0.47	-0.466	-0.469	-0.45399999999999996	-0.456	-0.435	-0.44299999999999995	-0.43200000000000005	-0.39299999999999996	-0.45399999999999996	-0.429	-0.46799999999999997	-0.479	-0.493
fti-277	Not Clinically Relevant	-0.428	-0.423	-0.433	-0.42100000000000004	-0.396	-0.39899999999999997	-0.442	-0.415	-0.424	-0.40299999999999997	-0.456	-0.408	-0.428	-0.384	-0.42200000000000004	-0.435	-0.441	-0.435	-0.451	-0.434
jnk inhibitor viii	Not Clinically Relevant	-0.43200000000000005	-0.44299999999999995	-0.455	-0.41200000000000003	-0.447	-0.429	-0.45799999999999996	0.418	-0.431	-0.40299999999999997	-0.43700000000000006	-0.42100000000000004	-0.40700000000000003	-0.426	-0.415	-0.462	-0.444	-0.44799999999999995	-0.455	-0.436
plx-4720	Not Clinically Relevant	-0.442	-0.41600000000000004	-0.073	-0.087	-0.42200000000000004	-0.076	-0.068	-0.040999999999999995	-0.055	-0.444	-0.052000000000000005	-0.451	-0.429	-0.431	-0.047	-0.433	-0.052000000000000005	-0.067	-0.449	-0.435
cgp-60474	Not Clinically Relevant	-0.445	-0.42200000000000004	-0.439	-0.40399999999999997	-0.428	-0.406	-0.44799999999999995	-0.39399999999999996	-0.447	-0.445	-0.42700000000000005	-0.436	-0.444	-0.405	-0.39	-0.431	-0.42200000000000004	-0.425	-0.43799999999999994	-0.449
bix02189	Not Clinically Relevant	-0.446	-0.483	-0.46299999999999997	-0.434	-0.462	-0.40299999999999997	-0.435	-0.43799999999999994	-0.466	-0.439	-0.436	-0.447	-0.455	-0.428	-0.375	-0.446	-0.452	-0.47200000000000003	-0.47700000000000004	-0.45799999999999996
ci-1040	Not Clinically Relevant	-0.44799999999999995	-0.43700000000000006	-0.436	-0.405	-0.4	-0.42100000000000004	-0.44299999999999995	-0.405	-0.43200000000000005	-0.435	-0.428	-0.42100000000000004	-0.424	-0.409	-0.425	-0.45899999999999996	-0.423	-0.435	-0.465	-0.466
bryostatin 1	Not Clinically Relevant	-0.452	-0.479	-0.48	-0.451	-0.45	-0.413	-0.517	-0.447	-0.486	-0.455	-0.48200000000000004	-0.46399999999999997	-0.46399999999999997	-0.46399999999999997	-0.42700000000000005	-0.455	-0.47100000000000003	-0.503	-0.504	-0.505
iox2	Not Clinically Relevant	-0.45299999999999996	-0.43200000000000005	-0.456	-0.439	-0.47100000000000003	-0.408	-0.46299999999999997	-0.514	-0.52	-0.429	-0.47600000000000003	-0.45899999999999996	-0.479	-0.45	-0.409	-0.507	-0.49700000000000005	-0.45799999999999996	-0.46299999999999997	-0.423
tozasertib	VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C	-0.45899999999999996	-0.45399999999999996	-0.483	-0.45	-0.445	-0.442	-0.494	-0.434	-0.488	-0.485	-0.43	-0.483	-0.479	-0.435	-0.40299999999999997	-0.475	-0.445	-0.456	-0.47200000000000003	-0.494
ro-3306	Not Clinically Relevant	-0.462	-0.469	-0.513	-0.436	-0.479	-0.434	-0.498	-0.426	-0.49200000000000005	-0.445	-0.465	-0.456	-0.446	-0.479	-0.45399999999999996	-0.45799999999999996	-0.467	-0.48200000000000004	-0.5	-0.49700000000000005
vismodegib	Hedgehog (Smoothened) antagonist (GDC-0449)	-0.46399999999999997	-0.461	-0.467	-0.456	-0.457	-0.42200000000000004	-0.491	-0.439	-0.48700000000000004	-0.45799999999999996	-0.457	-0.445	-0.461	-0.447	-0.442	-0.465	-0.442	-0.451	-0.5	-0.479
sb216763	Not Clinically Relevant	-0.46399999999999997	-0.48700000000000004	-0.5	-0.473	-0.435	-0.47700000000000004	-0.529	-0.418	-0.479	-0.47600000000000003	-0.45799999999999996	-0.46299999999999997	-0.447	-0.46	-0.45299999999999996	-0.494	-0.439	-0.475	-0.509	-0.496
z-llnle-cho	Not Clinically Relevant	-0.467	-0.466	-0.48100000000000004	-0.41100000000000003	-0.44	-0.41100000000000003	-0.47200000000000003	-0.42200000000000004	-0.456	-0.46	-0.449	-0.439	-0.44799999999999995	-0.43200000000000005	-0.41100000000000003	-0.449	-0.466	-0.457	-0.47200000000000003	-0.49700000000000005
whi-p97	Not Clinically Relevant	-0.469	-0.446	-0.455	-0.445	-0.428	-0.423	-0.46799999999999997	-0.42700000000000005	-0.439	-0.41600000000000004	-0.457	-0.439	-0.452	-0.42	-0.42200000000000004	-0.457	-0.445	-0.429	-0.47	-0.48
xav939	Not Clinically Relevant	-0.47200000000000003	-0.44799999999999995	-0.48100000000000004	-0.466	-0.49	-0.41600000000000004	-0.5	-0.44799999999999995	-0.46299999999999997	-0.44	-0.491	-0.457	-0.45299999999999996	-0.42200000000000004	-0.406	-0.47	-0.452	-0.498	-0.502	-0.489
cp724714	Not Clinically Relevant	-0.48100000000000004	-0.498	-0.47600000000000003	-0.49200000000000005	-0.483	-0.425	-0.57	-0.469	-0.466	-0.451	-0.483	-0.456	-0.502	-0.479	-0.489	-0.469	-0.479	-0.478	-0.528	-0.475
rapamycin	rapamycin, mTOR inhibitor	-0.486	-0.503	-0.48700000000000004	-0.46	-0.469	-0.45299999999999996	-0.524	-0.441	-0.496	-0.504	-0.48	-0.503	-0.49200000000000005	-0.469	-0.447	-0.501	-0.48	-0.49	-0.528	-0.537
681640	Not Clinically Relevant	-0.495	-0.494	-0.5329999999999999	-0.518	-0.467	-0.499	-0.562	-0.47	-0.506	-0.495	-0.488	-0.5	-0.496	-0.506	-0.48	-0.49200000000000005	-0.483	-0.485	-0.562	-0.526
qs11	Not Clinically Relevant	-0.505	-0.544	-0.5479999999999999	-0.517	-0.5	-0.495	-0.54	-0.46	-0.5589999999999999	-0.531	-0.524	-0.546	-0.516	-0.52	-0.496	-0.545	-0.513	-0.5529999999999999	-0.5429999999999999	-0.536
pelitinib	Not Clinically Relevant	-0.512	-0.516	-0.524	-0.519	-0.498	-0.485	-0.494	-0.506	-0.519	-0.526	-0.49700000000000005	-0.494	-0.506	-0.49200000000000005	-0.47200000000000003	-0.493	-0.518	-0.502	-0.535	-0.5489999999999999
kin001-260	Not Clinically Relevant	-0.528	-0.539	-0.583	-0.56	-0.557	0.514	0.525	-0.551	-0.536	-0.528	0.506	-0.513	-0.514	0.473	0.502	0.5429999999999999	-0.557	-0.557	-0.537	-0.541
az628	Not Clinically Relevant	-0.529	-0.535	-0.5670000000000001	-0.47	-0.506	-0.52	-0.565	-0.507	-0.565	-0.5660000000000001	-0.547	-0.54	-0.532	-0.508	-0.534	-0.5589999999999999	-0.5429999999999999	-0.551	-0.575	-0.589
idelalisib	Idelalisib,  PI3K/p110 inhibitor	-0.537	-0.591	-0.5379999999999999	-0.5479999999999999	-0.569	-0.5	-0.526	-0.569	-0.5660000000000001	-0.547	-0.53	-0.488	-0.55	-0.51	-0.519	-0.532	-0.5379999999999999	-0.568	-0.5579999999999999	-0.574
ruxolitinib	JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera	-0.54	-0.174	-0.517	-0.466	-0.16	0.514	-0.55	-0.52	-0.542	-0.166	-0.192	-0.174	-0.19399999999999998	-0.165	0.161	0.203	-0.486	-0.45799999999999996	-0.205	-0.5
y-39983	Not Clinically Relevant	-0.542	-0.5870000000000001	-0.586	-0.565	-0.536	0.532	0.5489999999999999	-0.523	-0.5579999999999999	-0.574	0.564	0.516	-0.564	0.547	0.541	0.561	-0.562	-0.5820000000000001	-0.588	-0.59
ql-xi-92	Not Clinically Relevant	-0.5579999999999999	-0.5479999999999999	-0.581	-0.518	-0.586	0.545	0.5820000000000001	-0.557	-0.5589999999999999	-0.604	0.569	0.5479999999999999	-0.5870000000000001	0.568	0.568	0.573	-0.562	-0.561	0.578	-0.565
nutlin-3a (-)	Not Clinically Relevant	-0.563	-0.5720000000000001	-0.629	-0.564	-0.55	-0.529	-0.604	-0.5429999999999999	-0.623	-0.5710000000000001	-0.56	-0.595	-0.5660000000000001	-0.56	-0.521	-0.594	-0.55	-0.626	-0.625	-0.625
rtrail	Not Clinically Relevant	-0.574	-0.545	-0.54	-0.516	-0.526	-0.501	-0.536	-0.544	-0.555	-0.496	-0.5589999999999999	-0.5489999999999999	-0.528	-0.5329999999999999	-0.496	-0.568	-0.5710000000000001	-0.54	-0.5479999999999999	-0.564
wz-1-84	Not Clinically Relevant	-0.5760000000000001	-0.593	-0.585	-0.512	-0.547	-0.578	-0.611	-0.547	-0.594	-0.573	-0.5820000000000001	-0.563	-0.584	-0.585	-0.5429999999999999	-0.626	-0.5589999999999999	-0.556	-0.623	-0.591
t0901317	Not Clinically Relevant	-0.5760000000000001	-0.5539999999999999	-0.569	-0.389	-0.622	-0.489	-0.514	-0.5329999999999999	-0.51	-0.499	-0.579	-0.551	-0.5820000000000001	-0.478	-0.521	-0.552	-0.529	-0.5820000000000001	-0.5760000000000001	-0.537
cyclopamine	Not Clinically Relevant	-0.5770000000000001	-0.61	-0.603	-0.557	-0.5720000000000001	-0.589	-0.615	-0.54	-0.617	-0.633	-0.562	-0.585	-0.589	-0.584	-0.5529999999999999	-0.586	-0.5660000000000001	-0.593	-0.601	-0.631
pd173074	Not Clinically Relevant	-0.5770000000000001	-0.563	-0.64	-0.618	-0.59	-0.521	-0.609	-0.583	-0.5770000000000001	-0.606	-0.586	-0.5379999999999999	-0.5720000000000001	-0.522	-0.529	-0.569	-0.598	-0.598	-0.619	-0.598
gnf-2	Not Clinically Relevant	-0.578	-0.541	-0.52	-0.5379999999999999	-0.544	-0.536	-0.5579999999999999	-0.537	-0.557	-0.5770000000000001	-0.518	-0.59	-0.5429999999999999	-0.545	-0.519	-0.56	-0.546	-0.519	-0.616	-0.5760000000000001
cetuximab	Not Clinically Relevant	-0.578	-0.573	-0.58	-0.52	-0.5589999999999999	-0.496	-0.629	-0.575	-0.53	-0.496	-0.5870000000000001	-0.5720000000000001	-0.525	-0.546	-0.58	-0.584	-0.615	-0.5379999999999999	-0.642	-0.5720000000000001
vx-11e	Not Clinically Relevant	-0.604	-0.624	-0.586	-0.583	-0.606	-0.5589999999999999	-0.5760000000000001	-0.613	-0.5720000000000001	-0.584	-0.586	-0.593	-0.599	-0.59	-0.5920000000000001	-0.57	-0.579	-0.625	-0.59	-0.612
gw441756	Not Clinically Relevant	-0.615	-0.637	-0.65	-0.639	-0.61	-0.568	-0.654	-0.591	-0.6459999999999999	-0.5429999999999999	-0.617	-0.6	-0.597	-0.621	-0.551	-0.622	-0.57	-0.628	-0.6779999999999999	-0.659
vnlg/124	Not Clinically Relevant	-0.636	-0.65	-0.608	-0.625	-0.6579999999999999	-0.63	-0.7140000000000001	-0.6679999999999999	-0.62	-0.6579999999999999	-0.684	-0.685	-0.626	-0.591	-0.583	-0.628	-0.601	-0.6890000000000001	-0.691	-0.629
motesanib	Not Clinically Relevant	-0.639	-0.513	-0.539	-0.441	-0.584	-0.5329999999999999	-0.56	-0.6459999999999999	-0.511	-0.5589999999999999	-0.547	-0.47600000000000003	-0.53	-0.529	-0.503	-0.522	-0.579	-0.54	-0.5710000000000001	-0.544
alectinib	ALK inhibitor, used to treat non-small-cell lung cancer (NSCLC)	-0.722	0.715	0.698	-0.6859999999999999	-0.7040000000000001	0.7190000000000001	0.732	-0.71	0.6859999999999999	-0.7090000000000001	0.7190000000000001	0.703	-0.696	0.684	0.7	0.738	-0.675	-0.701	0.742	-0.713
